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Abstract
Cytosolic Ca2+ elevated by receptor-operated (ROCE) or store operated Ca2+ en-
try (SOCE) and buffered by mitochondrial Ca2+ uptake plays an essential role in
physiological processes of lung cells. Disturbed Ca2+ homeostasis in precapillary
pulmonary arterial smooth muscle cells (PPASMC) induces pulmonary arterial hy-
pertension (PAH) or disrupts barrier function of murine pulmonary microvascular
endothelial cells (MPMVEC) resulting in vascular leakage and lung edema.
While SOCE is mediated by stromal interaction molecule (STIM1 and 2) dimers sens-
ing Ca2+ in Ca2+ stores and plasma membrane Orai channels, ROCE is mediated by
classical transient receptor potential (TRPC) channels via diacylglycerol (DAG) and
receptor-activated phospholipase C (PLC). To investigate if TRPCs are also involved
in SOCE, Ca2+ entry was analyzed in PPASMCs isolated from
STIM1/2flox/flox/TRPC1/3/6-/- mice as well as control mice and infected with Cre-
recombinase expressing lentiviruses to delete STIM1/2 protein expression. Deficiency
of STIM1/2 did only impair the long-lasting receptor-operated Ca2+ entry (ROCE),
but TRPC1, TRPC3 and TRPC6 channels may be activated indirectly by store-
operated Ca2+ entry (SOCE).
Lack of STIM1/2 or Orai1 in MPMVECs did not impair acetylcholine-induced va-
sodilatation of isolated aortic rings but pulmonary microvascular endothelial cells
(MPMVECS) isolated from endothelial cell-specific STIM1/2 or Orai1 knockout mice
(STIM1/2∆EC and Orai1∆EC) were protected from Ca2+-dependent nuclear factor of
activated T-cells c3 (NFATc3) nuclear translocation which is involved in expression
of proinflammatory mediators highlighting their important role in inflammation pro-
cesses. Migration and proliferation of MPMVECs was reduced in STIM1/2∆EC and
Orai1∆EC.
Disturbed mitochondrial Ca2+ uptake results in endothelial dysfunction and may af-
fect energy production. The influence of mitochondrial Ca2+ uniporter (MCU) and
mitochondrial Ca2+ uniporter regulator 1 (MCUR1) on mitochondrial bioenerget-
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ics was investigated in MPMVECs from respective endothelial cell-specific knockout
mice. Mitochondrial membrane potential and oxygen consumption rate was not im-
paired in MCUR1∆EC or MCU∆EC. ATP production was reduced in MCUR1∆EC
and MCU∆EC. Probably resulting from reduced ATP levels, uncoupling protein2
(UCP2) was upregulated in MCUR1∆EC. The upregulated UCP2 might flux pro-
tons to prevent mitochondrial membrane potential (∆Ψm) hyperpolarization, induce
a metabolic shift from oxidative phosphorylation to glycolysis or stimulate compen-
satory mechanisms to rescue [Ca2+]m-uptake. In accordance with lower superoxide
production in MCUR1∆EC and MCU∆EC, we observed a reduced proliferation and
migration in these cells. Low mitochondrial Ca2+ uptake and low cellular ATP levels
in MCUR1∆EC and MCU∆EC activated AMPK and turned on autophagy. There-
fore, cytosolic and mitochondrial Ca2+ handling is of foremost importance for lung
cell function and proteins involved in these processes may serve as pharmacological
targets for therapeutic approaches in patients with pulmonary hypertension or lung
edema.
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Zusammenfassung
Ca2+ gelangt durch einen Rezeptor-operierten (receptor-operated Ca2+ entry (ROCE))
oder Speicher-operierten Einstrom (store-operated Ca2+ entry (SOCE)) ins Zytosol
und wird dort durch die mitochondriale Ca2+ Aufnahme abgepuffert. Gestörte Ca2+
Homöostase in prekapillären, pulmonalen, arteriellen glatten Muskelzellen (PPASMC)
kann pulmonale arterielle Hypertonie (PAH) induzieren oder die Barrierefunktion
muriner, pulmonaler, mikrovaskulärer Endothelzellen (MPMVEC) vermindern und
die Bildung eines Lungenödems induzieren.
Während der Speicher-operierte Ca2+ Einstrom durch stromal interaction molecules
(STIM1 und 2) als Sensoren in den Ca2+ Speichern und plasmamembranären Orai-
Kanälen bewältigt wird, kann der Rezeptor-operierte Ca2+ Einstrom (receptor-operated
Ca2+ entry (ROCE)) durch classical transient receptor potential (TRPC) Kanäle über
Diacylglycerol (DAG) durch Rezeptor-aktivierte Phospholipasen C (PLC) erfolgen.
Um zu analysieren ob TRPCs am SOCE beteiligt sind, haben wir den Ca2+ Ein-
strom in TRPC1/3/6-/- und STIM1/2-defizienten Zellen, die durch Infektion von
STIM1/2flox/flox Zellen mit Cre Rekombinase exprimierenden Lentiviren erzeugt wird,
untersucht. Die Abwesenheit von STIM1/2 Protein hatte nur einen Einfluss auf den
lang-anhaltenden Rezeptor-operierten Ca2+ Einstrom, aber TRPC1-, TRPC3- und
TRPC6-Kanäle könnten durch den Speicher-operierten Ca2+ Einstrom indirekt ak-
tiviert werden.
Eine Acetylcholin-induzierte Vasodilatation in isolierten Aortenringen aus endothelzell-
spezifischen STIM1/2 und Orai1 defizienten Mäusen (STIM1/2∆EC and Orai1∆EC)
war im Vergleich zu Kontroll-Aortenringen unverändert. Jedoch zeigten MPMVECs
aus diesen Mäusen eine verringerte Translokation von nuclear factor of activated T-
cells c3 (NFATc3) in den Zellkern, die für eine Expression von proinflammatorischen
Mediatoren wichtig ist. Die Migration und Proliferation von MPMVECs war in
STIM1/2∆EC and Orai1∆EC verringert.
Eine gestörte mitochondriale Ca2+ Aufnahme resultiert in einer endothelialen Dys-
funktion und könnte die Energieproduktion beeinträchtigen. Deshalb wurde der Ein-
fluss des mitochondrialen Ca2+ Uniporters (MCU) und des mitochondrialen Ca2+
Uniporter Regulators1 (MCUR1) auf die mitochondriale Energieproduktion in MP-
MVECs aus endothelzell-spezifischen MCU- und MCUR1-defizienten Mäusen
(MCUR1∆EC und MCU∆EC) untersucht. Das mitochondriale Membranpotential und
die Sauerstoff Verbrauchsrate war in MCUR1∆EC or MCU∆EC nicht beeinträchtigt,
aber die ATP Produktion war vermindert. Wahrscheinlich resultierte aus der vermin-
derten ATP Produktion die vermehrte Produktion des Entkopplungproteins UCP2 in
MCUR1∆EC. Die Hochregulation von UCP2 könnte einen Protonentransport in die
mitochondriale Matrix ermöglichen und damit eine Hyperpolarisation des mitochon-
drialen Membranpotentials der der inneren mitochondrialen Membran verhindern.
Alternativ könnte die vermehrte UCP2-Expression zu metabolischen Veränderungen
führen oder kompensatorische Mechanismen zur mitochondrialen Ca2+-Aufnahme
stimulieren. Niedrige Superoxid Level in MCUR1∆EC or MCU∆EC bedingten eine
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verringerte Proliferation und Migration. Außerdem aktivierte die niedrige mitochon-
driale Ca2+ und die niedrigen ATP Spiegel in MCUR1∆EC or MCU∆EC die AMPK
und Autophagie. Aus diesem Grund kommt der zytosolischen und mitochondrialen
Aufnahme von Ca2+ Ionen eine elementare Rolle für die Funktion von pulmonalen
glatten Muskelzellen und Endothelzellen zu. In Zukunft könnten an diesen Prozessen
beteiligte Proteine als pharmakologische Zielsubstanzen zur Entwicklung von Medika-
menten gegen pulmonale Hypertonie und Lungenödemen dienen.
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Chapter 1
Introduction
1.1 Ca2+ as a cellular effector molecule
Intracellular Ca2+ regulates various cell functions. It is involved in exocytosis, cell
growth, proliferation, apoptosis, contraction of muscle cells and energy homoeostasis.
Ca2+ either originates from the extracellular space or from the intracellular pools,
most importantly from the endoplasmatic reticulum (ER) and the mitochondria. The
extracellular space contains approximately 1mM calcium, the cytosol 100-200 nM
and the internal stores up to 100µM calcium. The Ca2+ concentration of the internal
stores can vary tremendously during cell function. In particular, mitochondria are
able to buffer high cytosolic Ca2+ levels [106].
Ca2+ influx into the cell is regulated by various Ca2+ channels. The type of Ca2+
channel mainly expressed depends on the cell type. In excitable cells, such as muscle
and nerve cells, voltage-dependent Ca2+ channels and receptor operated Ca2+ (ROC)
channels dominate but also store-operated Ca2+ (SOC) channels are expressed. In
none-excitable cells, such as endothelial cells, the most important Ca2+ entry pathway
is via SOC channels (see figure 1.1) [102] [94].
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1.2 Ca2+ influx pathways
1.2.1 The store-operated Ca2+ influx pathway
Store-operated Ca2+ entry (SOCE) was first proposed by Putney et al. in 1986 who
investigated the Ca2+ entry of parotid acinar cells depending on the Ca2+ release
from internal stores [103]. His concept was further evidenced by Hoth and Penner in
1992 providing a store activated Ca2+ current in mast cells which they called Ca2+
release-activated Ca2+ current (CRAC) current [56]. ICRAC is non-voltage activated,
inwardly rectifying, selective for Ca2+ and has a low conductance[95].
The stromal interaction molecule (STIM) is an ER transmembrane protein that was
finally identified in an RNAi screen in S2 cells in Drosophila melanogaster [107] and
in HeLa cells in 2005 [74]- long after Putney had suggested the ER-plasma mem-
brane coupling model. Both STIM isoforms, STIM1 and STIM2 are ubiquitously
expressed. STIM1 expression is higher in most cell types and is assumed to be the
main operator in SOCE. STIM2 is more sensitive to sense luminal ER Ca2+ and is
therefore discussed to prevent uncontrolled activation of SOCE. STIM proteins have
an N-terminal EF-hand domain which binds Ca2+. Upon depletion of the ER Ca2+
store, Ca2+ dissociates from the EF-hand which triggers the translocation of STIM
into close ER– plasma membrane junctions [78]. Eight STIM molecules form a cluster
and interact electrostatically by their polybasic C-terminal STIM-Orai activating re-
gion (SOAR) region with the acidic C-terminal cytoplasmic domain of one tetrameric
Orai channel [122].
Similar to the STIM proteins, the Orai1 protein was identified in an RNAi screen
in Drosophila S2 cells in 2006 [37]. Ca2+ entry via CRAC channels is the main
calcium entry pathway in T cells. T cells isolated from patients with severe combined
immunodeficiency (SCID) have shown a functional deficiency in thapsigargin induced
SOCE [36], an impaired T cell activation, resulting into reduced T cell proliferation,
cytokine production and global gene expression, but normal T cell development [35].
As a result, patients are susceptible to fungal and viral infections and have a reduced
life expectancy [37]. In 2006, sequencing of genomic DNA of SCID patients revealed
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Figure 1.1: Store-operated Ca2+ entry (SOCE). A)The stromal interaction
molecule (STIM) dimers senses Ca2+ with its N-terminal EF-hand domain. Upon
Ca2+ depletion of the endoplasmic reticulum (ER), STIM oligomerizes and translo-
cates to ER– plasma membrane junctions where it interacts electrostatically with
Orai. B) Carbachol binds to its Gq protein coupled receptor (GqPCR) in the plasma
membrane which activates phospholipase C. Phospholipase C splits phosphatidyli-
nositol 4,5-bisphosphate (PIP2) into inositoltriphosphate (IP3) and diacylglycerol
(DAG). IP3 depletes the ER from Ca
2+ which induces STIM/Orai interaction and
subsequently SOCE. Thapsigargin induces SOCE experimentally by inhibiting the
sarcoplasmic/endoplasmic reticulum ATPase (SERCA) pump [122] (modified from
[78]).
a C→T missense mutation in exon 1 of human Orai1. Thus, arginine is replaced by
tryptophan at position 91 of the protein (R91W). Restoration of wildtype Orai1 in
mutated T cells from SCID patients rescued SOCE and ICRAC [37].
The name ’Orai’ originates from the Greek mythology, where the Orai are the keepers
of the heaven’s gate. The Orai proteins are plasma membrane proteins, with four
predicted transmembrane domains and intracellular C- and N-termini. Orai1 exists
mainly as a dimer under resting conditions and forms tetramers containing the Ca2+-
selective pore after store depletion [97]. The three Orai isoforms, Orai1, 2 and 3 differ
in their activation and inactivation kinetics, monovalent permeation, and response
to 2-APB (2-aminoethoxydiphenyl borate). Orai3, but not Orai2 was reported to be
able to restore SOCE in cells lacking Orai1 [35].
SOCE is initiated by binding of an agonist to a tyrosine kinase receptor or a GqPCR
in the plasma membrane, e.g. carbachol binds to its muscarinic acetylcholine receptor
and activates phospholipase C, which cleaves PIP2 into IP3 and DAG. The second
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messenger IP3 releases Ca
2+ from the internal stores of the ER via its receptor in
the ER plasma membrane. As a result of the depletion of the ER store, the stromal
interaction molecule (STIM) molecules oligomerize and activate Ca2+ channels in the
plasma membrane [122][35][25]. Ca2+ enters from the extracellular space and increases
the intracellular Ca2+ level. The Ca2+ pump of the ER, sarcoplasmic/endoplasmic
reticulum ATPase (SERCA), pumps intracellular Ca2+ into the ER, to refill its in-
ternal stores (see figure 1.1). To induce SOCE experimentally, the SERCA inhibitor
thapsigargin is used. Thapsigargin blocks the SERCA pump thereby blocking refilling
of the ER with cytosolic Ca2+. Because Ca2+ leaks through the ER membrane, the
ER is gradually depleted by Ca2+ after application of thapsigargin. Depletion of the
ER from Ca2+ triggers activation of SOC channels.
It is widely accepted that Orai channels are strictly store-activated. However there
are various reports about SOC channels which are less selective for Ca2+ than Orai-
induced CRAC channels [94]. It is suggested that TRPC channels could be involved
although they are nonselective for Na+ as well as Ca2+ and are activated downstream
of phospholipase C.
1.2.2 The receptor-operated Ca2+ influx pathway
Receptor-operated Ca2+ entry (ROCE) occurs when the second messenger diacyl-
glycerol directly activates plasma membrane Ca2+ channels. An example for ROCE
is the TRPC3/6/7 subfamily which can be activated by GqPCR agonists, such as
carbachol. As a consequence phospholipase C is activated which cleaves PIP2 into
DAG and IP3. DAG directly activates classical transient receptor potential 3, 6 and
7 (TRPC 3, 6 and 7) channels in the plasma membrane [25]. The influx of cations
through classical transient receptor potential (TRPC) channels depolarizes the mem-
brane, activates voltage-dependent calcium channels and increases the intracellular
calcium concentration (see figure 1.2).
The TRPC channels are the first TRP channels which were cloned and characterized
in mammals, share the closest homology to the Drosophila TRP channels and are
therefore termed as ’classical’ or ’canonical’ TRP channels. However, it is still a mat-
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Figure 1.2: Receptor-operated Ca2+ entry (ROCE). A GqPCR agonist acti-
vates phospholipase C (PLC) which cleaves PIP2 into DAG and IP3. DAG activates
TRPC3/6/7 channels. PIP2: phosphatidylinositol 4,5-bisphosphate, DAG: diacyl-
glycerol, IP3: phosphatidylinositoltriphosphate (from [32]).
ter of debate, if TRPC channels are also store-operated. The transient receptor poten-
tial (TRP) genes were discovered in the fruit fly Drosophila melanogaster by Cosens
and Manning over 40 years ago. They recorded a transient response to steady light in
a visually impaired TRP mutant fly instead of a sustained response in a wild type fly.
According to this observation they named the mutant ’transient receptor potential’
[18]. 20 years later, Montell and Rubin identified the trp gene [87]. The superfamily
of TRP channels can be divided into seven families depending on the protein homol-
ogy: TRPC (canonical), TRPV (vanilloid), TRPM (melastatin), TRPA (ankyrin),
TRPML (mucolipin), TRPP (polycystin) and TRPN (NO-mechano-potential C). All
TRP channels are characterized by intracellular amino and carboxyl tails which vary
from subfamily to subfamily, six transmembrane domains (S1 to S6) and a pore-
forming loop between S5 and S6 (see figure 1.3) [91].
The TRPC family is also characterized by four amino-terminal ankyrin repeats and
can be further divided into four subfamilies: TRPC1, TRPC2, TRPC3/6/7 and
TRPC4/5. TRPC1 is structurally and functionally unique but TRPC 4/5 share
65% amino acid sequence homology and the TRPC 3/6/7 subfamily shares 70%-80%
amino sequence homology [26].
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Figure 1.3: Structure of transient receptor potential (TRP) channels. a)
TRP channels consist of six transmembrane domains (1–6), a pore forming-loop (P)
between S5 and S6 and intracellular carboxyl (C) and amino (N) termini. b) Four
TRP channels form a functional cation channel [91] (from [148])
The first subfamily consists only of the TRPC1 channel. It was the the first human
TRP channel which was cloned in 1995 [145] and characterized in 1996 [155]. The
human TRPC1 gene is localized on chromosome 3, while the murine TRPC1 is lo-
calized on chromosome 9 [16]. The molecular structure of the TRPC1 channels is
similar to the other TRP channels. The physiological role TRPC1 is still a matter
of debate. TRPC1 is expressed in most human and murine tissue [145]. TRPC1
can build heterotetramers with TRPC4 and TRPC5 or with TRPC3, TRPC6 and
TRPC7 but may not function as homotetramer [52] [125].
The second subfamily consists only of TRPC2, a human pseudogene which does not
code for a functional protein in humans. The third subfamily consist of TRPC 4
and 5. Different from other TRPC channels, they own a postsynaptic density protein
95-binding motif. TRPC4 is expressed in most tissue, TRPC5 mainly in the central
nervous system [91].
The fourth subfamily consists of TRPC3, TRPC6 and TRPC7. They are activated
by diacylglycerol [53]. TRPC7 is mainly expressed in the pituitary glands, kidney,
central nervous system, heart and lung [91].
The first murine TRPC6 cDNA was isolated from brain [8] and the respective murine
TRPC6 gene is localized on chromosome 9. Human TRPC6 was cloned from placenta
[53] and its gene is localized on chromosome 11q21-q22 and has 13 exons [24]. TRPC6
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is ubiquitously expressed and shows higher expression levels in lung, placenta, ovary
and spleen [51]. The molecular structure of the TRPC6 channel is similar to that
of other TRP channels (see figure 1.3). Four TRPC6 monomers build a tetramer
with a functional pore domain in the center. The two glycosylation sites at the
first and second extracellular loops (Asn473, Asn561) determine that TRPC6 acts as
a receptor-operated calcium channel [28]. A mutation of Asn651 to Gln prevented
glycosylation and increased the basal activity of TRPC6 [28].
The dual glycosylation is responsible for the lower basal activity of the TRPC6 com-
pared to the single glycosylated TRPC3 channel [28]. The TRPC3 channel further
distinguishes from the TRPC6 channel by its lower Ca2+ selectivity and higher single
channel conductance [53] [28]. TRPC3 is mainly expressed in the central nervous
system, smooth and cardiac muscle cells. It has been described to be involved in
brain-derived neurotrophic factor mediated growth and glutamate receptor signaling
and as postsynaptic cation channel essential for metabotropic glutamate receptor1
(mGluR1)-dependent synaptic transmission in cerebellar Purkinje neurons [91].
1.2.3 The role of Ca2+ signaling during pulmonary arterial
hypertension (PAH)
Several research groups have studied the function of TRPCs, STIM and Orai in cells
of the lung and lung associated diseases, such as pulmonary arterial hypertension
(PAH). PAH is a progressive disease which is characterized by vascular remodeling,
vascular arterial wall stiffness, vasoconstriction and thrombosis [58]. Risk factors to
develop a PAH are hypoxia in parts of the lung, induced by COPD [144], idiopathic
pulmonary fibrosis [114], appetite suppressant drugs (such as aminorex, fenfluramine
derivatives and benfluorex) [117], a genetic predisposition (most of them mutations of
the bone morphogenetic protein receptor 2) [58], or changes in endothelin expression
[34].
Endothelin is the strongest vasoconstrictor known. It is synthesized from big endothe-
lin1 by the endothelin converting enzyme. Two different G-protein coupled endothelin
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receptors mediate the effect of endothelin1: the endothelin A and endothelin B recep-
tors [86]. Endothelin A receptors are mainly expressed in pulmonary vascular smooth
muscle cells where they mediate vasoconstriction and proliferation, while endothelin B
receptors are mainly expressed in endothelial cells where they promote vasodilatation.
There are regional differences in endothelin receptor localization and distribution in
the pulmonary vasculature. Due to these differences in distribution, endothelin in-
duces dilatation of the pulmonary circulation and at the same time vasoconstriction
of the systemic circulation [128] [33].
Takahashi et al. demonstrated that the mRNA levels of endothelin1 and the endothe-
lin A receptor were upregulated in lung of rats which had been exposed to hypoxia.
Immunostaining with anti-big endothelin1 antibody revealed that endothelin1, the
endothelin converting enzyme and endothelin A receptors were significantly increased
in distal segments. The shift of endothelin A receptor expression from proximal
arteries during normoxia to distal arteries after hypoxia might play a role during vas-
cular remodeling [128] [33]. Polymorphisms of the endothelin receptor might affect
endothelin signaling and the therapy with endothelin receptor antagonists [54].
Up to date PAH is treated with phosphodiesterase 5 inhibitors (e.g. sildenafil), cGMP
(cyclic guanosine monophosphate) activator (e.g. riociguat, cinaciguat), NO-releasing
substances, prostanoids (e.g. epoprostenol) or endothelin-receptor antagonists (e.g.
bosentan) (see figure 1.4) [58]. The reduced production and bioavailability of NO
in endothelial cells is targeted by the phosphodiesterase 5 inhibitor, the cGMP acti-
vator and NO-releasing substances. The NO-synthase releases NO when catalyzing
the reaction of L-arginine to L-citrulline. NO activates the soluble guanylate cyclase
(sGC) which in turn induces the formation of cyclic guanine monophosphate (cGMP)
and cGMP relaxes smooth muscle cells. Phosphodiesterase 5 degrades cGMP and its
inhibition enhances the bioavailability of cGMP as well as increases vasodilatation.
Prostanoids are prostacyclin analogues. Prostacyclin is produced endogenously from
arachidonic acid by the cyclooxygenase and prostacyclin synthase. It has vasodilata-
tory, anti-inflammatory and antiproliferative effects on the blood vessel. Endothelin
receptor antagonists prevent the binding of endogenous endothelin on its receptor and
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therefore prevent vasoconstriction [58].
Even though this symptomatic treatment can slow down the progression and the
subsequent right heart failure, it does not interfere with the development of PAH.
Ca2+ signaling in precapillary pulmonary arterial smooth muscle cells (PPASMC)
and mouse pulmonary microvascular endothelial cells (MPMVEC) plays an essential
role in the development and progression of PAH but is not affected by currently
available therapeutic drugs. A combination of the previously used therapeutic drugs
with new Ca2+ channel blockers may have the potential to improve the therapy for
PAH patients.
PPASMC are located in the small, arterial vessels (<500 µm in diameter [142]) which
regulate the vascular tone [29]. This fact and because remodeling of these smooth
muscle cells is an essential step during PAH formation [58], prompted us to isolate
smooth muscle cells from precapillary arteries for our experiments. PPASMC appear
in two different phenotypes: the quiescent contractile vascular phenotype and the
proliferative and migratory phenotype. While the beneficial contractile phenotype
regulates the vascular tone, the pathophysiological proliferative phenotype is involved
in remodeling. A switch to this phenotype can be induced by inflammatory mediators
or mechanical stress [115]. Many Ca2+ channels have an altered gene expression and
are dysregulated during PAH inducing high cytosolic Ca2+ concentrations. This rise in
intracellular Ca2+ concentration triggers proliferation, migration and vasoconstriction
in PPASMCs. Proliferation is regulated by Ca2+-dependent kinases, such as CaMK,
and Ca2+-dependent transcription factors, such as nuclear factor of activated T-cells
(NFAT). Moreover, Ca2+ affects gene expression by protein kinase C and calmodulin
activation [65] [26].
Quantitative RT-PCR-analysis revealed that TRPC1 and TRPC6 are the main iso-
forms expressed in non-passaged PPASMC cultivated for 5 days. The other TRPC
channels play only a minor role in PPASMC [143]. Quantitative RT-PCR-analysis
of thoraic aortas and cerebral aortas from TRPC6-/- mice demonstrated a compen-
satory upregulation of TRPC3 [29]. Resulting from the compensatory upregulation of
TRPC3, TRPC6-/- mice show a higher smooth muscle contractility in isolated aortic
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rings [29]. To circumvent this upregulation, we used TRPC 1/3/6 deficient mice for
investigating functional SOCE in PPASMC.
Figure 1.4: Treatment of pulmonary arterial hypertension (PAH). PDE:
phosphodiesterase, sGC: soluble guanylate cyclase, GTP: guanosine-5’-triphosphate,
cGMP: cyclic guanine monophosphate, GMP: guanine monophosphate, NO: nitric ox-
ide, PGI2: prostacyclin, cAMP: cyclic adenosine monophosphate, IP receptor: prosta-
cyclin receptor. For more details see text (from [58])
TRPC6 and TRPC3 have been shown to be upregulated in smooth muscle cells of
idiopathic pulmonary arterial hypertension (IPAH) patients and in a rat model of
pulmonary hypertension. TRPC6 siRNA downregulated the TRPC6 expression in
smooth muscle cells of IPAH patients and decreased proliferation. Genomic DNA
analysis of IPAH patients identified a single nucleotide polymorphism in the promotor
of the TRPC6 gene in patients inducing enhanced nuclear factor kappa B-mediated
promoter activity and increased TRPC6 expression [150].
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TRPC6 and TRPC1 have been demonstrated to be involved in hypoxic pulmonary
vasoconstriction. Isolated, buffer-perfused, and ventilated mouse lungs of TRPC6-/-
mice did not show an acute response to hypoxia which was observed in Wt lungs. But
similar to Wt lungs, an increase in pulmonary arterial pressure during sustained re-
sponse was observed in TRPC6-/- lungs [143]. When TRPC6-/- mice were exposed to
chronic hypoxia, they developed similarly a pulmonary hypertension compared to Wt
mice [143]. In contrast to TRPC6-/- mice, TRPC1-/- mice showed an unchanged acute
and sustained response to hypoxia. When mice were kept under hypoxic conditions
for 21 days, wildtype mice developed a pulmonary hypertension but TRPC1-/- mice
were protected [79]. PPASMC from mice chronically treated with hypoxia, displayed
upregulated TRPC1, but unchanged TRPC3 and TRPC6 mRNA levels. Proliferation
of PPASMC exposed to hypoxia for 24h was reduced significantly in PPASMC iso-
lated from TRPC1-/- or TRPC1/6-/- mice but unchanged in PPASMC isolated from
TRPC6-/- mice [79].
STIM2 and Orai2, but not STIM1, have been shown to be upregulated in PPASMC
from IPAH patients and enhanced SOCE in PPASMC from IPAH patients was re-
duced after transfection with STIM2 specific siRNAs [123]. PPASMC from IPAH
patients treated with STIM2 siRNA showed similar proliferation levels after 72hrs
as cells from non-pulmonary hypertension donors [123]. Overexpression of STIM2 in
control PPASMC did neither enhance SOCE nor proliferation and PPASMCs treated
with hypoxia for 48hrs showed enhanced STIM2 and Orai2 protein expression levels
[123].
1.2.4 Do TRPCs interact with STIM and induce SOCE?
It is widely accepted that SOCE resulting from STIM-Orai interaction is the molecular
correlate of the ICRAC in immune cells [56] [11]. However, in recent years the question
arose if STIM may also interact with other plasma membrane Ca2+ channels besides
Orai in other cells forming a SOCE current clearly different from ICRAC. There are
two main hypotheses describing the involvement of TRPCs in SOCE reported by the
research groups from Shmuel Muallem and Lutz Birnbaumer.
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The Muallem group claims that STIM can activate both Orai and TRPCs directly (see
figure 1.5A).The STIM protein contains a positive charged lysine domain. Zeng et al.
analyzed the TRPC protein for negatively charged complement domain which could
interact electrostatically with the STIM protein. Mutation analysis revealed that neg-
atively charged aspartates in TRPC1(639DD640) interact electrostatically with the pos-
itively charged STIM1(684KK685). Similar gating was observed with TRPC3(697DD698)
[152]. However, Lee et al. have shown that the STIM1 lysine domain is not required
for binding, but close contacts between the SOAR region of STIM and the coiled coil
domains of TRPC [68]. While the SOAR region of STIM seems to activate both Orai
and TRPC, the electrostatic interaction only occurs between STIM and TRPC [68].
Figure 1.5: Schematic presentation of two hypotheses for TRPC-Orai inter-
action. A)The research group of Shmuel Muallem claims that STIM can activate
both Orai and TRPCs directly. SOCE mediated by Orai and SOCE by TRPCs could
interact but fulfill different cellular functions e.g. in precapillary pulmonary arterial
smooth muscle cells (PPASMC) (from [80]). B)The research group of Luz Birn-
baumer is presenting data in favor for a TRPC-Orai octamer (from [70]). TRPCs in
these heteromeric channels could contribute to SOCE. Are less then four Orai dimers
part of the channel, the channel acts as receptor-operated channel (ROC). BMP:
bone morphogenetic protein, NOX: NADPH oxidase, SR: sarcoplasmic reticulum,
PIP2: phosphatidylinositol 4,5-bisphosphate, PLC: phospholipase C, IP3: inositol
1,4,5-trisphosphate, IP3R: inositol 1,4,5-trisphosphate receptor,
The research group of Lutz Birnbaumer claims that TRPCs and Orai form heteromers.
Orai could act as regulatory subunits of TRPC channels in these heteromeric SOC
channels. Are less then four Orai dimers part of the octameric channel, the TRPC
channels act as ROC. The Birnbaumer group bases their hypothesis on the data pre-
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sented in two manuscripts [71] [73]. Liao et al. observed a functional interaction
between TRPCs and Orai e.g. Orai1 interacted with the N- and C-termini of TRPC3
and TRPC6 in co-immunoprecipitation experiments. HEK293 cells stably overex-
pressing TRPC3 and TRPC6 and transfected with Orai1, 2 or 3 showed increased
SOCE as compared with control cells not expressing TRPC3 and TRPC6. HEK293
cells stably overexpressing TRPC3 or TRPC6 showed reduced single-channel cation
currents after Orai1 overexpression [71]. Moreover, 1 µM Gd3+ blocks SOCE but not
ROCE mediated by TRPC channels. The dominant negative Orai1 mutant G91W
prevented Gd3+ induced ROCE in HEK 293 cells. The same mutant reduced OAG-
mediated Ca2+ entry in stably or transiently expressing TRPC3 HEK 293 cells. These
results suggest that TRPC and Orai form a complex which could be involved in both
SOCE and ROCE [73] (see figure 1.5B).
It is suggested that TRPC1 is only functional with other TRPC channels [52]. TR-
PCs haven been shown to form homo- or heterotetramers within the TRPC1/4/5
and TRPC3/6/7 subfamilies by Foerster resonance energy transfer (FRET) and
co-immunoprecipitation [52]. TRPC1 channels were detected in heterodimers with
TRPC3 and TRPC4 with TRPC6 [151]. Recently it was demonstrated that TRPC1
reduces Ca2+ permeability in heteromeric channels with TRPC3, TRPC4, TRPC5,
TRPC6 and TRPC7. Interestingly, these heteromeric channels displayed a signifi-
cantly reduced Ca2+ influx compared to homomeric channels [125].
It was also reported that TRPC1 is colocalized with STIM1 in lipid rafts and its
expression is controlled by Orai [14]. The same research group described that block-
ing of SOCE by gadolinium, extracellular Ca2+ free medium, Orai1 knockdown or
expression of dominant- negative mutant Orai1 lacking a functional pore (E106Q)
prevented TRPC1 expression in the plasma membrane. STIM1 was able to interact
by its polybasic tail with PIP2 in the plasma membrane lipid domains and deletion of
the polybasic tail resulted in abrogation of SOCE and inhibition of STIM1 punctae
formation in the ER membrane [14].
TRPC6, Orai1 and STIM1 were also analyzed in human platelets. Double deficient
Orai1-/-/Trpc6-/- platelets showed a stronger reduction in thapsigargin-induced SOCE
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than Orai1-/- platelets. TRPC6 channels are activated by DAG and DAG can be
produced by two different ways in platelets: hydrolysis of PIP2 by phospholipase C
(PLC) as well as hydrolysis of phosphatidic acid (PA) by phospholipase D (PLD)
and phosphatidic acid phosphohydrolase (PAP) (see figure 1.6). A radioactive PLD
assay revealed a strong reduction in PLD activity in Orai1-/- platelets. An IP-ELISA
identified a reduced PLC activity in Orai1-/- compared to wild-type platelets in the
presence of thapsigargin and extracellular calcium. Stimulation of different GPCRs by
platelet agonists demonstrated that Orai is not necessary for PLC and PLD activation
by platelet GPCRs under physiologic conditions. However, Orai1-mediated activation
of phospholipase C and D might play a role during pathophysiological platelet hy-
perreactivity [13] (see figure 1.6). The STIM1/Orai1/TRPC6 interaction was further
analyzed in human platelets by Jardin et al. [59]. They reported an interaction of
hTRPC6 and STIM1 and Orai1 in co-immunoprecipitation experiments after inducing
SOCE by thapsigargin. Stimulation by the diacylglycerol analogue OAG (1-oleoyl-
2-acetyl-glycerol) or dimethyl-BAPTA (1,2-bis-(o-aminophenoxy)ethane-N,N,N’,N’-
tetra-acetic acid) loading abolished the interaction and enhanced the association of
hTRPC6 with hTRPC3 [59].
The physiological role of the proposed STIM/TRPC/Orai interaction is not yet
known. Isolated platelets from TRPC1 knockout mice showed an intact SOCE [137].
This contradicted previous results of other authors who had claimed a TRPC1 involve-
ment in SOCE after using TRPC1 antibodies of questionable quality [108]. However,
in salivary gland acinar cells isolated from TRPC1-/- mice no SOCE was detectable
after thapsigargin stimulation, while the expression of STIM1 and other TRPC chan-
nel was unchanged in these cells [75]. Along these line, pancreatic acinar cells from
TRPC1-/- mice showed decreased SOCE and Ca2+-activated Cl- channel activity [55].
However in thoracic smooth muscle cells from TRPC1-deficient mice, no changes in
thapsigargin-induced Ba2+ influx was detected, and there was no significant difference
in the membrane capacitance and current densities of wildtype and TRPC1-/- cells
[27].
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Figure 1.6: Orai-induced Ca2+ entry activates PLC and PLD which pro-
duces DAG and activates TRPC3 and TRPC6. DAG: diacylglycerol, IP3:
inositol 1,4,5-trisphosphate, IP3R: inositol 1,4,5-trisphosphate receptor, PC: phos-
phatidylcholine, PLD: phospholipase D, PA: phosphatidic acid, PAP: phosphatidic
acid phosphohydrolase, PIP2: phosphatidylinositol 4,5-bisphosphate, PLC: phospho-
lipase C, TP: thromboxane A2 receptor, TxA2: thromboxane A2. For more details
see text (from [13])
1.3 The role of SOCE in vascular endothelial and
smooth muscle cells during physiology and patho-
physiology
1.3.1 SOCE in vaso- and bronchoconstriction
Ca2+ signaling in PPASMC and MPMVEC plays an essential role in the development
and progression of PAH. Under hypoxic conditions vasoconstriction in PPASMC at
the low ventilated areas redirect the blood flow to the still oxygen rich regions to sup-
ply the body with sufficient O2 even if parts of the lung are destroyed. The contraction
of PPASMCs has therefore some characteristic features which distinguishes it from
the contraction of skeletal or cardiac muscle cells. PPASMC undergo slow, sustained
and tonic contractions. The contraction can be either initiated by changes in mem-
brane potential or by pharmacomechanical coupling. Regardless of the mechanism
of initiation, a rise in cytosolic Ca2+ induces PPASMC contraction and pulmonary
vasoconstriction. Intracellular Ca2+ binds to calmodulin which activates the myosin
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light chain kinase to phosphorylate the myosin light chain. This phosphorylation
induces hydrolyzation of ATP (adenosine triphosphate) by ATPases and the myosin
head crossbridges to the actin filament which causes contraction. Dephosphorylation
of the myosin light chain, which does not require Ca2+, induce smooth muscle cell
relaxation[78].
A model widely used to investigate the capacity of smooth muscle constriction or
relaxation is the myograph. Intact rings from different vessels can be isolated from a
mouse model and mounted in a physiological organ bath. Upon receptor stimulation,
the mechanical force is transduced into an electrical signal which is recorded. Tra-
cheal ring and thoraic aorta segments have been used in numerous studies. Tracheal
smooth muscle cells mainly express the muscarinic acetylcholine receptor subtypes
M2 (Gαi) and M3 (Gαq) which can be stimulated with carbachol. At the M3 recep-
tor, Carbachol induces a Gq-coupled signaling cascade by activating phospholipase
C leading to increased intracellular Ca2+ levels [118]. Different from smooth muscle
cells of the trachea, stimulation of the muscarinic acetylcholine receptor in vascular
endothelial cells induces relaxation. High intracellular Ca2+ in PPASMCs can be
passed to MPMVECs via gap junctions and induce Ca2+-dependent NO production
[78]. This apparently opposing mechanism is highly beneficial because it limits the
smooth muscle contraction and therefore fine tunes vasoconstriction. Similar to the
pathway in PPASMCs, carbachol binds to its M3 receptor in endothelial cells and
induces a Gq-mediated signaling pathway which elevates the cytosolic Ca
2+. Ca2+
enables the endothelial NO-synthase to produce NO. NO diffuses into smooth mus-
cle cells of the tunica media and activates guanylate cyclases which convert GTP
into cGMP activating protein kinase G. Stimulation of protein kinase G induces de-
phosphorylation of myosin light chains by its phosphatases which results into smooth
muscle relaxation and vasodilatation [45].
The role of SOCE in vasoconstriction and vasodilatation has already been investi-
gated by several research groups. Aortic rings from mice with a STIM1-deficiency in
smooth muscle cells (STIM1∆SMC) displayed a reduced phenylephrine-induced aortic
vasoconstriction [83]. This result was reproduced by Kassan et al. in aortic rings [61].
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After depleting internal Ca2+ stores by phenylephrine and thapsigargin, aortic rings
from STIM1∆SMC mice showed a reduced SOCE-mediated contraction. The research
group of Donald Gill further performed Ca2+ refilling experiments after store deple-
tion to elucidate the molecular background of the myograph contraction experiments.
They demonstrated that the Ca2+ refilling rates after store depletion are reduced
in STIM1∆SMC after repetitive treatment with cyclopiazonic acid in the presence of
extracellular Ca2+ in comparison to wild-type (WT) SMCs. [83]. Moreover, Kassan
et al. demonstrated that STIM1∆EC aortic rings treated with acetylcholine dilatated
significantly less than heterozygous STIM1∆EC and wildtype aortic rings [61].
1.3.2 SOCE during inflammation and edema formation
STIM1 and Orai1 are involved in inflammatory processes. Loss of function mutations
in STIM1 and Orai1 in human patients causes a severe combined immunodeficiency
which is characterized by an impaired T-cell function [35]. The role of STIM1 and
Orai1 in T-cells has already been extensively studied by other authors. However,
not only circulating immune cells are involved in inflammation but also endothelial
cells play an important role. Endothelial cells are specialized epithelial cells which
line the interior of all blood vessels. Intact endothelial cells form a tight barrier
between blood and interstitium. If endothelial cells are dysfunctional, barrier perme-
ability is decreased and fluid can pass and induce edema [99]. Bacterial products like
lipopolysaccharide (LPS) and endogenous cytokines stimulate the endothelium and
increase the endothelial barrier permeability. This response enables neutrophils and
monocytes to penetrate infected tissue and kill the pathogens during infection. But
at the same time it allows protein-rich edema fluid to leak into the alveoli causing
impaired gas exchange and hypoxemia [116].
LPS (lipopolysaccharide) is the main component of the outer gram negative bacterial
membrane, for example in Klebsiella pneumoniae, a bacterium which can induce
pneumoniae, an inflammation of the alveoli, in human and mice. In experimental
pneumoniae models, bacteria are applied intratracheally or intranasally. When LPS
binds to the toll-like receptor 4, this initiates a signaling cascade via the two adaptor
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proteins TRIF and myD88 and results in nuclear translocation of AP-1, NF-κB,
and IRF3. As a consequence, several inflammatory cytokines, such as TNF-α, IL-6
and IFN-β are expressed. TNF-α binds to its respective receptor at the endothelial
plasma membrane and induce a signaling cascade which results in gene expression of
inflammatory genes, such as E-selectin, intercellular adhesion molecule 1 (ICAM1),
vascular cell-adhesion molecule 1 (VCAM1) and COX2 [99]. Finally, the inflamed
endothelial cells become dysfunctional, allow fluid to leak through tight junctions
and form a lung edema.
Figure 1.7: STIM1 is essential for LPS-mediated NFAT activation. A) In-
tact pulmonary endothelial cells form a barrier between blood vessels, interstitium and
alveoli, B) Lipopolysaccharide (LPS)-induced reactive oxygen species (ROS) accumu-
lation, Ca2+ oscillations and nuclear factor of activated T-cells (NFAT) accumulation
makes the endothelial barrier leaky. TLR4: Toll-like receptor4 (from [116]).
LPS can not only be used experimentally to induce pneumoniae, but also to in-
duce acute lung injury by intraperitoneal application. In this model, LPS binds to
its Toll-like receptor4 (TLR4) in endothelial cells and thereby elevates intracellular
ROS levels. According to Gandhirajan et al., STIM senses the increase of ROS by
S-glutathionylation of its cysteine residues. This induces high-frequency Ca2+ oscilla-
tions through Ca2+ originating from the ER and the extracellular space via membrane
Ca2+ channels and results into nuclear NFAT translocation (see figure 1.7) [39]. The
NFATs are Ca2+-sensitive transcription factors which are involved in transcription of
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proinflammatory mediators. Inactive, phosphorylated NFAT is located in the cyto-
plasm. Upon intracellular Ca2+ elevation, the calmodulin-dependent serin/theronine
phosphatase calcineurin dephosphorylates NFAT and triggers translocation into the
nucleus. The NFAT isoforms c1 and c3 control vascular development, angiogenesis
and are involved in inflammation of the vasculature [105].
Gandhirajan et al. investigated how a STIM1-deficiency in endothelial cells (STIM1∆EC)
affects NFAT translocation and endothelial barrier function. They demonstrated
that STIM1∆EC cells heterologously expressing GFP-tagged NFATc3 (NFATc3-GFP)
translocated a significant lower amount of NFATc3 to the nucleus compared to wild-
type MPMVECs. The constitutively active STIM1 mutant C56A showed SOCE and
NFATc3-GFP nuclear translocation in MPMVECs which were lacking a subunit of
the ROS producing NADPH oxidase. To investigate endothelial barrier function,
Gandhirajan et al. induced a vascular inflammation in STIM1∆EC mice by inject-
ing LPS (1mg/kg body weight) intraperitoneally. 24hs after LPS treatment, the mice
were injected with 5% FITC-dextran via the facial vein and vascular permeability was
assessed based on the fluorescence intensity in the extravascular space. STIM1∆EC
mice showed significantly less extravascular FITC-dextran leakage than STIM1 floxed
control mice. The reduced vascular leakage in the LPS-treated STIM1∆EC mice re-
sulted in less lung edema formation indicated by a reduced lung wet-to-dry weight
ratio. Delivery of the unspecific SOCE blocker 3,5-bis(trifluoromethyl)pyrazole re-
duced vascular leakage and lung wet-to-dry weight ratios in LPS-treated wildtype
mice [39].
Vascular permeability of endothelial cells can be investigated on cellular levels using
the coagulation protease thrombin. Thrombin induces formation of stress fibers and
an opening of the cellular tight junctions. When MPMVECs are stimulated with
the PAR1 receptor agonist thrombin, Gq, G12/13 and Gi coupled signaling cascades
are induced resulting in elevated intracellular Ca2+ levels and RhoA activation. Gq-
mediated phospholipase C signaling induces ROCE and SOCE through TRPC, STIM
and Orai and the resulting elevated intracellular Ca2+ establishes a Ca2+-calmodulin
complex. Ca2+-calmodulin activates the myosin light chain kinase (MLCK) which
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Figure 1.8: Thrombin-induced disruption of the endothelial barrier. Throm-
bin induces induces elevated intracellular Ca2+ levels and RhoA activation which
results into stress fiber formation and opening of tight junctions. PAR1: protease-
activated receptor1, CaM: Ca2+-calmodulin, MLCK: myosin light chain kinase,
MLCP: myosin light chain phosphatase (from [42]).
phosphorylates the myosin light chain (MLC). Simultaneously, thrombin induces the
G12/13-mediates RhoA signaling cascade. Specifically, the free G-protein βγ sub-
units activate guanine nucleotide exchange factor (Rho–GEF) which converts inac-
tive RhoA-GDP to active RhoA-GTP. RhoA-GTP induces Rho-dependent kinase
(ROCK) phosphorylation which results in inactivation of MLC phosphatase. Phos-
phorylated MLC contracts actin filaments which are bound to tight junctions and
adherens junction complexes thereby opening junctions between endothelial cells and
inducing leakage of plasma proteins. Under resting conditions, MLC phosphatase
dephosphorylates MLC and consequently prevents opening of tight junctions. Af-
ter Gq-protein-coupled-receptor stimulation, MLC is phosphorylated and induces an
opening of the tight junctions (see figure 1.8) [121]. F-actin filaments can be stained
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with phalloidin to quantify their intensities. The opened tight junctions allow either
FITC-dextran or an electrical current to pass. Therefore, the fluorescence of FITC-
dextran which has passed the barrier can be quantified in a transwell permeability
assay or the resistance of a small alternating current which is applied to the endothelial
layer can be analyzed using the Electrical Cell-Substrate Impedance Sensing (ECIS).
The influence of STIM and Orai in the endothelial barrier function has been in-
vestigated by Shinde et al. in siRNA transfected human umbilical vein endothelial
cells (HUVECs) and human dermal microvascular endothelial cells (HDMECs). They
demonstrated that thrombin-induced reduction of endothelial resistance is attenuated
in HUVECs transfected with STIM1 specific siRNAs. Transfection of HUVECs with
Orai1 specific siRNAs did not show any differences in thrombin-induced transendothe-
lial resistance in comparison to untreated control cells. Thrombin-induced SOCE was
also absent in HDMECs transfected with STIM1 and Orai1 specific siRNA. These re-
sults indicate that SOCE via Orai1 is not essential for endothelial barrier disruption.
Thrombin-induced stress fiber and VE-cadherin cell junction formation was reduced
in HUVECs after application of STIM1 specific siRNAs while RhoA activity was
enhanced. The thrombin-induced enhanced RhoA activity of HUVECs transfected
with STIM1 specific siRNA was attenuated, but not in HUVECs transfected Orai1
specific siRNA. Thus, it is assumed that STIM1 could also be an upstream effector
of of RhoA [121].
1.3.3 SOCE induced endothelial migration and proliferation
Endothelial cell migration and proliferation is an essential process during formation of
new blood vessels (angiogenesis)and vascular repair. Moreover, both play an impor-
tant role in pathophysiological processes such as atherosclerosis. The characteristics
of endothelial cells vary according to the tissue they originate from. The process of
endothelial migration can be divided into several steps. Before an endothelial cell
moves, it senses the chemotaxical gradient, mostly driven by vascular endothelial
growth factor (VEGF), via its filopodia. Afterwards, protruding lamellipodia at-
tach to the focal adhesion sites. The following stress fiber-mediated contraction of
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the cell induces a forward movement. Finally, the rear is released by focal adhesion
disassembly and adhesive and signaling components are recycled [67].
Endothelial migration is induced by several stimuli, such as shear stress, chemotaxis
and binding of integrins [67]. Even though one major stimulus for migration is the
expression of VEGF, other stimuli also contribute, such as intracellular Ca2+, ROS
or NO. Endothelial migration is often investigated experimentally by the scratch as-
say. Scratching of an endothelial monolayer disrupts contact inhibition and induces
Ca2+ entry from the extracellular space [15]. High intracellular Ca2+ activate protein
kinase C and calmodulin-dependent protein kinases. As a result, the immediate early
genes c-fos and c-jun are transcribed and induce expression of secondary genes, such
as VEGF [133]. The basal Ca2+ concentration of the leading edge of the endothelial
cell is reduced compared to the trailing edge. This Ca2+ gradient within the cell al-
lows a fine-tuned regulation of endothelial migration [15]. Both the Ca2+ originating
from the internal stores and from the extracellular space is assumed to contribute to
migration. The intracellular Ca2+ affects the cytoskeletal remodeling, the focal ad-
hesion turnover, the matrix degradation and formation of lamellipodia - all functions
which affect the endothelial migration [90].
The endothelial migration has shown to be affected by SOCE. Kimura et al. demon-
strated that inhibition of SOCE reduced wound healing after scratch formation. They
treated bovine aortic endothelial cells with thapsigargin or cyclopiazonic acid for 6h
or 24h and quantified the number of cells which migrated. When cyclopiazonic acid
was removed after 6h the destructed migration was rescued. Comparing intracellular
Ca2+ levels of non-migrating and migrating cells demonstrated that basal [Ca2+]i was
lower but the total amount of stored Ca2+ was higher in migrating cells. These results
indicate that a functional SERCA pump is essential endothelial migration. In which
way cytosolic Ca2+-binding proteins or the mitochondrial Ca2+ uptake/release af-
fects endothelial migration after thapsigargin or cyclopiazonic acid stimulation needs
further investigation [15]. The importance of STIM and Orai during migration has
been confirmed in smooth muscle cells. Aortic smooth muscle cells transfected with
STIM1 or Orai1 specific siRNAs showed a reduced PDGF-induced migration in a
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Boyden chamber [124]. SiRNA-mediated knockdown of STIM1 and Orai1 in vascular
smooth muscle cells reduced wound healing 12h or 24h after scratch formation [6]
[101] while knockdown of STIM2, Orai2 and Orai3 was not effective [6].
ROS is produced in vascular endothelial cells by NADPH oxidase (NOX). NOX are
proteins which mediate a redox reaction during which oxygen is reduced to superox-
ide and electrons are transferred across a biological membrane. The NOX isoforms
(NOX1, NOX2, NOX3, NOX4, NOX5, DUOX1, and DUOX2) fulfill different func-
tions according to the cells they are expressed. NOX1, NOX2, NOX4 and NOX5 are
expressed in endothelial cells [5] and regulate cell differentiation, proliferation, mi-
gration, angiogenesis and vascular tone [111]. NOX2 is the prototypical NOX which
was first described in neutrophils and macrophages. NOX2 in endothelial cells plays
an important role during ROS production and bioavailability of endothelium derived
NO [5] and it suggested to play an important role during angiogenesis [136] NOX1
and NOX4 have been reported to be involved in cell growth and growth suppression.
The function of NOX5 in endothelial cells is still poorly understood [111].
NOX constantly releases low levels of superoxide but upon stimulation can increase
superoxide production [136]. MPMVECs derived from STIM1∆EC mice showed sim-
ilar NOX2 protein levels and cytosolic superoxide production by DHE fluorescent
staining as MPMVECs from wiltype mice. NOX2 can be stimulated experimentally
to produce ROS by application of LPS which binds to the cellular TLR4 receptor,
interacts with NOX2 and elevates intracellular ROS levels.
Gandhirajan et al. showed that LPS/TLR4 and NOX2 mediated increased ROS levels
induced Ca2+ oscillations in MPMVECs. Inhibition of NOX2 abrogated these Ca2+
oscillations. Moreover, they demonstrated that ROS can induce STIM1-mediated
SOCE by ROS sensing of STIM1 through S-glutathionylation of its cysteine residues
[39][116]. The NOX-mediated superoxide production stimulates migration in vascular
endothelial cells [136]. In accordance with the unaltered NOX2 and and cytosolic
superoxide production, STIM1∆EC migrated similarly to wildtype MPMVECs 24h
after scratch formation [39].
NO is produced by the nitrite oxide synthase (NOS) and is a major player in the
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induction of vasodilatation. In the inactive, unphosphorylated, state, NOS exists as
a monomer which transfers electrons from reduced nicotinamide adenine dinucleotide
phosphate (NADPH) to flavin adenine dinucleotide (FAD) and flavin mononucleotide
(FMN) but with a low capacity. It can bind calmodulin but neither the cofactor
tetrahydrobiopterin (BH4), nor the substrate L-arginine and subsequently does not
catalyze NO production. In the active, phosphorylated, state, NOS exists as a dimer.
It has several phosphorylation sites which enhance the sensitivity of NOS for Ca2+
which is required for calmodulin binding. The phosphorylation site, serine (Ser)1177,
is activated by AMP-activated protein kinase (AMPK), Ca2+/calmodulin dependent
protein kinase II or protein kinase A which is mainly induced by fluid shear stress.
Active NOS transfers electrons from NADPH to hem where L-arginine is oxidized to L-
citruline and NO. NO stimulates the soluble guanylyl cyclase, generates cyclic guano-
sine monophosphate (cGMP) and induces vasodilatation. Under oxidative stress,
NOS produces superoxide and peroxynitrite instead of NO which is described by the
term uncoupling. In detail, radicals of NO and oxygen react to peroxynitrite instead
of NO which can oxidize BH4 to the inactive trihydrobiopterin (tBH3). The lack of the
cofactor BH4 and the substrate L-arginine are discussed as causes for the uncoupling
from oxygen reduction of NO [127]. As a consequence of uncoupling NO availability
is reduced and the existing oxidative stress enhanced, depolarisation of Ψm increased
and respiratory control ratio is decreased [38]. Similar to the superoxide produced by
NOX, the superoxide produced by endothelial NOS (eNOS) can stimulate endothelial
migration.
Endothelial proliferation after vascular injury occurs much slower than migration.
Scientists are discordant if the proliferating cells originate either from resident vascu-
lar endothelial cells or endothelial progenitor cells. Hagensen et al. demonstrated that
endothelial cells of the neoendothelium originated from the transplanted artery seg-
ment formed after wire-injury [46]. Other authors suggested that endothelial derived
microparticles promote proliferation of resident endothelial cells [154] [62]. Similar to
endothelial migration, Ca2+ affects endothelial proliferation.
Abdullaev et al. has shown that downregulation of STIM1 and Orai1 reduced prolif-
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eration in HUVECs. HUVECs transfected with siRNAs specific for STIM1, Orai1 or
STIM1 plus Orai1 were counted 96h later by trypan blue exclusion. Downregulation
of Orai1 and both STIM1 plus Orai1 induced significant reduced cell numbers as com-
pared to STIM1 knockdown. Combined transfection of STIM1 and STIM2 specific
siRNAs reduced cell numbers significantly but to a minor extent than Orai1 knock-
down. These results could indicate that Orai1 proliferation is partly independent
of STIM. Propidium iodide staining revealed that transfection with Orai1 specific
siRNAs and a mixture of STIM1 and Orai1 specific siRNAs increased the propor-
tion of cells in the S and G2/M phases of the cell cycle compared to control cells.
Transfection by siRNA specific for STIM1 alone had a much smaller effect[1]. Fur-
thermore, the role of STIM1 was demonstrated in a rat carotid artery balloon injury
model by Guo et al. Knockdown of STIM1 by adenovirus delivery of specific siRNAs
suppressed neointima hyperplasia 14 days after injury. The re-expression of human
STIM1 reversed this effect. In vitro, proliferation and migration of STIM1 deficient
vascular SMCs was reduced [44]. In summary, other groups have demonstrated that a
SOCE defect in smooth muscle cells or endothelial cells reduces endothelial migration
and proliferation. Because in most experiments immortalized cells transfected with
siRNA were used, theses results need further investigation in primary cells isolated
from knockout mice.
1.4 Mitochondrial Ca2+ homeostasis
1.4.1 The role of MCUR1 in mitochondrial Ca2+ influx
pathways
Mitochondrial calcium uptake is mediated by an inner mitochondrial membrane pro-
tein, the mitochondrial Ca2+ uniporter (MCU). Integrative bioinformatics and RNAi
screening approaches, discovered three components of the MCU complex (mitochon-
drial calcium uptake 1 (MICU1) [98], MCU [4] [21] and mitochondrial Ca2+ uniporter
regulator 1 (MCUR1) [81] [82] [49]). The MCU complex is further regulated by:
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MICU2, MCUb, EMRE and SLC25A23. Even though some of the MCU complex
components have been investigated, the precise structure and regulation of the MCU
complex is still unknown [21].
MCU is a 40 kDa protein with low affinity but high capacity and high selectivity
to Ca2+(dissociation constant ≤ 2 nM). Due to these properties, MCU can induce
mitochondrial Ca2+ rises above 100µM despite of relative low cytoplasmic Ca2+ con-
centrations [21]. The MCU-mediated Ca2+ uptake is dependent upon the negative
(-160 mV) mitochondrial membrane potential ∆Ψm and pH [43] [82] [19] [112] and
can be blocked by ruthenium red. The IMCU is produced by an inward rectifying
channel with a high half-saturation of 20 mM [Ca2+]c [64]. Physiologically, the rapid
mitochondrial Ca2+ uptake by MCU is essential for mitochondrial functions such as
ATP production and cell signaling processes [31] [41] [106] and for buffering patho-
physiological high cytosolic Ca2+ concentrations [106].
MICU1 prevents Ca2+ uptake via MCU at low cytosolic Ca2+ concentrations and
enables uptake at high concentrations. When extramitochondrial Ca2+ increases,
the gatekeeper MICU2 is inhibited and the stimulator MICU1 is activated. MICU1
interacts via its polybasic region and a Ca2+ sensing EF-hand with the coiled-coil
domain of MCU [49]. This enables MCU-dependent Ca2+ uptake. EMRE (essential
MCU regulator) is a single pass transmembrane inner mitochondrial membrane pro-
tein which is essential for MCU complex formation but its exact role is not known
yet [21] [50] [81] [110].
MCUR1 was identified as a positive regulator of the MCU complex through its in-
teraction with MCU and enhances the MCU-mediated Ca2+ uptake. It has been
demonstrated that the N-terminal domain of MCU interacts with MCUR1 and regu-
lates ruthenium-red-sensitive MCU-dependent Ca2+ uptake. Stable shRNA mediated
knockdown of MCUR1 in HeLa cells disrupted oxidative phosphorylation, lowered
cellular ATP levels and activated AMPK-dependent autophagy. Thus MCUR1 is an
essential component for MCU complex formation, and maintenance of normal cel-
lular bioenergetics [81]. Knockdown of MCUR1 in immortalized human fibroblasts
resulted in a cytochrome c oxidase assembly defect, decreased ∆Ψm and reduced
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mitochondrial Ca2+ uptake [96].
Figure 1.9: The MCU-mediated Ca2+ uptake. Mitochondrial Ca2+ uniporter
(MCU)-mediated Ca2+ uptake is regulated by several proteins which form a complex
with MCU: MICU1, MICU2, MCUb, MCUR1, EMRE and SLC25A23 (omitted for
simplicity). When extramitochondrial Ca2+ increases, the gatekeeper MICU2 is in-
hibited and the stimulator MICU1 activated. This enables MCU-dependent Ca2+ up-
take. EMRE: essential MCU regulator, MICU: mitochondrial Ca2+ uptake, MCUR1:
mitochondrial Ca2+ uniporter regulator1 (from [21]).
1.4.2 Coupled oxidative phosphorylation, uncoupling and ATP
production in mitochondria
Mitochondria are the major energy production units of the cell. ATP as the car-
rier of cellular energy is mainly produced in mammalian cells by either glycolysis
or oxidative phosphorylation in the respiratory electron chain [154]. The respira-
tory electron chain consists of five complexes which generate a proton gradient over
the inner mitochondrial membrane that drives ATP synthesis. The process of ATP
synthesis in the mitochondrial respiratory chain is called oxidative phosphorylation.
NADH and FADH2 provided by glycolysis, fatty acid oxidation or the citric cycle feed
the respiratory chain with electrons. These electrons are transported to O2 which is
reduced to H2O in complex IV. NADH and FADH2 are oxidized at complex I and II
which releases electrons and produces H+. H+ is pumped out of the mitochondrial
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matrix by complex I, III and IV. The uneven distribution of H+ generates a proton
gradient. Because the intermembrane space is charged positive relative to the matrix
side, a transmembrane electrical potential -the mitochondrial membrane potential,
Ψm -is created. The membrane potential has a large negative potential of -180mV.
The process of electron donation by NADH in complex I is depending on substrate
oxidation of pyruvate/malate in the citric cycle. Complex II oxidizes succinate and
reduces FAD+ to FADH2. In the same way as NADH, FADH2 feeds its electrons to
the respiratory chain. H+ produced during these reactions which generates the proton
gradient is therefore tightly coupled to electron donation. Because the electrons are
finally used to reduce O2 to H2O, the oxygen reduction rate is an accurate measure
for the proton gradient. The rate by which O2 is reduced is defined as oxygen con-
sumption rate (OCR). Addition of complex I and II substrate consequently results
into an enhanced electron flow, proton gradient and OCR. The energy of substrate
oxidation that is conserved in this proton gradient is used to synthesize ATP from
ADP and inorganic phosphate when H+ flows back to the matrix through complex
V. The term ’coupled’ in this context describes the dependance of ATP synthesis on
the proton gradient. Accordingly, addition of substrates enhances the proton gradi-
ent and thereby drives H+ reentry through complex V which results into higher ATP
synthesis. However, how much oxygen is required to produce one molecule of ATP
is dependent on factors such as the complex substrate. For example, consumption
of succinate and pyruvate/maleate requires both one unit of oxygen but succinate
pumps in turn 6 H+ while pyruvate/maleate pumps 10 H+. [109] [9] [129] [17] [10].
H+ does not only flow back to the mitochondrial matrix through the ATP synthase
but also through the uncoupling proteins (UCP) and adenine nucleotide transporters
(ANT). This process separates the electron transport and proton gradient from the
ATP synthesis and is therefore described with the term ’uncoupling’. The energy
conserved in the proton gradient which is used for ATP production during ’coupling’
is released as heat during ’uncoupling’ if H+ flows back via UCP [119]. Among the five
UCP isoforms UCP1 is involved in uncoupling during thermogenesis in brown adipose
tissue [127]. Based on the sequence homology of UCP2 and UCP1 a similar function
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Figure 1.10: Oxidative phosphorylation. The respiratory electron chain con-
sists of five complexes which generate a proton gradient over the inner mitochon-
drial membrane that drives adenosine triphosphate (ATP) synthesis. The process
of ATP synthesis in the mitochondrial respiratory chain is called oxidative phospho-
rylation. OMM: outer mitochondrial membrane, IMS: intermembrane space, IMM:
inner mitochondrial membrane, CoQ: co-enzyme ubiquinol, PON2: paraoxonase2,
cyto c: cytochrome c, NOX4: nicotinamide adenine dinucleotide phosphate oxidase4,
UCP2: uncoupling protein2, mitoKATP, mitochondrial ATP-sensitive potassium chan-
nel, eNOS: endothelial NO synthase, NO: nitric oxide GPX: glutathione peroxidase,
MnSOD: manganese superoxide dismutase, CuZnSOD: Copper-zinc superoxide dis-
mutase, VDAC: voltage-dependent anion channel (from [10]).
was assumed for UCP2 [139]. UCP2 and UCP3 are the main isoforms expressed in
endothelial cells. But the involvement of UCP2 in uncoupling is questioned by many
scientists. One argument against the role of UCP2 and UCP3 in uncoupling is the
low amount of UCP2 and UCP3 in the mitochondrial membrane. Therefore UCP2
and UCP3 probably do not have the capacity to induce a proton leak by uncoupling
which is high enough to lower the ∆Ψm. Moreover, unlike UCP1-deficient mice,
UCP2-/- mice are not susceptible to obesity even when they are fed with a high fat
diet and depletion of UCP2 in spleen or lung which express endogenously high levels of
UCP2, did not change the uncoupling state [66]. It has also been postulated that the
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’mild uncoupling’ of UCPs would protect from oxidative damage of reactive oxygen
species (ROS) produced during high ∆Ψm. However, only succinate-mediated ROS
production seems to be sensitive to high ∆Ψm. During conditions of reversed electron
flow, it is questionable if the succinate level of 0.5mM is reached physiologically
because succinate is only an intermediate product in the citric acid cycle. The citric
acid substrates which fuel complex I 2-oxoglutarate, pyruvate, glutamate and malate
produce only minor amounts of ROS. This ROS production is not influenced by
changes of the proton gradient and therefore addition of the uncoupler FCCP does
not have an effect on ROS production [119].
More and more evidence has accumulated suggesting that the main role of UCP2 is
in the reprogramming of metabolic pathways [139]. Endothelial cells cover their main
energy demand by glucose, fatty acids and glutamine. They preferentially use glucose
for glycolysis and not for oxidative phosphorylation even when oxygen is present. As
long as glucose and NAD+ are available, glycolysis produces as much ATP as oxidative
phosphorylation. Glutamine can fuel oxidative phosphorylation instead. This feature
allows endothelial cells to ensure energy supply even during conditions of low oxygen
which is required in particular during the formation of new blood vessels. Glucose
is oxidized to pyruvate and glutamine is metabolized to α-ketoglutarate. Pyruvate
and α-ketoglutarate fuel the tricarboxylic acid cycle (TCA) cycle. The TCA cycle
intermediates feed oxidative phosphorylation [100].
One study evidencing that UCP2 plays a role in metabolic pathways was conducted by
Vozza et al. They showed that UCP2 operates as a metabolite transporter which de-
termines substrate oxidation in mitochondria. More specifically, they demonstrated
that UCP2 exchanges intramitochondrial C4 intermediates against H+ and Pi un-
der high glucose supply. UCP2KD HepG2 cells (liver hepatocellular cells with stable
knockdown of UCP2) grown in high glucose DMEM showed an increased ∆Ψm and
ATP/ADP ratio. Moreover, UCP2KD HepG2 revealed elevated TCA intermediates
(citrate, 2-oxoglutarate, succinate, fumarate, L-malate)and reduced lactate levels by
mass spectrometry [139]. The elevated TCA intermediates level suggested that the
higher ATP/ADP ratio is due to an impaired TCA function. The low amount of
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lactate indicates that most of the ATP produced does not originate from glycoly-
sis. Based on these findings Vozza et al. hypothesized that UCP2 could transport
C4 metabolites, such as pyruvate which regulates the oxidation of pyruvate- derived
acetyl-CoA in mitochondria. Accordingly, UCP2 but not UCP1 catalyzed the sub-
strate uptake of radioactive phosphate, L-malate and L-aspartate into liposomes con-
taining the same substrate. Cell swelling experiments with isosmotic ammonium phos-
phate solution applied to isolated yeast mitochondria further demonstrated that the
inward H+-coupled Pi transport depends on the endogenous Mir1P or UCP2 protein.
Addition of FCCP increased the exchange between external Pi and internal malate.
It can be concluded from these experiments that the substrates malate, oxaloacetate
and aspartate are exchanged for Pi and H
+ across the mitochondrial inner membrane
suggesting that UCP2 negatively regulates the oxidation of acetyl-CoA-producing
substrates such as glucose by removing substrates of the Krebs cycle from the mito-
chondrial matrix. As a consequence the redox pressure of the mitochondrial chain,
the ATP/ADP ratio and the ROS production is reduced. In contrast to the effect of
UCP2 on glucose oxidation, UCP2 promotes the use of glutamine, feeding the Krebs
cycle, enhancing the redox pressure and therefore ATP/ADP ratio. Thus increased
UCP2 expression limits the contribution of glucose on mitochondrial oxidative phos-
phorylation and promotes oxidation of substitute substrates such as glutamine and
fatty acids [139]. Kukat et al. further confirmed that high UCP2 levels inhibit glucose
oxidation and promote fatty acid oxidization in an in-vivo model. They demonstrated
that UCP2-/- mice had reduced lactate levels and normal circulating free fatty acid
levels under normal chow diet at 25 weeks. The maximal OCR in mitochondria
isolated from the heart of UCP2-deficient mice was significantly reduced after ad-
dition of CCCP. The maximal OCR upon addition of octanoyl-carnitine+glutamate
was unchanged in UCP2 KO mitochondria but significantly reduced after addition of
palmitoyl-carnitine+glutamate. This result indicates that UCP2 upregulation might
allow better fatty acid oxidation in the heart [66].
Dysfunction of the mitochondrial respiratory chain can be investigated experimentally
by measuring the OCR. This is achieved by monitoring the OCR in response to
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addition of substrates, uncouplers or inhibitors. The physiological background will
be discussed here, for technical information refer to the methods section. During basal
respiration, the OCR is mainly dominated by the ATP turnover and partly by proton
leakage. To determine to which extend ATP synthesis influences the basal state, the
ATP synthase can be blocked with oligomycin. The remaining OCR is due to the
proton leakage and therefore caused by uncoupling. Because oligomycin blocks the
ATP synthesis during oxidative phosphorylation, the cell shifts its ATP production
to glycolysis. To maintain the ATP production, glycolysis accelerates approximately
10-fold. This increase of glycolysis can be measured by the extracellular acidification
rate (ECAR). Pyruvate is converted to lactic acid during anaerobic glycolysis. When
lactic acid is released it acidifies the extracellular space and can be measured as an
increase in ECAR.
The maximum respiration rate can be induced by addition of the uncoupler FCCP
(Carbonyl cyanide-p- trifluoromethoxyphenylhydrazone). An uncoupler is a lipid sol-
uble compound that allows H+ to diffuse back to the matrix while bypassing the
ATP synthase. As a results the ∆Ψm collapses. In an attempt to rescue the ∆Ψm
the OCR accelerates and the cell switches its metabolism from oxidative phosphory-
lation to glycolysis which increases ECAR. As a result, any substrate available in the
medium is oxidized and contributes to the maximal respiration rate [113] [10].
If mitochondrial electron transport chain is inhibited only the OCR caused by non-
mitochondrial respiration remains. The non-mitochondrial respiration is caused by
desaturation and detoxification enzymes and is only responsible for approximately
10% of total cellular oxygen consumption. Inhibitors such as rotenone in combina-
tion with antimycin A completely block the mitochondrial electron transport chain.
Rotenone inhibits the electron transfer from complex I to ubiquinone and thereby pre-
vents usage of the potential energy of NADPH. Antimycin A blocks the cytochrome
c reductase and therefore disrupts the proton gradient across the inner mitochondrial
membrane resulting in a decreased OCR and an increased ECAR to maintain energy
homeostasis. Cyanide inhibits complex IV and also some haem-containing enzymes
responsible for non-mitochondrial oxygen consumption[113] [10].
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1.4.3 How does Ca2+ influence bioenergetics?
Rapid mitochondrial Ca2+ uptake is import for various mitochondrial functions, such
as maintenance of the ∆Ψm, ATP production and various cellular signaling processes
[31] [106] [41]. Consequently, the disruption of mitochondrial Ca2+ uptake results into
reduced oxygen consumption, reduced ATP levels and activation of the AMPK which
activates cell death pathways. The outer mitochondrial membrane is permeable to
Ca2+ but through the inner mitochondrial membrane (IMM) which is impermeable
to ion flux, Ca2+ passes via MCU. Ca2+ acts as an energy production messenger for
various transport mechanisms while minimizing electron leak and subsequent damage.
Important Ca2+ regulated mitochondrial functions are ATP production and enzyme
activity depending on MCU-mediated Ca2+ uptake which is regulated by the ∆Ψm
and the mitochondrial respiratory electron chain [12] [146].
Mitochondrial Ca2+ stimulates ATP production directly and indirectly. It stimulates
indirectly ATP production by enhancing the activity of the mitochondrial complexes
I, III and IV during conditions of elevated Ca2+. Increased activity of these complexes
stimulates mitochondrial respiration and leads to an increase in Ψm. Ψm, NADH but
also Ca2+ itself regulates the activity of the ATP synthase (complex V). NADH is re-
duced Ca2+-dependently from NAD+ during the tricarboxylic acid cycle (TCA) cycle.
The pyruvate dehydrogenase which fuels the TCA cycle is also Ca2+ dependent. Pyru-
vate dehydrogenase phosphatase activates the dehydrogenase by dephosphorylation.
The dephosphorylated pyruvate dehydrogenase feeds acetyl coenzyme A (acetyl-CoA)
to the cycle and isocitrate dehydrogenase and α-ketoglutarate dehydrogenase break
down metabolites of the cycle. During these reactions NAD+ is reduced to NADH.
NADH feeds complex I and thus enhances electron flow and ATP production. The
increased autofluorescence of NADPH after Ca2+ stimulation of the Ca2+-dependent
enzymes can be measured experimentally [106] [130] [146] [93].
Mitochondrial Ca2+ influx is driven by the electrochemical potential gradient for Ca2+.
If ∆Ψm is in the physiological range, mitochondrial influx and efflux mechanisms op-
erate uni-directionally to allow the recycling of Ca2+ across the inner mitochondrial
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membrane. This mechanism is controlled kinetically by the maximal Ca2+ uptake
rate through MCU (e.g. 5.5 nmol Ca2+ per min-1 and mg-1 in liver mitochondria).
The kinetic control allows Ca2+ distribution without disrupting ∆Ψm and δpH and
therefore without disturbing ATP synthesis. In detail, the ∆Ψm is maintained by the
following mechanism: If Ca2+ enters the mitochondrium via MCU the positive ion
charge depolarizes the ∆Ψm. To equilibrate the ion charge of extra- and intramito-
chondrial space, Ca2+ effluxes by Na+-Ca2+ and Na+-H+ exchanger and H+ enters the
mitochondrium instead. The exchanger thereby transports Ca2+ out of the mitochon-
drium against its electrochemical potential gradient. Because the netto ion charge
inside the mitochondrium remains unaltered the ∆Ψm and δpH are not affected. If
the ∆Ψm collapses, the electrochemical potential does not drive Ca
2+ influx anymore
which results into a lack of mitochondrial Ca2+ uptake [31] [89].
UCP2 has been shown to be involved in the mitochondrial uptake of intracellular
Ca2+ [140]. Deak et al. further investigated the role of UCP2 in mitochondrial Ca2+
uptake. Knockdown of UCP2 (UCP2KD) in HeLa cells stimulated with histamine
in Ca2+-free medium showed an impaired mitochondrial Ca2+ uptake. In contrast,
thapsigargin stimulated UCP2KD cells did not show an impaired mitochondrial Ca2+
uptake after restoration of Ca2+. These results indicate that a UCP2 knockdown im-
pairs mitochondrial uptake only if the Ca2+ originates from the cytosol or ER but not
after SOCE stimulation [22]. Large currents in mitochondrial mitoplast (mitochon-
dria without their outer membranes) have been investigated by Bondarenko et al. in
HeLa cells overexpressing UCP2 or UCP2 knockdown HeLa cells. SiRNA mediated
UCP2 knockdown reduced the open probability of the large mitoplast currents by
approximately 38%. Overexpression of UCP2 enhanced the current approximately
3-fold. However, it has to be taken into account that these results were obtained
in mitoplast and can therefore not directly extrapolated on intact cells [7]. It is
assumed that UCP2 indirectly mediates MCU activity because Sancak et al. demon-
strated the absence of a direct interaction between UCP2 and MCU in a proteomic
assay. They analyzed MCU-Flag expressing HEK293T cells containing heavy or light
amino acid isotopes during quantitative mass spectrometry. Mass spectrometry iden-
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tified five proteins to form a complex with MCU which were detected by protein
immunoblotting as EMRE, MICU1, MICU2 and MCU. The mitochondrial Ca2+ han-
dling proteins LETM1, NCLX,UCP2 and 3, MCUR1, and TRPC3 did not form a
complex with MCU [110].
1.4.4 Formation of reactive oxygen species (ROS) during res-
piration and autophagy
ROS is mainly generated in the cell by cytosolic enzymes such as NADPH oxidases or
cyclooxygenases and during oxidative phosphorylation. However, it is also assumed
that approximately 90% of the cellular ROS is related to mitochondrial activity. Be-
tween 0.15% and 2% of the cellular oxygen may be used to produce superoxide instead
of being reduced to H2O by complex IV. The premature utilization of oxygen can oc-
cur at complex I, II and III. ROS formed at complex I and II is released into the
matrix, ROS produced at complex III can be released to both the matrix and mi-
tochondrial inner membrane and could therefore act as a signaling molecule in the
cytosol [47]. The reactive superoxide can be formed because the oxygen molecule is
capable of accepting an additional electron. Superoxide can be converted by super-
oxide dismutase to hydrogen peroxide which reacts with NO and forms peroxynitrite.
Peroxynitrite can irreversibly damage proteins of the electron transport chain [20].
The antioxidant scavenging enzymes catalase, glutathione peroxidase and peroxire-
doxin catalyze the reaction of the toxic H2O2 to H2O [3]. Superoxide production can
occur for example if the supply of oxygen, ADP or FADH is not sufficient. As a
result the electron flow through the respiratory chain is disturbed and can reverse.
For example in complex I, nicotinamide adenine dinucleotide (NADH) is not oxidized
to NAD+ anymore but NAD+ is reduced to NADH. Consequently, NADH reduces
molecular oxygen to superoxide [127].
UCPs and ANTs limit the ROS production by lowering the∆Ψm. The ANT exchanges
ATP against ADP across the inner mitochondrial membrane and therefore supplies
the ATP synthase constantly with ADP. H+ which enters the matrix does not couple
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directly to ATP synthesis and therefore reduces ∆Ψm. Thus, activation of UCP
or ANT reduces ROS production by lowering the ∆Ψm. If ROS accumulates, it
activates UCP or ANT which dissipate the proton gradient, decreases ∆Ψm and as a
consequence lowers ROS production. If the function of ANT is impaired, ANT can
contribute to apoptosis [63].
While moderate levels of ROS are essential for cell signaling, cell growth, prolifera-
tion and inflammatory responses, excessive ROS levels are associated with cell death
and autophagy [3] [47] [127]. Autophagy is a protective mechanism in response to
stress but excessive or insufficient autophagy can contribute to cell death. During
autophagy, moderate levels of ROS degrade misfolded proteins or defective organelles
clearing the cell from dysfunctional proteins and providing an alternative energy
source by self-digestion during starvation. By inducing autophagy the cell might pro-
long its own survival. If a cytosolic dysfunctional organelle is detected, it is engulfed
in the autophagosome, a double- or multimembrane vesicle. The autophagosome is
fused with lysosomes which degrade its content and recycle the amino and fatty acids
to generate ATP. Decreased cellular ATP levels can not only be enhanced by au-
tophagy but also by activation of the AMPK. The AMPK phosphorylates substrates
to limit anabolic pathways, that consume ATP and activates catabolic pathways to
generate substrates to support oxidative phosphorylation. AMPK is regulated by the
calmodulin-dependent protein kinase kinases (CaMKK) which is depending on cy-
tosolic Ca2+. High ATP levels inactivate the AMPK or accelerate ATP consumption
[12] [48].
The role of mitochondrial Ca2+ ([Ca2+]m)in the formation of ROS and induction of
autophagy and cell death has been investigated by several research groups. Excessive
Ca2+m is associated with increased ROS production. If ROS levels exceed the antiox-
idant capacity of the scavenging enzymes, ROS in turn might disrupt Ca2+ handling
pathways [20]. An overload of mitochondrial Ca2+ reduces the ∆Ψm and can result
into loss of the inner membrane impermeability. This allows molecules which can not
pass without a transporter under physiological conditions to enter the matrix and
induce apoptotic cell death. This phenomenon is called the ’opening of the mem-
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brane permeability transition pore (PTP)’ [57]. The effect of several MCU complex-
associated components on ROS production and induction of autophagy and cell death
has been explored. Rasmussen et al. investigated the effect of MCU overexpression
on ROS in an ischemia-reperfusion model. They perfused hearts isolated from cardiac
specific MCU overexpressing mice, loaded with the ∆Ψm indicator TMRE and the
cytosolic ROS indicator DCF ( 2’,7’-dichlorofluorescein) during an injury-reperfusion
model. 10, 20 and 30min after reperfusion, they did not observe a significant change in
TMRE but reduced DCF levels in the MCU overexpressing hearts. Furthermore, they
showed that reduced ROS levels resulted from reduced manganese sodium dismutase
levels [104]. Their result suggests that manganese sodium dismutase is upregulated
compensatory in MCU overexpressing hearts and reduced the superoxide levels that
only moderate levels were measurable.
The expression of the negative MCU regulator MICU1 has been reported to limit
superoxide production, to ensure the expression of antioxidant enzymes, to promote
proliferation and migration and to limit cell death. MICU1, MCU and MCUR1 are
tightly linked to each other in the MCU complex [49] [82] but proteomic analysis
demonstrated that MCUR1 can bind to MCU and EMRE independent of MICU1
[132]. Human cardiovascular derived endothelial cells have higher Ca2+mlevels and
increased basal superoxide levels after knockdown of the negative MCU regulator
MICU1. MICU1KD EA.hy926 cells (human endothelial cell line ATCCRCRL-2922Tm)
showed significantly elevated superoxide levels which were downregulated by the res-
cue of MICU1. Furthermore, the MCUI1 knockdown reduced the glutathione content
in MICU1KD EA.hy926 cells and reconstitution of MICU1 rescued the glutathione
levels. The proliferation rate was reduced in MICU1KD endothelial cells but rescued
after reconstitution with shRNA (short hairpin RNA)-insensitive MICU1 cDNA. The
human cardiovascular derived endothelial cells migrated less than control cells and
migration was rescued by stable expression of MICU1 [49]. Basal superoxide levels
were elevated in a MICU1KD endothelial cell line. Double knockdown of MCU and
MICU1 or rescue of MICU1 abrogated the elevation in superoxide levels. Thus it can
be concluded that the lack of MICU1 inhibiting MCU-mediated Ca2+ influx gives
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rise to superoxide production. Heterologous expression of mitochondrial manganese
superoxide dismutase and the cytosolic glutathione peroxidase in MICU1KD endothe-
lial cells decreased AMP/ATP ratio and elevated basal OCR. From this result it can
be concluded that chronically enhanced mitochondrial Ca2+ promotes the generation
of excessive ROS which inhibits the Ca2+-activated oxidative phosphorylation. LPS
and cyclohexamide induced cell death was enhanced in MICU1 KD endothelial cells,
and revoked by MICU1 rescue while overexpression of the mitochondrial manganese
superoxide dismutase and the cytosolic glutathione peroxidase protected MICU1KD
endothelial cells from cell death [82].
The soluble carrier SLC25A23 transports ATP-dependently Ca2+ into the matrix.
Hoffman et al. demonstrated that the direct interaction between SLC25A23 and
MCU is essential for MCU-mediated Ca2+ uptake. Knockdown of SLC25A23 in Hela
cells did not alter the∆Ψm and resulted into preserved ATP production. Interestingly,
SLC25A23 knockdown cells decreased basal superoxide levels indicated by MitoSox
red fluorescence. They were further protected from oxidative stress (applied via t-
butyl hydroperoxide) induced cell death which was demonstrated by annexinV and
propidium iodide staining. Rescue of SLC25A23 elevated MitoSox red levels and
cell death markers. T-butyl hydroperoxide mediated cell death requires Ca2+ [50]
and MCU expression protected from oxidative stress induced cell death. Liao et al.
demonstrated that short hairpin RNA-mediated down-regulation of MCU expression
in HeLa cells(shMCU HeLa cells) showed reduced H2O2 induced apoptosis after 24h
detected by FITC-labeled annexin-V staining during flow cytometry. Overexpression
of Flag-MCU (flag is a polypeptide protein tag used to label poorly immunogenic
proteins when protein specific antibodies are not available) in HeLa cells significantly
enhanced the H2O2 induced apoptosis rate [72].
Knockdown of the mitochondrial Ca2+-H+ exchanger LETM1 reduced ATP produc-
tion, basal OCR, complex IV activity and proliferation in HeLa cells, but NADPH lev-
els were not changed. These results indicate that reduced complex IV activity lowers
respiration and therefore basal OCR. As a result of the decreased OCR, ATP produc-
tion was decreased which was rescued by shRNA insensitive LETM1. The decreased
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proliferation in siRNA-mediated down-regulation of LETM1 expression (LETM1KD)
in HeLa cells was rescued by shRNA insensitive LETM1 as well. LETM1KD signifi-
cantly elevated superoxide production which was abrogated by the expression of the
mitochondrial-targeted manganese superoxide dismutase and glutathione peroxidase.
Overexpression of antioxidant superoxide dismutase and glutathione peroxidase fur-
ther restored complex IV activity and ATP levels. Disabled complex IV activity can
not retain partially reduced oxygen anymore. Consequently this oxygen contributes
to basal ROS production. Based on the low ATP levels Doonan et al. hypothesized
that the AMP/ATP ratio could be high which induces the phosphorylation of AMPK.
According to their expectation, they detected high phosphorylated AMPK levels in
LETM1KD HeLa cells which were rescued by reconstitution of LETM1.
Activation of AMPK results into autophagosome formation which can be monitored
by expression of the microtubule-associated protein light chain (LC)3 protein. LC3-I
and LC3-II were elevated in LETM1KD HeLa cells which showed a disrupted cell cycle
progression [30]. In summary, these results demonstrate that several components of
the MCU complex are involved in mitochondrial superoxide production and apopto-
sis. While knockdown of MCU and SLC25A23 has protective effects, knockdown of
LETM1 or MICU1 elevates oxidative stress.
1.5 Aims of my thesis
As outlined in the introduction, cytosolic Ca2+ elevated by receptor-operated (ROCE)
or store operated Ca2+ entry (SOCE) and buffered by mitochondrial Ca2+ uptake,
plays an essential role in physiological processes of lung cells. An abnormal high intra-
cellular Ca2+ concentration induces excessive contraction in precapillary pulmonary
arterial smooth muscle cells (PPASMC) inducing pulmonary arterial hypertension
(PAH), while Ca2+ overload in endothelial cells (MPMVEC) decreases vasculopro-
tective NO-production and increases vascular leakage and formation of lung edema.
Moreover mitochondrial Ca2+ uptake may affect energy production and life time of
these cells. Therefore, we believe that identification of signaling components in intra-
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cellular Ca2+ handling at the plasma membrane, in the cytosol, and in mitochondria
which can be targeted by drugs might be beneficial in future therapeutic approaches
of PAH and lung edema.
Three hypotheses need to be investigated:
1. STIM and Orai proteins are not the only molecular correlates of SOCE in
PPASMC and MPMVEC, because TRPC proteins which regulate ROCE are
also involved.
2. Deficiency of SOCE or ROCE in PPASMCs and MPMVECs protects from
vasoconstriction and lung edema formation.
3. Mitochondrial Ca2+ uptake by mitochondrial Ca2+ uniporter (MCU) complexes
affects cellular bioenergetics and dysfunction of lung cells.
Investigation of the first hypothesis requires creation of quintuple
TRPC1/3/6/STIM1/2- deficient mice by mating STIM1/2 floxed mice with
TRPC1/3/6-/- mice. A STIM1/2 deficiency is induced by infecting cells with Cre-
recombinase expressing lentiviruses or by mating the mice with tissue specific Cre
lines for smooth muscle (Myh11-Cre) or endothelial cells (Cdh5-Cre).
To verify the second hypothesis, we aim to establish store-operated and receptor-
operated Ca2+ channel deficient mouse strains and validate SOCE protocols for live
cell-imaging as well as for quantification of vasoconstriction and endothelial barrier
function. Assessment of cell migration and proliferation, morphological examination
by histology, immunofluorescence as well as gene and protein expression also need to
be analyzed..
The third hypothesis aimed to elucidate the effects of reduced mitochondrial Ca2+-
uptake on mitochondrial membrane potential, energy homeostasis, mitochondrial
stress, proliferation and autophagy. Characterization of mouse samples should involve
simultaneous live-cell measurement of mitochondrial Ca2+-uptake and mitochondrial
membrane potential in permeabilized cells, mitochondrial respiration rate, confocal
live-cell imaging and protein expression analysis.
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Chapter 2
Material
Product Manufacturer Product number
Acetylcholine chloride Sigma Aldrich, Deisenhofen, Germany A6625
Agarose Carl Roth, Karlsruhe, Germany 2267.4
Antibiotic-antimycotic solution Thermo Fisher Scientific, Pittsburgh, PA, US 15240-062
Antimycin A Sigma Aldrich, Milwaukee, US A8674
BCA (bicinchoninic acid)
Protein assay kit Pierce, Thermo Fi. Sci., Schwerte, Germany 23225
Bradford assay Thermo Fisher Scientific, Pittsburgh, PA, US 23200
BSA (bovine serum albumin) Sigma-Aldrich, Deisenhofen, Germany 9418
Ca2+-free HBSS PAA, Cölbe, Germany 15-009
(Hank’s Buffered Salt Solution)
Camco Quick StainR II Thermo Fisher Scientific, Pittsburgh, PA, US 04-330-1
Carbamoylcholine chloride Sigma Aldrich, Deisenhofen, Germany C4382
Carbonyl cyanide Sigma Aldrich, Milwaukee, US C2759
m-chorophenylhydrazone (CCCP)
Cell Trace CFSE Thermo Fisher Scientific, Pittsburgh, PA, US C34554
(carboxyfluorescein succinimidyl ester)
cell proliferation kit
CellTiter-Glo luminescent Promega Corporation, Madison, US G7570
assay kit
CGP-37157 (7-Chloro-5-(2-chlorophenyl) Sigma Aldrich, Milwaukee, US C8874 Sigma
-1,5-dihydro-4,1-benzothiazepin-2(3H)-one
Collagenase/dispase Sigma Aldrich, Deisenhofen, Germany 11097113001
Collagenase Sigma Aldrich, Deisenhofen, Germany C5138
Cyclopiazonic acid Sigma Aldrich, Deisenhofen, Germany C1530
Digitonin Sigma Aldrich, Milwaukee, US D141
Dil-Ac-LDL Harbor Bio products, Norwood, MA, US J65597
DMEM Thermo Fisher Scientific, Pittsburgh, PA, US HyClone
(Dulbecco’s Modified Eagle’s Medium) SH30022.01
Dynabeads protein G Thermo Fisher Scientific, Pittsburgh, PA, US 1004D
ECGS (endothelial cell Merck Millipore, Billerica, MA, US 02-102
growth supplement-heparin)
EconoTaq polymerase Lucigen, Middleton, US F93481-1
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EGTA (ethylene glycol-bis(β-aminoethyl Sigma Aldrich, Milwaukee, US 34596
ether)-N,N,N’,N’-tetraacetic acid)
Eosin Thermo Fisher Scientific, Pittsburgh, PA, US s176
FCCP (carbonyl cyanide-4- Sigma Aldrich, Milwaukee, US C2920
(trifluoromethoxy)phenylhydrazone
Formaldehyde Sigma Aldrich, Deisenhofen, Germany 252549
Fe3O4 Sigma-Aldrich,Deisenhofen, Germany 310050
FITC (fluorescein isothiocyanate) Molecular Probes, Invitrogen 46945
dextran 70 kDa
Fluo-4Tm Thermo Fisher Scientific, Pittsburgh, PA, US F14201
Fura-2-AM Fluka, Sigma-Aldrich, Deisenhofen, Germany 47989
(acetoxymethyl-ester)
GenEluteTm Sigma Aldrich, Deisenhofen, Germany G1N70-1KT
Goat serum Bio-West, Nuaille, France S2000-100
Hematoxylin Thermo Fisher Scientific, Pittsburgh, PA, US s212A
Heparin Sigma Aldrich, Milwaukee, US H3393
Hoechst Sigma Aldrich, Deisenhofen, Germany 33342
InviTrapTm STRATEC Molecular GmbH, Berlin, Germany 1060100300
JC-1Tm Thermo Fisher Scientific, Pittsburgh, PA, US T3168
Krebs-Henseleit-Buffer Sigma Aldrich, Deisenhofen, Germany K3753
Low-melting-point agarose Sigma Aldrich, Deisenhofen, Germany A9045
MacConkey Agar BD Biosciences, Franklin Lakes, NJ, US BD 212123
Mammalian Genomic Sigma Aldrich, Deisenhofen, Germany G1N70-1KT
DNA Miniprepkit
MitoSOX RedTm Invitrogen, Eugene, OR, US M36008
Mounting media Dako, Hamburg, Germany 53023
Mygliol Caelo, Hilden, Germany 3274
Oligomycin Sigma Aldrich, Milwaukee, US 75351
Phosphate-buffered saline (PBS) Thermo Fisher Scientific, Pittsburgh, PA, US 10010056
PermountTm Thermo Fi.Sci, Schwerte, Germany SP15-100
Phalloidin-TRITC Sigma Aldrich, Deisenhofen, Germany P1951
(tetramethylrhodamine)
Phenylephrine Sigma Aldrich, Deisenhofen, Germany P1250000
PluronicR F-127 Thermo Fisher Scientific, Pittsburgh, PA, US P6867
Polyethylene glycol BioCat, Heidelberg, Germany LV825A
precipitation solution
Protease inhibitor Roche, Sigma Aldrich, Milwaukee, US 04693116001
RestoreTM Western Blot Thermo Fisher Scientific, Pittsburgh, PA, US 21059
Stripping Buffer
Reverse transcriptase Thermo Fi.Sci, Schwerte, Germany K1632
Rhod-2 AMTm Thermo Fisher Scientific, Pittsburgh, PA, US R1245MP
Rhodamin 123Tm Thermo Fisher Scientific, Pittsburgh, PA, US R302
RIPA buffer Merck Millipore, Billerica, MA, US 20-188
Rotenone Sigma Aldrich, Milwaukee, US R8875
Ru360 Santa Cruz Biotechnology Inc., Dallas, TX, US sc-222265
Smooth Muscle Cell PromoCell, Heidelberg, Germany C-22062
Growth Medium 2
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Sodium nitroprusside dihydrate Sigma Aldrich, Milwaukee, US 71778
Sodium pyruvate Sigma Aldrich, Milwaukee, US P2256
Spin Universal RNA MiniKit Stratec Molecular, Berlin, Germany 1060100300
Succinate Sigma Aldrich, Milwaukee, US 14160
Sulphinpyrazone Sigma Aldrich, Milwaukee, US S9509
SuperSignalTM West Femto Pierce,Thermo Fi.Sci, Schwerte, Germany 34096
Maximum Sensitivity Substrate
SuperSignalTM West Pico Pierce,Thermo Fi.Sci, Schwerte, Germany 34080
Chemiluminescent Substrate
SYBR Green I Pierce,Thermo Fi.Sci, Schwerte, Germany AB 1159B
Tamoxifen Sigma Aldrich, Deisenhofen, Germany T5648
Thapsigargin Calbiochem, Darmstadt, Germany 586005
TMRM (tetramethylrhodamine Thermo Fisher Scientific, Pittsburgh, PA, US T668
methyl ester)
Triton X-100 Carl Roth, Karlsruhe, Germany 3051.2 Carl Roth
Thrombin Calbiochem, Merck, Darmstadt, Germany 605157
XF Cell Mito Stress Test KitTm Seahorse Bioscience, North Billerica, MA, US 103015-100
Table 2.1: List of chemicals and reagents
Antibody specific for Product number Manufacturer Dilution
α-Drp1 sc-32898 Santa Cruz Biotechnology Inc., Dallas, TX, US 1:500
α-Mfn2 sc-100560 Santa Cruz Biotechnology Inc., Dallas, TX, US 1:500
α-SMA A5228 Sigma Aldrich, Milwaukee, US 1:1000
α-TOM20 sc11415 Santa Cruz Biotechnology Inc., Dallas, TX, US 1:1000
β-actin sc-4778 Santa Cruz Biotechnology Inc., Dallas, TX, US 1:10000
AMPK 2532 Cell Signaling Technology, Beverly, MA,US 1:1000
anti-cycF ab110324 Abcam,Cambridge, MA, US 1:1000
anti-goat IgG-HRP sc-2056 Santa Cruz Biotechnology Inc., Dallas, TX, US 1:5000
anti-mouse IgG-HRP 7076S Cell Signaling Technology, Beverly, MA,US 1:5000
anti-mouse IgG-FITC F9006 Sigma Aldrich, Milwaukee, US 1:50
anti-rabbit FITC- A11008 Thermo Scientific 1:200
labelled antibody
anti-rabbit IgG-HRP 7074S Cell Signaling Technology, Beverly, MA,US 1:5000
CD-144 BD 55528 clone 11D4.1 BD biosciences, Heidelberg, Germany
(VE-Cadherin5)
eNOS 9572S Cell Signaling Technology, Beverly, MA,US 1:500
LC3 L8918 Sigma Aldrich, Milwaukee, US 1:5000
MCU custom-made antibody 1:500
MCUR1 ARP44777_P050 Aviva Systems Biology, San Diego, CA, US 1:1000
Mitocomplex ab110411 Abcam,Cambridge, MA, US 1:500
mTFA ab138351 Abcam,Cambridge, MA, US 1:5000
Orai1 sc-68895 Santa Cruz Biotechnology Inc., Dallas, TX, US 1:500
OXPHOS ab110413 Abcam,Cambridge, MA, US 1:250
p62 5114S Cell Signaling Technology, Beverly, MA,US 1:1000
PGCI-α ab54481 Abcam,Cambridge, MA, US 1:500
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phospho-AMPK 40H9 Cell Signaling Technology, Beverly, MA,US 1:1000
phospho-eNOS 9571 Cell Signaling Technology, Beverly, MA,US 1:500
(Ser1177)
STIM1 4917S Cell Signaling Technology, Beverly, MA,US 1:500
STIM1 sc-66173 Santa Cruz Biotechnology Inc., Dallas, TX, US 1:500
UCP2 sc-6525 Santa Cruz Biotechnology Inc., Dallas, TX, US 1:500
ZO-1 40220 Life Technologies, Darmstadt, Germany 1:100
Table 2.2: List of antibodies
Buffer Composition
PBS 1.06mM KH2PO4, 1.55NaCl
2.97mM Na2HPO4-7H2O)
ECM 121 mM NaCl, 5 mM NaHCO3, 10 mM Na-HEPES, 4.7 mM KCl
(extracellular 1.2 mM KH2PO4, 1.2 mM MgSO4
medium) 2 mM CaCl2, 10 mM glucose, and 2.0% BSA
Running buffer 250mM tris base, 1,920M glycin, 35mM SDS
Transfer buffer 250mM tris base, 1,920M glycin, 7mM SDS
Table 2.3: List of buffers
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Chapter 3
Methods
3.1 Breeding and genotyping of gene deficient mice
The heterozygous STIM1+/- Orai1+/- were provided by Dr. Attila Braun, Rudolf-
Virchow- Center Würzburg, Germany. Mutated embryonic stem (ES) cell lines origi-
nally established by BayGenomics using the gene-trap technology [126] were used to
generate heterozygous mice for STIM1 [137] (MGI Symbol: STIM1Gt(RRS558)Byg) and
Orai1 [138] (MGI Symbol: Orai1Gt(XL922)Byg). A double STIM1+/- Orai1+/- mouse
line was established by breeding both strains in our animal facility. We needed to
design new specific primers to genotype the offspring. The forward primers bind to
the sequence of intron 7 (STIM1) or intron 1 (Orai1) and the reverse primers to the
beta-geo cassette (see figure 3.1 and table 3.1). Details of the used PCR program and
expected PCR products are summarized in (see table 3.2).
59
Primer
STIM1 Wt 5’-GTC ATA GCC TGT AAA CTA GA-3’
5’-GTA GCT GCA GGT AGC ACT AG-3’
STIM1+/- 5’-TGT ATG CTT GGG CTA CAG GTG-3’
5’-TGT GCT GCA AGG CGA TTA AG-3’
Orai1 Wt 5’-CTC TTG AGA GGT AAG AAC TT-3’
5’-GAT CCC TAG GAC CCA TGT GG-3
Orai1+/- 5’-TTG AGC GAG CCG TTC ACT TT-3
5’-AGG GGT CTT GGG TTA GAG GG-3
Table 3.1: Primer for genotyping of STIM1+/- Orai1+/- mice
STIM1 Wt STIM1+/- Orai1 Wt Orai1+/-
5 min 96◦C 5 min 96◦C 3 min 96◦C 5 min 96◦C
45 cycles of: 45 cycles of: 45 cycles of: 45 cycles of:
(1 min 94◦C (1 min 94◦C (1 min 94◦C (1 min 94◦C
1 min 51.5◦C 1 min 60.0◦C 1 min 51.5◦C 1 min 53.0◦C
1 min 72◦C ) 1 min 72◦C) 1 min 72◦C) 1 min 72◦C)
5 min 72◦C 10 min 72◦C 5 min 72◦C 10 min 72◦C
store at 14◦C store at 14◦C store at 14◦C store at 14◦C
Expected fragments 750 bp 500 bp 900 bp 250 bp
Table 3.2: Wt and STIM1+/-Orai1+/- PCR program
The LoxP/Cre technology was used for a tissue-specific deletion of STIM1 and STIM2
genes in smooth muscle cells. STIM1 and STIM2 floxed mice were provided by Dr.
Stefan Feske , New York University, US (see figure 3.2) [92] and the Myh11-Cre/ERT2
line was purchased by Jackson Laboratory (B6.FVB-Tg(Myh11-Cre/ERT2)1Soff/J;
#019079) [147].
In the Myh11-Cre/ERT2 mice, the Cre-recombinase is expressed under the control
of the smooth muscle cell specific promotor of the myosin heavy chain 11 (Myh11)
gene. Therefore, the Cre-recombinase only deletes the STIM1/2 exons in smooth
muscle cells. In the used Cre line however the Cre recombinase is fused to the estro-
gen receptor 2 (ERT2) which is only activated by tamoxifen injected in the mouse
model. The mutated ligand binding domain of ERT2 prevents binding of its natu-
ral ligand estradiol. Cre-ERT2 is bound to the heatshock protein 90 which inhibits
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Figure 3.1: Gene trapping method to generate heterozygote STIM1+/-
Orai1+/- C57BL/6 mice. A trap vector is randomly integrated in transcriptional
active genes of ES cells [126]. The ES cell line carrying the gene trap cassette in the
gene of interest can be selected from the database of the International Gene Trap
Consortium.The trap vector consists of the splice acceptor site (SA), a selection con-
struct (e.g. β-geo) and a polyadenylation tail (pA). The endogenous transcription
continues at the splice acceptor site but is interrupted by the polyadenylation signal
and results in a truncated mRNA. Primers binding to the trap cassette were used for
sequencing the mRNA product in 3’ to 5’ direction to identify the trapped gene. To
generate gene deficient mice which only produce truncated mRNAs and proteins from
the gene of interest, a fusion protein containing LacZ is produced instead to detect
transcriptional active tissues of the gene of interest in the corresponding gene trap
mouse model [40].
Figure 3.2: Generation of STIM1/2 floxed mice [92]. Exon2 of the STIM1 gene
and exon3 of the STIM2 gene were replaced by the neomycin resistance gene flanked
by loxP and Frt recombination sites. Exon2 codes for the EF hand motif of the
STIM1 gene and exon3 codes for sequences c-terminal to the EF-hand of the STIM2
gene. The modified embryonic stem cells were injected into blastocyts to generate
chimeric mice. Mating of the STIM1neo/+ or STIM2neo/+ mice with the ‘Flp deleter’
transgenic mice removed the neomycin cassette but not the loxP site [92]. The exon2
or exon3 flanked by the loxP sites are deleted after mating the mouse model with
a line expressing Cre recombinase under the control of a promoter from a protein
(myosin heavy chain 11) specifically expressed in smooth muscle cells.
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the Cre-recombinase activity. Upon tamoxifen application, the heatshock protein is
dissociated and the Cre-recombinase is activated. The Cre-recombinase removes the
floxed DNA segments resulting in STIM1/2 gene deficient ‘knock-out’ only in smooth
muscle cells (see figure 3.3). A STIM1/2 mediated interaction with store-operated
Ca2+ channels (e.g. Orai) is not possible anymore.
Figure 3.3: Inducible smooth muscle cell specific knockout using tamoxifen.
The Cre-recombinase is expressed under the control of the Mhy11 promotor only in
smooth muscle cells. Upon tamoxifen application, the Cre-recombinase is activated
and deletes the floxed STIM1/2 exon. See text for a more detailed description
The transgene coding for Cre/ERT2 sequence under the control of the Myh11 pro-
moter is inserted in the Y chromosome (B6.FVB-Tg(Myh11-Cre/ERT2)1Soff/J; #019079)
[147]. Therefore only males express Cre/ERT2 fusion protein in their smooth muscle
cells and can be used for tamoxifen induced recombination. Male Myh11-Cre/ERT2
STIM1/2 flox mice were injected intraperitoneal with corn oil only (controls) or with
tamoxifen dissolved in corn oil (100µl, 20 mg/ml tamoxifen) every second day three
times. As additional controls, wildtype mice were injected with tamoxifen. After a
period of 14 days, PPASMC were isolated from all mice. PCRs from the genomic
DNA and reverse transcribed cDNA from the isolated mRNA (see figure 3.2) of dif-
ferent smooth muscle tissues and PPASMCs was performed to identify a successful
deletion of STIM1/2 exons (see table 3.3 and 3.4). Animal experiments with these
mice were approved by the federal government of Oberbayern and implemented at
the Walther-Straub-Institute for Pharmacology and Toxicology, Munich, Germany.
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Primer
STIM1 Wt 5’-CGA TGG TCT CAC GGT CTC TAG TTT-3’
STIM1 AS 5’-GGC TCT GCT GAC CTG GAA CTA TAG TG-3’
STIM1 KO 5’-AAC GTC TTG CAG TTG CTG TAG GC-3’
STIM2 Wt 5’-CAT CAG AAG GTA AAA CTG TGC AGT GCT C-3’
STIM2 AS 5’-GGA TGT CCT GGA CTC ACT CTG TAG ACC A-3’
STIM2 KO 5’-GCT GAA CTG TGT GCT TGA CTG TAG C-3’
Table 3.3: Primer for genotyping of STIM1 flox and STIM2 flox mice
STIM1 flox STIM1 KO STIM2 flox STIM2 KO
2 min 96◦C 2 min 96◦C 2 min 96◦C 2 min 96◦C
30 cycles of: 30 cycles of: 30 cycles of: 30 cycles of:
( 20sec 96◦C ( 20sec 96◦C (20 sec 97◦C (20 sec 97◦C
30 sec 60◦C 30 sec 60◦C 30 sec 61◦C 30 sec 68◦C
25 sec 72◦C) 25 sec 72◦C) 25 sec 72◦C) 40 sec 72◦C)
5 min 72◦C 5 min 72◦C 5 min 72◦C 5 min 72◦C
store at 14◦C store at 14◦C store at 14◦C store at 14◦C
Expected 399 bp STIM1 flox 580 bp 335 bp STIM2 flox 683 bp
fragments 348 bp Wt STIM1 KO 262 bp Wt STIM2 KO
Table 3.4: Wt and STIM1 flox and KO and STIM2 flox and KO PCR
program
STIM1/2∆EC, Orai1∆EC, MCU∆EC [76] and MCUR1∆EC [132] mice were gener-
ated by breeding the respective flox/flox mice with B6.Cg-Tg(Cdh5- Cre)7Mlia/J;(VE-
Cre) mice (stock 006137, The Jackson Laboratory) which express a constitutively
active Cre-recombinase under the control of the cadherin 5 (Cdh5) promoter only in
endothelial cells. STIM1/2∆EC, Orai1∆EC, MCU∆EC and MCUR1∆EC knockout
mice did neither show any developmental defects nor any changed behavior to wild-
type mice was observed. The presence of the floxed gene sequence was confirmed by
genotyping from ear clips. The endothelial specific knockout was confirmed by mRNA
and protein detection in freshly isolated MPMVEC from lungs. Animal experiments
with these mice were approved by Temple University’s IACUC, followed AAALAC
guidelines and implemented at Temple University, Philadelphia, US.
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3.2 RNA isolation and analysis by quantitative
reverse transcription (RT)-PCR
RNA was isolated using the InviTrapTmSpin Universal RNA MiniKit (1060100300,
Stratec) according to the manufacturer’s instruction. In brief, tissue or cells were
lysed. The lysate was first passed through a column to remove genomic DNA and
through a second column which binds RNA. After washing, the purified total RNA
was eluted and stored at -80 ◦C for further analysis.
Single-stranded RNA was transcribed into complementary DNA (cDNA) by the re-
verse transcriptase (K1632, ThermoScientific) in a Thermocycler (Peqstar 96 Univer-
sal Gradient, Peqlab). The resulting cDNA was used for quantitative (reverse tran-
scription) polymerase chain reaction (PCR). During quantitative PCR, the cDNA is
amplified using specific primers (see table 3.5). SYBR Green I (AB 1159B, Thermo-
Scientific) binds double stranded DNA during amplification resulting in an emission
of light of 521 nm after excitation at 494 nm. The signal is proportional to the cDNA
content and therefore potentiates after each cycle. The relative expression of the ’gene
of interest’ is expressed in ratio to a ’housekeeping gene’, such as β-actin.
Primer
STIM1 forward 5’-AAG CTT ATC AGC GTG GAG GA-3’
STIM1 reverse 5’-CCT CAT CCA CAG TCC AGT TGT-3’
STIM2 forward 5’-GAG GGC GCA GAG TGT GAG-3’
STIM2 reverse 5’-TTT AGA GCC ATG CGG ACCT-3
Table 3.5: Quantitative, reverse, transcription (RT)-PCR primer
3.3 DNA extraction and purification
Genomic DNA was isolated from tail clips, intestine, aorta or PPASMCs using the
GenEluteTm Mammalian Genomic DNA Miniprepkit (G1N70-1KT, Sigma Aldrich)
according to the manufacturer’s instruction. In brief, tissue or cells were lysed with
proteinase K and purified on a anion exchange column. PCR products were ampli-
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Primer
STIM1 Cre forward 5’-ACG ATG CCA ATG GTG ATG TG-3’
STIM1 Cre reverse 5’-TCT GAT GAC TTC CAC GCC TT-3’
STIM2 Cre forward 5’-AGT CAC CTG CAC AGA GAA GA-3’
STIM2 Cre reverse 5’-GGA GTG TTG TTC CCT TCA CA-3
Table 3.6: Quantitative, reverse, transcription (RT)-PCR primer in tissue
specific gene deficient mice To detect deleted mRNA transcripts in tissue specific
gene deficient mice primer were used which anneal to the deleted exon sequences
(exon 2 for STIM1 and exon 3 for STIM2).
fied from purified genomic DNA by EconoTaq polymerase (Lucigen, F93481-1) using
specific primers (see table 3.3 and 3.4. The resulting DNA fragments were separated
by gel electrophoresis and visualized under UV-light using ethidiumbromide.
3.4 Production of lentiviruses
The production of recombinant lentiviruses which are derived from the human im-
munodeficiency virus (HIV-1) requires additional lab biosafety procedures and was
done in the S2 tissue culture lab of the Walther-Straub-Institute. Lentiviral vectors
can deliver, integrate and control the expression of transgenes in dividing cells.
Three vectors were transfected by calcium phosphate transfection into HEK293T
cells to produce lentiviruses: the lentiviral coding plasmid (pLM-CMV-R-Cre, plas-
mid #27546 from addgene), the packaging plasmid (psPAX2, plasmid #27546 from
addgene) and a plasmid coding for the envelope protein (PMD2.G, plasmid #12259
from addgene) (see figure 3.5). After transfection, they recombine, integrate and the
cellular machinery produces recombinant virus particles which are released into the
cell supernatant. When the virus from this supernatant infects STIM1/2 floxed cells,
the viral RNA is reverse-transcribed into DNA, enters the nucleus and is stably inte-
grated into the chromosomal DNA of the target cell (see figure 3.4). We used a second
generation lentivirus system, which is designed in a way that it is less probable that
replication competent viruses are formed from the lentiviral infected cells. This is
achieved by separate expression of the transfer, envelope and packaging components
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Figure 3.4: Production of recombinant lentiviruses and cell infection. Re-
combinant lentiviruses are produced in HEK 293T cells transfected with three plas-
mids expressing essential lentiviral genes. The produced recombinant lentiviruses can
be used to infect target cells, where they are stably integrated in the host genome
(modified from [2]).
Figure 3.5: Map of plasmids used for lentivirus production. For more details
see text [2]
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on different vectors. The lentiviral transfer vector contains the Cre-recombinase gene
sequence that is incorporated into the host genome. Therefore, it stably induces the
expression of the Cre-recombinase but it does not express envelope proteins and genes
required for packaging which are essential to produce replication competent virus par-
ticles. To obtain a 1 to 2 log higher viral titer we concentrated the lentivirus with
a polyethylene glycol precipitation solution (product number #LV825A from Bio-
Cat). PPASMCs were infected at 70-80% confluence with naked or mCherry-tagged
lentivirus which produced a red fluorescence in infected cells (plasmid #27546 from
addgene) or control lentivirus (G5A, eGFP-5-Aequorin). After 7days, the recombina-
tion efficiency was checked by PCR or detection of fluorescent cells [2]. Our protocol
was adapted from the lentivirus production protocol of the Tronolab [135] [2].
3.5 Isolation of cells and cell culture
3.5.1 Precapillary pulmonary arterial smooth muscle cells
(PPASMC)
Mouse precapillary PPASMC were isolated from small pulmonary arterial vessels
(30µm to 150µm in diameter). In detail, the lung of a heparinized (500U) and euth-
anized (125mg/ml xylazine and 100mg/ml ketamine) mouse was flushed with PBS
and instilled with 0.5% low-melting-point agarose (A9045, Sigma-Aldrich) containing
0.5% Fe3O4 particles (310050, Sigma-Aldrich) via a catheter in the right ventricle.
The lungs were removed, chopped and digested with 0.1mg/ml collagenase (C5138,
Sigma Aldrich) at 37 ◦C for 1 hour. Afterwards, the digestion was stopped, the so-
lution was sheared with a 18G (4665120, Sterican, Braun) needle and placed into a
magnetic holder. As a result, only the iron particles which are stuck in the precapil-
lary arterial vessels are drawn to the magnet and are separated from other cell types
released during digestion. The vessels were plated on coverslips in Smooth Muscle
Cell Growth Medium 2 (C-22062, PromoCell) and cells were grown for 5 or 6 days
before passaging and staining with α-smooth muscle actin antibody (A5228 Sigma
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Aldrich) to identify them as smooth muscle cells according to the method described
in [143].
3.5.2 Tracheal smooth muscle cells (TSMC)
The trachea of a heparinized (500U) and euthanized (125mg/ml xylazine and 100mg/ml
ketamine) mouse was dissected and cleaned mechanically from surrounding tissue and
endothelium. It was cut into small pieces, grown in Smooth Muscle Cell Growth
Medium 2 (C-22062, PromoCell) and grown for 5 or 6 days before passaging.
3.5.3 Murine pulmonary microvascular endothelial cells
(MPMVEC)
Primary murine MPMVECs were isolated from lungs of four mice. Briefly, freshly
harvested mouse lungs were digested with 1mg/ml collagenase/dispase (11097113001
Roche) and incubated with CD-144 (VE-Cadherin5 BD 55528 clone 11D4.1 BD bio-
sciences) antibody labeled magnetic dynabeads (1004D protein G Thermo Scientific).
Endothelial cells which adhered to the beads were washed and plated in MPMVEC
media. MPMVECs were cultured in DMEM (HyClone SH30022.01 Thermo Fisher
Scientific), containing 4.5 g/ml glucose, 4mM glutamine, 10% FBS, 1% antibiotic-
antimycotic solution (15240-062 Thermo Fisher Scientific), 11 µg/ml ECGS (02-102
Merck Millipore ) and 17U/ml heparin (H3393 Sigma-Aldrich). MPMVECs were
always plated at a minimum of 60% confluency on 0.2% gelatine coated flasks, split
once or twice a week and used between passage 2 and 8.
To identify MPMVECs, Dil-Ac-LDL (10 µg/ml) was added to the growth media for
4h at 37 ◦C. After washing cells with PBS several times, fluorescence was visualized
using a rhodamine excitation/emission filter.
3.5.4 Murine lung fibroblasts (MLF)
Cells which were not bound to the dynabeads during isolation of MPMVEC were
plated separately and grown as murine lung fibroblasts (MLF). MLF contain the
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loxP sites but not the Cre-recombinase which is under the promotor of VE-Cadherin
and is only expressed in endothelial cells. Therefore, excision of the floxed exons was
achieved by infection with house-made adenoviruses constitutively expressing the Cre
recombinase (50-100MOI, different batches: 1x108 IFU/ml or 3.1x1010 IFU/ml or
1.27x109 IFU/ml) for 10days. Downregulation of STIM1/2 and Orai1 was confirmed
by quantitative RT-PCR and Western Blot.
3.6 Protein analysis by Western Blotting
Western blots have been run in our lab in Munich according to the following method:
In brief, proteins were lysed with 1x RIPA buffer (10x RIPA buffer: 1% Igepal CA
630, 0,5% Na-deoxycholat, 0,1% SDS in 1 X PBS) and the concentration of the lysate
was measured with a BCA Protein assay kit (23225, Pierce). 4x Laemmli buffer was
added to the lysate and boiled at 95 ◦C to break the disulfide bonds and tertiary
structure of the protein. Equal amounts of proteins were loaded on an acrylamide
gel and run at constant 20mA. After protein separation, proteins were transferred
to a polyvinylidene difluoride membrane. The transfer was confirmed by Ponceau S
which binds proteins unspecifically. Membranes were blocked with 5% milk powder in
PBST, incubated with primary, HRP-conjugated secondary antibodies and developed
with the SuperSignalTM West Femto Maximum Sensitivity Substrate (34096, Thermo
Scientific) or SuperSignalTM West Pico Chemiluminescent Substrate (34080, Thermo
Scientific) using the Chemismart analyzer.
Western blots have been run in the lab of Madesh Muniswamy in Philadelphia ac-
cording to the following method:
Cells were lysed in 1x RIPA buffer (20-188 Millipore) and 1x protease inhibitor
(04693116001 Complete, Roche). Equal amounts of protein were loaded per lane
and separated on a 4 to 12% bis-tris polyacrylamide gel, transferred to a polyvinyli-
dene difluoride membrane, blocked and probed with primary antibodies (see table
2.2). Secondary antibodies used were: anti-rabbit (7074S Cell signaling 1:5000), anti-
goat (sc-2056 Santa Cruz Biotechnology Inc., 1:5000) and anti-mouse (7076S, Cell
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signaling, 1:5000) conjugated to horse radish peroxidase. Western blots were devel-
oped using either SuperSignalTM West Femto Maximum Sensitivity Substrate (34096,
Thermo Scientific) or SuperSignalTM West Pico Chemiluminescent Substrate (34080,
Thermo Scientific). If membranes were reprobed with antibody, they were stripped
with RestoreTM Western Blot Stripping Buffer (21059, Thermo Scientific).
3.7 Analysis of bronchial reactivity
3.7.1 Myograph
The primary bronchus, trachea and thoracic aorta were dissected from STIM1+/-
Orai1+/-, STIM1/2∆EC or Orai1∆EC mice, cleaned from connective tissue, cut in rings
and mounted in a myograph (610M, DMT) containing physiological (37 ◦C warm
Krebs-Henseleit-Buffer (K3753, Sigma Aldrich) perfused with carbogen gas (95% O2
/5% CO2) (see figure 3.6.) Tissue was pre-streched to 4.5mN for aortic rings and to
2.5mN for tracheal rings from primary bronchi and equilibrated 1h while the buffer
was changed every 20min. 120mM KCl was added which induces a membrane de-
polarisation and activates voltage-dependent calcium channels. Tissue which did not
respond to KCl treatment was classified as non-functional and not used for further
analysis.
Aortas of STIM1/2∆EC or Orai1∆EC mice mice were treated with 1 µM phenylephrine
(PE). Phenylephrine, an α1-adrenoceptor agonist, activates Gq-coupled receptors and
phospholipase C producing DAG which activates TRPC3/6/7 channels. Membrane
depolarisation, activation of voltage-gated calcium channels and influx of extracellu-
lar calcium, subsequently contracted aortic rings. At the steady maximal contraction,
cumulative concentrations of acetylcholine (ACh, 0.01 µM-30 µM) and finally sodium
nitroprusside (SNP, 3 µM) were added. Cumulative concentrations of ACh induced
endothelium-dependent relaxation, SNP induces an endothelium-independent relax-
ation. The relaxation was normalized to the PE contraction of the same aorta.
The primary bronchus of STIM1+/- Orai1+/- mice was dissected and mounted. After
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confirming the vitality of the tracheal rings from primary bronchi, they were incu-
bated with Ca2+-free Krebs-Henseleit-Buffer. To deplete intracellular stores, tracheal
rings were stimulated with cumulative concentrations of the muscarinic acetylcholine
receptor agonist, carbachol (CCH, 500nM, 1 µM, 10 µM) before 2mM Ca2+ was re-
stored. Restoration of Ca2+ resulted into a contraction of the tracheal rings. After
washing and reaching baseline contraction levels, this protocol was repeated at least
five times with the same tracheal rings. The contraction response was normalized to
the first contraction of the same ring.
Figure 3.6: Measurement of contraction and dilatation with a myograph.
Rings from blood vessels, trachea or bronchi are mounted in an organ bath of a
myograph (610M, DMT) and stimulated by different pharmacological agonists. The
resulting contraction or dilatation was recorded.
3.7.2 Precision cut lung slices (PCLS)
The lung of an euthanized mouse was filled with low-melting point agarose. After the
agarose had solidified the lung was cut into 200µM thick slices using a vibratome.
Slices were cultivated in a cell culture incubator for several days. Their vitality was
confirmed by their ciliary movement and intact bronchial smooth muscle layer under
a microscope. Intact PCLS were mounted in an imaging chamber and hold in position
with a metal ring. Additive concentrations of carbachol (500nM-2,3mM, over a period
of 40min) were applied to the PCLS. Images were taken as a time lapse series using
the bright field mode of a Zeiss LSM710 META microscope.
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3.8 Scratch assay
MPMVECs were seeded at equal density in 6-well plates to form a confluent mono-
layer. A 1.8mm scratch was cut per well using a sterile 200µl tip. The wells were
washed with PBS and filled with DMEM, containing 2% FBS. Immediately after the
scratch, after 24h and after 48h, cells were fixed with CAMCO Quick StainR II and
bright field images were taken with a 4x objective at multiple locations. Migration
was quantified using the Image J software (NIH) and results are expressed as percent
gap closure.
3.9 Proliferation assay
MPMVECs were stained with 5-(and-6)-carboxyfluorescein diacetate succinimidyl es-
ter (CFSE) using a Cell Trace CFSE cell proliferation kit (C34554; Invitrogen). Cells
were labeled with 5 µM CFSE for 15min at 37 ◦C and 5% CO2 and plated on T75
flasks for 72h. These cells were used as ’proliferated cells’ after 72hs. ’Nonprolifer-
ated cells’ were stained in the same way but used directly for the experiment without
plating and growing for 72hs. 15’000 events/sample were assessed using standard
gating procedures with a BD FACSCaliburTm. Relative fluorescence intensities were
analyzed using FlowJo software.
3.10 Analysis of vascular permeability and edema
formation
3.10.1 Immunohistochemistry and phalloidin staining
Cells were fixed with 3.7% formaldehyde (252549 Sigma-Aldrich), permeabilized and
blocked with 0,3% Triton X-100 (3051.2 Carl Roth) and 5% goat serum (S2000-100
Bio-West). Primary antibody was diluted (in 1% BSA in PBS and 0,3% Triton X-100)
and incubated overnight at 4 ◦C. After washing (PBS 0.1% BSA, 9418 Sigma-Aldrich),
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the secondary antibody was incubated at room temperature, in the dark, for 2 hours.
Hoechst (33342 Sigma-Aldrich 1:5000 in PBS) was used to stain the nuclei. The
coverslips were mounted on microscope slides using Dako Mounting media (53023,
Dako Hamburg) and transparent nail polish.
To induce stress fiber formation, MPMVECs were stimulated with 5nM thrombin
(605157, Calbiochem, Merck, Darmstadt) for 5min. After permeabilization and fix-
ation, cells were stained with phalloidin-TRITC (tetramethylrhodamine) (50 µg/ml,
P1951 Sigma-Aldrich) in the dark, for 40min. Phalloidin stabilizes the F-actin fila-
ments of the cytoskeleton which can be visualized under a fluorescence microscope.
3.10.2 Adenoviral Nuclear Factor of Activated T cells
(NFATc3) translocation assay
On glass cover slip grownMPMVECs were infected with adenovirus expressing NFATc3-
GFP (100 MOI) for 36 hours, treated with LPS (1 µg/ml) and imaged after additional
16h with 488-nm excitation using a 40x oil objective (Zeiss LSM510 META). Im-
ages were analyzed and quantified using ZEN2 2010 software. Cells with nuclear
NFATc3-GFP were manually counted and quantified as percentage of cells with nu-
clear translocation.
3.10.3 Infection of mice with Klebsiella pneumoniae
Klebsiella pneumoniae was isolated from the lung of a mouse which had been in-
fected with the bacteria. The lung homogenate was plated on MacConkey Agar (BD
212123 BD Biosciences) and a single colony picked to grow bacteria which were used
to infect other mice. When the bacterial culture reached an OD600 of 0.8, 100µl
of the bacterial culture was pelleted, diluted with PBS 1:10 and solubilized in 50 µl
PBS. Mice were anesthetized with AvertinTm (tribromoethanol/2-methyl-2-butanol)
and instilled intranasally with 8x106 colony forming units (CFU) Klebsiella pneumo-
niae (OD600=0.8). After 20h, broncho-alveolar lavage was collected and mice were
either injected with FITC (fluorescein isothiocyanate) dextran (70 kDa, 5% in saline;
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Molecular Probes, Invitrogen) or lungs were fixed in formalin (see figure 2.10.5).
3.10.4 FITC-dextran vascular leakage
Mice were anesthetized with AvertinTm (tribromoethanol/2-methyl-2-butanol), in-
jected intraocularly with FITC-dextran (70 kDa, 5% w/v in saline; Molecular Probes,
Invitrogen) and allowed to rest for 10min. After euthanasia, 0.5ml PBS (+ 0.5%EDTA)
was instilled into the lung via a tracheal catheter, retrieved and frozen at −80 ◦C for
further analysis. The lung was filled completely with PBS via the trachea, the trachea
was tied with a cotton threat and the lung mounted in an imaging chamber. Images
were collected at different regions of the lung using a 20x water immersion objec-
tive with Zeiss 710 META NLO 2-photon microscope equipped with a Chameleon
CoherentTm IR laser. The alveolar area and the background fluorescence of the alve-
olar space which was defined as vascular leakage was quantified using the ZENTm
(Zeiss) program. Broncho alveolar lavage (BAL) fluid was used to quantify FITC-
dextran leakage by excitation at 488nm with a Tecan plate reader (InfiniteR 200Pro.
Protein content was measured using a commercially available Bradford assay (23200,
Thermo Scientific).
3.11 Measurement of cytosolic and mitochondrial Ca2+
and the mitochondrial membrane potential (∆Ψm)
To investigate the store-operated Ca2+ entry (SOCE) in living cells, PPASMCs were
analyzed in Alexander Dietrich’s lab and MLFs in Madesh Muniswamy’s lab.
PPASMC were grown on glass coverslips and loaded with 2 µM fura-2-acetoxymethyl
ester (47989, Sigma Aldrich) in Hepes Ringer solution (140 mM NaCl, 5mM KCl,
1mM MgCl2, 10mM hepes, 5mM glucose, 2mM CaCl2) at room temperature for
30min. Coverslips were mounted in Ca2+-free HBSS (15-009, PAA, 5.33mM KCl,
0.44mM KH2PO4, 4.17mM NaHCO3, 137.93mM NaCl, 0.34mM Na2HPO4, 5.56mM
D-Glucose) supplemented with 0.005% EGTA in an imaging chamber. After base-
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line recording, PPASMCs were stimulated with the SERCA inhibitor thapsigargin
(586005, Calbiochem) or cyclopiazonic acid (CPA) (C1530, Sigma Aldrich). Either
2 µM thapsigargin or 10 µM CPA was used to empty the ER from Ca2+. After the
ER Ca2+ was released, CaCl2 solution was added to reach a final extracellular Ca
2+
concentration of 2mM to induce SOCE. The emitted fluorescence after excitation
at 340 and 380 nm was recorded with a 14-bit EMCCD camera (iXON3 885, Andor,
Belfast, UK) of a monochromator-equipped (Polychrome V, TILL-Photonics, Martin-
sried, Germany) inverted microscope (Olympus IX 71 with an UPlanSApo 20x/0.85
oil immersion objective). Intracellular Fura-2 AM bound to Ca2+ emits maximal
fluorescence at an excitation wavelength of 340 nm, while Fura-2 AM without Ca2+
has its emission maximum at an excitation wavelength of 380nm. Accordingly, the
ratio 340nm/380nm determines the intracellular Ca2+ concentration independent of
variabilities in dye loading.
To investigate the mitochondrial function of MLFs and MPMVECs, cells were grown
on glass cover slips and loaded with the mitochondrial calcium indicator 2 µM Rhod-
2 AM for 50min and the cytosolic calcium indicator 5 µM Fluo-4 AM for 30min in
extracellular medium (ECM), pH 7.4, in the presence of 100µM sulphinpyrazone
(Sigma Aldrich) and 0.003% pluronic acid (Thermo Fisher Scientific) which improved
the dye loading. Coverslips were mounted on a stage of a Zeiss LSM510 META
microscope. After 1 min of baseline recording, 1 µM ionomycin was added and Ca2+
influx in the cytosol and the mitochondria was quantified.
Alternatively, cells were loaded with 100nM tetramethyl rhodamine methyl ester
(TMRM), a ∆Ψm indicator, and 2.5 µM Dihydrorhodamine 123, an mitochondrial
dye labeling active mitochondria, in ECM at 37 ◦C for 30 min. Mitochondrial super-
oxide production was quantified using MitoSOX Red (Invitrogen; 10 µM) for 40 min
in ECM at 37 ◦C and 5% CO2.
After dye loading cells were washed with mounting ECM containing 0.25% BSA and
sulfinpyrazole, mounted in an open perfusion microincubator (PDMI-2; Harvard Ap-
paratus) at 37 ◦C and imaged. Rhod-2 AM, TMRM and MitoSox Red were visualized
at an excitation wavelength of 561nm, Fluo-4 AM at 488-nm every 3 seconds. TMRM
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and Rhodamin1/2/3 were visualized using a a 63x oil objective, Rhod-2 AM, TMRM,
MitoSox Red and Fluo-4 AM using a 40x oil objective of a confocal microscope (Zeiss
LSM510 META, Inc.). Images were analyzed using ZEN2 2010 software (Zeiss).
3.12 Ca2+ uptake and membrane potential (∆Ψm)
measurement in the permeabilized cell system
Equal numbers of MPMVECs were resuspended and permeabilized with 20 µg/ml
digitonin in 1.5 ml of intracellular medium composed of 120 mM KCl, 10mM NaCl,
1mM KH2PO4, 20mM Hepes-tris (pH 7.2) and 2 µM thapsigargin to block the SERCA
(sarcoplasmic/endoplasmic reticulum Ca2+ ATPase) pump. The mitochondrial sub-
strate succinate (5mM) and the intracellular Ca2+ indicator Fura-2FF (0.5 µM, Fura-
FF pentapotassium salt), which is relatively insensitive to Mg2+, were added and the
cuvette was immediately mounted in a multiwavelength excitation, dual-wavelength
emission fluorimeter (DeltaRAM, Photon Technology International). The sample was
stirred constantly and temperature controlled at 37 ◦C. Extramitochondrial Ca2+ was
monitored at an excitation ratio of 340 nm/380 nm of Fura-2FF fluorescence. After
baseline recording, the ∆Ψm indicator JC-1 (800 nM, Thermo Fisher Scientific) was
added. The dye JC-1 accumulates potential dependent in mitochondria, which is
indicated by the ratio fluorescence at an excitation wavelength of 490nm and 570nm.
A mitochondrial membrane depolarization is consequently visualized by a reducing
fluorescence ratio at 490/570nm. The intracellular, extramitochondrial Ca2+ con-
centration was analyzed simultaneously at an excitation wave length of 340nm and
380nm by Fura-2FF. Several 10 µM Ca2+ pulses were added in 50 seconds intervals
and intracellular Ca2+ fluorescence of Fura2-FF and ∆Ψm of JC-1were recorded si-
multaneously. Mitochondrial Ca2+ uptake was visualized by a decline in intracellular
Ca2+ fluorescence. When the mitochondrial Ca2+ uptake was exhausted and ∆Ψm
collapsed, the total mitochondrial Ca2+ content was verified by the mitochondrial
uncoupler FCCP (2 µM) which generates a nonspecific proton leak.
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3.13 Cellular ATP measurement
Cellular ATP levels were measured using the commercially available CellTiter-Glo
luminescent assay kit (Promega, Madison, WI, USA) according to the manufacturer’s
instruction. Metabolically active cells produce ATP which reacts with the CellTiter-
Glo substrate to induce a luciferase reaction and generates a luminescent signal.
Because this signal is dependent on the number of cells, the luminescent signal was
normalized to the protein content of the samples.
3.14 XF-96 Extracellular Flux AnalyzerTm
The XF-96 Extracellular Flux AnalyzerTm (Seahorse Bioscience) can be used to mea-
sure the oxygen consumption rate (OCR) and extracellular acidification rate (ECAR)
in adherent, permeabilized cells. The preloading of reagents and the automatic anal-
ysis of the 96-well plate allows a higher throughput than with conventional methods.
Figure 3.7: An oxygen sensor measures the OCR.. The OCR rate changes after
addition of oligomycin - which inhibits the coupling efficiency, FCCP - an uncoupler,
and antimycin A - an electron chain inhibitor [113].
The XF Cell Mito Stress Test KitTm was used according to the manufacturer’s in-
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struction. In brief, 1x104 MPMVECs per well were seeded in the XF Mitoplate and
grown overnight. On the following day, the medium was changed to the Seahorse
Assay medium and the plate was incubated at 37 ◦C in a CO2 free incubator for
1h. Different reagents were preloaded into the reagent delivery chamber and injected
pneumatically into the media. An oxygen sensor which is coupled to a fiber-optic
waveguide (Seahorse Bioscience XF96 Flux AnalyzerTm) recorded the OCR emission
at an excitation wavelength of 532nm [149]. Data was analyzed by the Wave Software.
Basal mitochondrial respiration is dominated by proton flow through the ATP syn-
thase and proton leakage before addition of any reagents. The first injection, oligomycin
(1µM), inhibits the ATP synthase (Complex V). The remaining non-mitochondrial
oxygen consumption is due to the proton leak across the inner mitochondrial mem-
brane. The second injection, FCCP (1 µM), uncouples respiration from oxidative
phosphorylation and therefore allows H+ to diffuse back to the matrix without pass-
ing the ATP synthase. As a result, any substrate available in the medium is oxidized
and contributes to the maximal respiration rate. At last, the electron transport chain
inhibitors rotenone, a complex I inhibitor and antimycin A, a complex III inhibitor
(both 1 µM) are added. The residual respiration after blocking the electron chain is
non-mitochondrial (see figure 3.7) [113].
Similar to analyzing the OCR with an oxygen sensor, ECAR can be analyzed using a
pH sensor at an excitation wavelength of 470nm. Pyruvate is converted to lactic acid
during anaerobic glycolysis. When lactic acid is released, it acidifies the extracellular
space and can be measured as an increase in ECAR [113] [10]. Basal glycolytic
flux is measured in glucose-free media. The first injection, glucose at saturating
concentration (10mM), is generates glycolysis and thereby produces ATP and protons.
The protons are released into the media and can be measured as an increase in ECAR.
The second injection, oligomycin (1 µM), inhibits mitochondrial ATP production and
therefore shifts metabolically the energy production to glycolysis (maximal glycolytic
capacity). The final injection, 2-DG (2-deoxy-D-glucose), a glucose analog, inhibits
the first enzyme during glycolysis glucose hexakinase. The residual ECAR after
blocking glycolysis is non-glycolytic [113].
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3.15 Clark electrode
The Clark electrode can be used to measure mitochondrial respiration in intact or
permeabilized cells or isolated mitochondria. It is composed of a platinum cathode
and a silver anode which are linked by an electrolyte solution. When a small voltage is
applied, the platinum electrode adopts the externally applied potential. This negative
potential induces that oxygen is reduced at the platinum surface to hydrogen peroxide.
Consequently, a current flows towards the silver electrode and silver is oxidized to
silver chloride which is deposited at the anode. The current is correlated to the
oxygen consumed at the platinum cathode [141].
3x105 MPMVECs were resuspended in intracellular medium composed of 120 mM
KCl, 10mM NaCl, 1mM KH2PO4, 20mM Hepes-tris (pH 7.2). 40 µg/ml digitonin,
to permeabilize membranes, and 10 µM thapsigargin, to block the SERCA pump,
were added. The cell suspension was transferred immediately to the MT200A Mito-
Cell chamber of a MT200A MitoCell Clark-type electrode (Strathkelvin Instruments,
Motherwell, United Kingdom) and stirred constantly at 37 ◦C. After baseline record-
ing, mitochondrial substrates were added in 30 seconds intervals via a Hamilton sy-
ringe. 1mM pyruvate and 1mM malate were added first. Pyruvate oxidation in the
tricarboxylic acid cycle (TCA) cycle generates electrons from NADH which feed com-
plex I. Malate supports the TCA cycle. Electrons from complex I are passed down the
respiratory electron chain and enhance complex III and IV activity. Then, succinate
(1mM) was added which provides electrons for complex II and bypasses complex I.
Next, 0.5 mM TMPD (tetramethylphenylendiamin), an artificial electron donor, and
1mM ascorbate as antioxidants keeping TMPD in its reduced state was added. At
last, excessive natriumazide was added to block complex IV and the OCR decreases
to the calibrated instrument baseline [153]. The rate of oxygen consumption was
measured and displayed as nmol O2/min.
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3.16 Statistical analysis
Data from multiple experiments were quantified and illustrated as means ± SD if
not indicated otherwise. Differences between groups were analyzed by an unpaired
t-test, one-way ANOVA or rank sum test. P < 0.05 was considered significant. Data
were analyzed with ZEN2 2010 software, ImageJ or FlowJo and plotted with either
GraphPad Prism version 5.0 or SigmaPlot 11.0 software.
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Chapter 4
Results
4.1 Roles of STIM1/2/Orai proteins and TRPC
channels in receptor and store-operated Ca2+
entry (ROCE/SOCE)
4.1.1 Analysis of heterozygous STIM1+/-/Orai1+/- mice
Homozygous STIM and Orai knockout mice die perinatally of unknown reason. Thus,
we have established a heterozygous STIM1+/-/Orai1+/- C57BL/6 mouse strain by
mating two independent STIM1+/- and Orai1+/- mouse strains generated by the gene-
trapping method (see figure 3.1 of methods section). We designed specific primers
and established the genotyping of the double heterozygous mice. One of the primers
binds to the β-geo cassette (encoding β-galactosidase-neomycin fusion protein)
Figure 4.1: Location of primer for genotyping of double heterozygous
STIM1+/-/Orai1+/- C57BL/6 mice. Primers bind to the β-geo cassette (en-
coding β-galactosidase-neomycin fusion protein) and in the adjacent genomic intron
DNA. SA: splicing acceptor site, pA: polyA tail
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the other in the adjacent genomic intron DNA (see figure 4.1). Figure 4.2 shows
resulting DNA fragments from a typical PCR-genotyping of DNAs from mouse tails
of heterozygous STIM1+/- and Orai1+/- mice.
Figure 4.2: Agarose gel electrophoresis of genomic DNA fragments from
a typical PCR-genotyping of DNAs from mouse tails of heterozygous
Stim1+/- and Orai1+/- mice. A) Wt-PCR PCR-fragments amplified from the Wt
(lane 1) and the mutated STIM1 gene locus (lane 2) B) PCR- fragments amplified
from the mutated Orai1 gene locus (lane 2). M: 100bp DNA marker
Figure 4.3: STIM1 and Orai1 mRNA expression in TSMCs and PPASMCs
isolated from STIM1+/-/Orai1+/- mice. A) Wt-mRNA expression from the
STIM1 and Orai1 genes in TSMCs of STIM1+/-/Orai1+/- mice, passage 2 B) Wt-
mRNA expression from the STIM1 gene in PPASMCs of STIM1+/- mice, passage 0,
3-4 mice per group, P values were determined by unpaired t-test; * P<0.05
M-RNA-transcription from the Wt STIM1 and Orai1 allele was quantified in
STIM1+/-/Orai1+/- and Wt mice. Figure 4.3 shows that STIM1 and Orai Wt mRNA
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was significantly reduced in STIM1+/-/Orai1+/- tracheal smooth muscle cells (TSMC).
In contrast to these results, STIM1Wt mRNA expression in PPASMC from STIM1+/-
mice was not significantly different compared to PPASMC from wildtype mice.
STIM1 protein is downregulated significantly in MPMVECs from STIM1+/-/Orai1+/-
mice compared to MPMVECs from Wt mice by 11% (see figure 4.4). This reduction
however is less than expected and makes it difficult to interpret the results obtained
with this mouse line.
Figure 4.4: STIM1 protein expression in STIM1+/-/Orai1+/- and Wt MP-
MVECs. A) Representative blot B) Quantification of STIM1 protein on n=3 blots,
P values were determined by unpaired t-test; * P<0.05
Figure 4.5: CPA-induced SOCE in STIM1+/-/Orai1+/- PPASMCs. A) CPA-
induced ER depletion and restoration of external Ca2+ to 2mM results in SOCE B)
Quantification of maximum Ca2+ influx during CPA-induced SOCE at the indicated
time point. Graphs show the result of 33-43 cells, isolated from three mice per group
± SEM, unpaired t-test; * P<0.05, CPA: cyclopiazonic acid
Next, we analyzed if reduced STIM1+/-/Orai1+/- levels resulted into a functional
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SOCE defect. PPASMCs were grown on glass cover slips and loaded with the Ca2+
indicator Fura2-AM. After depletion of internal Ca2+ stores by 10 µM CPA in Ca2+-
free HEPES solution containing 2mM EGTA, extracellular Ca2+ solution was added
to quantify the store-operated calcium influx. The maximum Ca2+ influx after store
depletion was quantified (see figure 4.5).
After emptying internal stores by 10 µM CPA, external Ca2+ was restored to 2mM
which resulted into SOCE. We observed a significantly reduced SOCE in PPASMCs
isolated from STIM1+/-/Orai1+/- mice (see figure 4.5). Nevertheless, this reduction
was much smaller than expected and makes it difficult to draw conclusions from the
planned experiments.
Figure 4.6: Repetitive contraction of tracheal rings from primary bronchi
of STIM1+/-/Orai1+/- and Wt mice. A) Contraction of tracheal rings follow-
ing carbachol-induced (10 µM) ER depletion in (Ca2+-free buffer) and restoration of
external Ca2+ to 2mM B) Four repetitive contractions of of the same bronchus were
quantified and normalized to the first contraction of the same bronchus, n=3-5 mice,
unpaired t-test; * P<0.05,
To test if the small but significant STIM1 and Orai1 downregulation is sufficient to
detect differences in repetitive contraction of tracheal rings from primary bronchi
we used a myograph system. Isolated primary bronchial rings were mounted in a
myograph and incubated with Ca2+-free Krebs-Henseleit-Buffer. Intracellular stores
were depleted by carbachol (CCH, 500nM, 1 µM, 10 µM) which induced only a weak
bronchoconstriction. When extracellular Ca2+ was restored to 2mM, tracheal rings
contracted again (see figure 4.6). The contraction protocol was repeated at least four
times on the same tracheal ring to investigate if primary bronchi of STIM1+/-/Orai1+/-
mice exhaust faster than primary bronchi of Wt mice. The contraction response was
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normalized to the first contraction of the same bronchus. As shown in figure 4.6 we
were not able to detect any differences between STIM1+/-/Orai1+/- and Wt bronchi.
Quality control of mounted tracheal or aortic rings is only possible by the response to
other stimuli, such as the response of potassium chloride (KCl) on membrane depolar-
isation and the following activation of voltage-dependent Ca2+ channels which results
in contraction. Some bronchi or aortae display a good KCl response but are not able
to hold the contraction over a longer period or start oscillating. This results into
variations in contraction or dilatation between the samples which makes it difficult to
analyze the results. Therefore, we tried to establish a contraction model using preci-
sion cut lung slices (PCLS) as an alternative to the myograph. 200µM thick PCLS
which have been cultivated for several days were examined for intact smooth muscle
layers and ciliary activity. Only intact PCLS were treated with cumulative concen-
trations of carbachol (500nM-2,3mM) which resulted into a bronchoconstriction after
40min (see figure 4.7).
Figure 4.7: Carbachol-induced bronchoconstriction in precision cut lung
slices. Contraction of a bronchus before and after application of carbachol in precision
cut lung slices (PCLS). Slices were treated repeatingly with additive concentrations
of carbachol (500nM-2,3mM) over a period of 40min, representative bronchus
Even though we were able to record a strong bronchoconstriction of some bronchi,
many bronchi responded weak or not all all. Fig 4.7 shows a representative bronchus
which constricted almost completely after 40min. Moreover, the analyzed bronchus
was not focused any more after changing buffers which is essential to establish a
SOCE protocol. Therefore, we decided not to proceed with this method.
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4.1.2 Analysis of a tamoxifen-induced smooth muscle cell-specific
STIM1/2 knockout in STIM1/2(Myh11-Cre/ERT2) mice
Mice with an overall STIM1 knockout die 1-4 weeks after birth of unknown reason, but
smooth muscle cell specific STIM1 knockout mice have been shown to be viable [83].
We therefore generated STIM1/2flox(Myh11-Cre/ERT2) mice to induce a smooth
muscle cell specific knockout of STIM1 and STIM2 proteins after tamoxifen injection
by mating a STIM1/2 floxed mouse line with Mhy11-Cre/ERT2 mice.
Myh11-Cre/ERT2 mice express the Cre-recombinase under the control of the smooth
muscle cell specific promotor Mhy11. Therefore, the Cre-recombinase only deletes
the STIM1/2 exons in smooth muscle cells. ERT2-Cre-recombinase is only expressed
after tamoxifen injection of the mouse because the Cre-recombinase is fused to the
ligand binding domain of the human estrogen receptor.
Figure 4.8: Inducible smooth muscle cell specific knockout of STIM1 and
STIM2 alleles using tamoxifen. The Cre-recombinase is expressed under the
control of the promotor Mhy11 only in smooth muscle cells. Upon tamoxifen applica-
tion, the Cre-recombinase is activated and deletes the floxed STIM1/2 exons. HSP90:
heatshock protein90, Cre: Cre-recombinase, ERT2: estrogen receptor2, see text for
more details
Moreover, three point mutations in the ligand binding domain prevent the binding
with its natural ligand estradiol. In the absence of tamoxifen, Cre-ERT2 is bound to
the heatshock protein 90 which inhibits the Cre-recombinase activity. Upon tamoxifen
application, the heatshock protein is dissociated and the Cre-recombinase is now
86
activated and deletes the floxed exons from the STIM1 and STIM2 genes resulting in
a STIM1/2 knockout only in smooth muscle cells (see figure 4.8).
Figure 4.9: Agarose gel electrophoresis of DNA fragments from PCR-
genotyping of genomic DNAs from intestine cells and PPASMCs isolated
from STIM1/2 flox (Myh11 Cre/ERT2) mice after injection of tamoxifen.
Genomic DNA from the intestine or PPASMC were isolated for PCR A)Separation
of PCR products from the floxed (STIM1 flox) and the deleted (STIM1 KO) STIM1
allele. B) Separation of PCR products from the floxed (STIM2 flox) and the deleted
(STIM2 KO) STIM2 allele. M: 100bp DNA marker
However, intraperitoneal injections of tamoxifen induced only a partial knockout of
PPASMC (see figure 4.9). First we assumed, that the tamoxifen injection protocol
was not optimal. But neither an increase of the tamoxifen dosage nor of the injection
frequency improved the efficiency. Therefore, we decided to induce the deletion of
STIM1 and STIM2 exons in PPASMCs directly.
4.1.3 Analysis of SOCE and ROCE in STIM1/2, TRPC1/3/6
and quintuple knockout PPASMC.
Therefore, we treated the isolated cells with a lentivirus encoding for the Cre-recombinase
to obtain a STIM1/2 knockout in the STIM1/2 floxed but Mhy11-Cre negative cells
from STIM1/2 floxed mice. The lentivirus was produced as described in the methods
sections. The mCherry-tagged Cre-recombinase plasmid was obtained from addgene
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and used to produce recombinant lentiviruses expressing Cre-recombinase and the
mCherry fluorescent protein in the infected cell. During Ca2+ imaging we were there-
fore able to select cells with red fluorescence as STIM1/2 knockout and cells without
fluorescence as control cells (see figure 4.10B).
Figure 4.10: Characterization of lentiviral transfected cells by PCR and flu-
orescence imaging. A) Agarose gel electrophoresis of DNA fragments from PCR-
genotyping of genomic DNAs from PPASMCs infected (STIM1/2∆SMC) or not infected
(STIM1/2floxSMC) with lentiviruses expressing Cre recombinase. Left panel: prod-
ucts from a STIM1 genotyping PCR (lane 2 nontransfected, lane 3 and 4 transfected
cells). Right panel: products from a STIM2 genotyping PCR (lane 1 nontransfected,
lane 2 and 3 transfected cells). B) Transfection efficiency of mCherry tagged Cre-
recombinase lentivirus 4 days after transfection of PPASMC. Transfected cells can be
identified by their red fluorescence.
Unfortunately, we faced a very low transfection efficiency of approximately 5% with
the mCherry-tagged Cre-recombinase virus. Accordingly, we were only able to mea-
sure a few cells per coverslip (see figure 4.10). When we had used Cre-recombinase
adenoviruses for other experiments, we observed a similar low transfection efficiency
in the GFP-tagged ad-Cre virus and a nearly complete transfection of cells with
lentiviruses coding for the untagged Cre-recombinase.
Therefore, we assumed that loxP-mediated deletion with untagged Cre-recombinase
lentivirus would be similarly complete as with an untagged Cre-recombinase ade-
novirus. As expected, the transfection with untagged Cre-recombinase lentiviruses
resulted into an almost complete deletion of STIM1/2 exons (see figure 4.11) in
PPASMC isolated from STIM1/2flox/flox mice.
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Figure 4.11: Wt-STIM1- and STIM2-mRNA quantification after lentivi-
ral expression of Cre-recombinase 4 days after infection (STIM1/2
KO) compared to uninfected PPASMC (STIM1/2 Wt) isolated from
STIM1/2flox/flox mice. n=3-5 mice, P values were determined by t test; * P<0.05
4.1.4 Contribution of TRPC1/3/6 in receptor- and store-operated
Ca2+ entry (ROCE and SOCE)
We isolated PPASMC from STIM1/2flox/flox and STIM1/2flox/flox/TRPC1/3/6 -/- mice,
cultivated them until passage two and transfected the cells with untagged or mCherry-
tagged Cre-recombinase lentivirus. Four days after transfection, loxP-induced dele-
tion by Cre recombinase was complete as determined by quantitative, reverse, tran-
scription (RT)-PCR. These cells were used as STIM1/2∆SMC (PPASMCs with deleted
STIM1 and 2 genes) and STIM1/2∆SMC/TRPC1/3/6 -/- PPASMC (PPASMC with
deleted STIM1/2 and TRPC1/3/6 genes) for calcium imaging experiments. A G5A
control virus was used to transfect wildtype PPASMCs. One day before the analysis,
cells were split and seeded on glass cover slips. PPASMCs were loaded with the Ca2+
indicator Fura2-AM.
To quantify ROCE, infected cells with different genotypes were loaded with the Ca2+
indicator Fura2-AM and stimulated with 1 µM endothelin in HEPES solution con-
taining 2mM Ca2+. As expected, ROCE was unchanged in STIM1/2∆SMC com-
pared to Wt cells when comparing the maximal ROCE at the indicated time point
or quantifying enothelin1-induced ROCE areas under the curves (AUC). However,
when STIM1/2∆SMC ROCE was compared to Wt cells at time points 4 or 4.5 min,
a significant difference was observed in comparison to STIM1/2 flox cells. Therefore,
STIM1/2 proteins by mediating Ca2+ influx through Orai channels may be important
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for the long lasting ROCE.
Figure 4.12: Endothelin-1 induced ROCE in STIM1/2∆SMC, TRPC1/3/6 -/-
and STIM1/2∆SMC/TRPC1/3/6 -/- PPASMC. A) Endothelin-1 induced
ROCE in STIM1/2∆SMC transfected with lentiviral Cre-recombinase compared
to STIM1/2flox/flox PPASMC B) Endothelin-1 induced ROCE in TRPC1/3/6 -/-
PPASMC compared to STIM1/2flox/flox PPASMC C) Endothelin-1 induced ROCE
in STIM1/2∆SMC/TRPC1/3/6 -/- transfected with lentiviral Cre-recombinase com-
pared to STIM1/2flox/flox PPASMC D) Quantification of endothelin-1 induced ROCE
of PPASMCs, 28-32cells from n=3-5mice, all cells were in passage 3 (G5A GFP-tagged
control lentiviruses n=1, 8 cells) Kruks-Wallis test, Dunn’s multiple comparison test
* P<0.05
TRPC1/3/6 -/- PPASMCs reduced significantly ROCE compared to Wt cells.
STIM1/2∆SMC/TRPC1/3/6 -/- did not further reduce ROCE compared to
TRPC1/3/6 -/- PPASMCs. This result was obtained when quantifying both the max-
imum ROCE at the indicated time point (2.37 min) and the AUC of ROCE. The
clearly reduced ROCE in TRPC1/3/6 -/- KO PPASMCs matches our hypothesis that
TRPCs are mainly receptor-operated (see figure 4.12).
After depletion of internal Ca2+ stores by 1 µM thapsigargin in Ca2+-free HEPES
solution containing 2mM EGTA, extracellular Ca2+ solution was added to quantify
the store-operated calcium influx. First of all, SOCE induced by adding thapsigargin
(Tg) and recalcification was similar in wildtype cells transfected with G5A lentiviruses
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Figure 4.13: Thapsigargin-induced store-operated Ca2+ entry (SOCE)
in STIM1/2∆SMC, TRPC1/3/6 -/- and STIM1/2∆SMC/TRPC1/3/6 -/-
PPASMC. A) Thapsigargin-induced SOCE in STIM1/2∆SMC transfected with
lentiviruses coding for Cre-recombinase compared to Wt non-transfected PPASMCs
B) Thapsigargin-induced SOCE in TRPC1/3/6 -/- PPASMC compared to Wt
PPASMC C) Thapsigargin-induced SOCE in STIM1/2∆SMC/TRPC1/3/6 -/- trans-
fected with lentiviruses coding for Cre-recombinase compared to Wt PPASMC D)
Quantification of thapsigargin induced SOCE, mean of 29-48 cells from n=4-7 mice,
all cells were in passage 3 (except for G5A GFP-tagged control lentiviruses transfected
PPASMCs: 8 cells from 1 Wt mouse), Kruks-Wallis test, Dunn’s multiple comparison
test * P<0.05
and non-transfected wildtype cells indicating that lentiviral transfection itself does
not have an impact on SOCE. As expected, SOCE was almost completely inhibited
in STIM1/2∆SMC when the maximal SOCE was compared to wildtype SOCE at the
time point indicated by a line (see figure 4.13). Quantification of the areas under the
curves (AUC) of SOCE confirmed these results (see figure 4.14).
Moreover, we observed a small but significantly different reduction of SOCE in
TRPC1/3/6 -/- cells compared to wildtype PPASMC indicating a contribution of
TRPC1/3/6 channels to SOCE. There was no significant different reduction in quintu-
ple (STIM1/2∆SMC/TRPC1/3/6 -/-) PPASMC identified as compared to STIM1/2∆SMC
cells.
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Figure 4.14: Quantification of maxima and area under the curves for store-
operated Ca2+ entry (SOCE) and receptor-operated Ca2+ entry (ROCE).
A) Quantification of SOCE maxima displayed as scatter blot B) Quantification of
ROCE maxima displayed as scatter blot C) Quantification of areas under the curves
(AUC) for SOCE D) Quantification of areas under the curves (AUC) for ROCE, mean
± SEM of 28-48cells from 3-7mice, Kruks-Wallis test, Dunn’s multiple comparison
test P<0.05
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4.2 Analysis of SOCE in endothelial cells and its
contribution to vasodilatation, edema formation,
proliferation and migration
4.2.1 Isolation and identification of Wt and STIM1/2/Orai1-
deficient murine pulmonary microvascular endothelial
cells (MPMVECs)
MPMVECs were isolated using CD-144 (VE-Cadherin5) antibody labeled magnetic
dynabeads. The identity of endothelial cells was confirmed by Dil-Ac-LDL staining in
passage 3 (see figure 4.15). Dil-Ac-LDL only stains endothelial cells and macrophages,
but macrophages do not adhere to the culture dishes. There were still dynabeads at-
tached to some MPMVECs at this passage which usually get lost during the following
passages.
Figure 4.15: Dil-Ac-LDL staining of MPMVECs. Representative image of MP-
MVECs isolated from Wt mice (passage 3) and stained with Dil-Ac-LDL
MPMVECs deficient of STIM1/2 and Orai proteins were isolated from STIM1/2∆EC
and Orai1∆EC mice. For generation of the endothelial cell-specific knockout mice
(∆EC mice), floxed STIM1/2 and floxed Orai1 mice were bred with a mouse line
carrying the Cre-recombinase gene under the control of the endothelium-specific cad-
herin 5 promoter. The knockout was confirmed by immunoblotting of protein lysates
from MPMVECs. STIM1, STIM2 and Orai1 was markedly reduced in STIM1/2∆EC
and Orai1∆EC MPMVEC (see figure 4.16).
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Figure 4.16: Expression of STIM1, STIM2 and Orai1 in STIM1/2∆EC and
Orai1∆EC. A) Representative Western Blots of protein lysates from STIM1/2∆EC,
Orai1∆EC and VE-Cre MPMVEC.
Figure 4.17: Lungs of STIM1/2∆EC and Orai1∆EC mice injected with FITC-
dextran. Representative images of mice injected intraocularly with FITC-dextran.
The fluorescent dye distributes in the vasculature and visualizes the pulmonary vessels
in the ex-vivo lung.
Furthermore, the STIM1/2∆EC and Orai1∆EC knockout did not affect the pulmonary
vascular distribution (see figure 4.17). STIM1/2∆EC and Orai1∆EC knockout mice
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were injected intraocularly with 5% FITC-dextran. The fluorescent dye distributes
in the vasculature and visualizes the pulmonary vessels in the ex-vivo lung when
imaged at 488nm excitation with a Zeiss 710 META NLO 2-photon microscope. Lungs
from STIM1/2∆EC and Orai1∆EC mice did not show any morphological differences
compared to lungs from VE-Cre mice (see figure 4.17).
4.2.2 Contribution of SOCE to endothelium-induced
vasodilatation
We used thoraic aortic rings as a model for vasoconstriction and -dilatation. Previous
authors have already shown that aortic rings isolated from STIM1∆EC mice treated
with acetylcholine dilatated significantly less than heterozygous STIM1∆EC and wild-
type aortic rings [61]. Consequently, we hypothesized that an endothelial STIM1/2
double knockout would result even in a stronger impaired vasodilatation than a single
endothelial STIM1 knockout.
Figure 4.18: Relaxation of STIM1/2∆EC and Orai1∆EC aortic rings. A) Aortic
rings were treated with 1 µM phenylephrine. At steady maximal contraction increas-
ing concentrations of ACh (0.01 µM-30 µM) were added B) Quantification of ACh-
induced (1µM) relaxation C) Quantification SNP-induced (3 µM) relaxation, ACh:
acetylcholine, SNP: sodium nitroprusside, n=5 mice, P values were determined by
unpaired t-test
Accordingly, we mounted aortic rings of STIM1/2∆EC and Orai1∆EC mice in a wire
myograph and treated them with cumulative concentrations of acetylcholine (ACh)
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and sodium nitroprusside (SNP). The resulting vasodilatation however, was not dif-
ferent from Wt mice after ACh or SNP addition (see figure 4.18).
4.2.3 SOCE in endothelial migration and proliferation
Migrating endothelial cells have been shown to have lower intracellular Ca2+ levels.
Bovine aortic endothelial cells treated with SERCA-inhibitors have been reported to
migrate less and removal of cyclopiazonic acid 6hs after scratch formation rescued
migration measured after 24hs [15].
Consequently, we hypothesized that the migration of STIM1/2∆EC and Orai1∆EC
would be reduced compared to VE-Cre MPMVECs. According to our expectations,
the wound healing was significantly reduced in STIM1/2∆EC and Orai1∆EC 24hs and
48hs after gap formation (see figure 4.19).
Superoxide is produced during oxygen reduction by NOX proteins [5] and NOX-
mediated superoxide production stimulates migration in vascular endothelial cells
[136]. Gandhirajan et al. has demonstrated that cytosolic superoxide production
and NOX levels were unaltered in STIM1∆EC but Szewczyk et al. showed that a
dysfunctional eNOS, which is affected by Ca2+, produces superoxide instead of NO
[127] [38].
Therefore, we speculated that a reduced SOCE would negatively affect NO produc-
tion and ROS levels. As a result superoxide and eNOS levels would be altered in
STIM1/2∆EC and Orai1∆EC. Even though we measured reduced phosphorylated
eNOS protein levels in STIM1/2∆EC and Orai1∆EC lysates in some Western blots,
high background did not allow a reliable quantification.
To analyze if superoxide levels were altered in STIM1/2∆EC and Orai1∆EC, we stained
MPMVECs with MitoSox red and quantified the intensity of mitochondria. Sur-
prisingly, STIM1/2∆EC and Orai1∆EC demonstrated significantly elevated superoxide
levels compared to mitochondria from VE-Cre mice (see figure 4.20).
We assumed that similar to migration, proliferation of endothelial cells requires
SOCE. Therefore, we investigated if the proliferation of endothelial cells was reduced
in STIM1/2 and Orai1 deficient MPMVECs isolated from endothelial cell-specific
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Figure 4.19: Migration of STIM1/2∆EC and Orai1∆EC after gap formation.
A) Representative images of VE-Cre (control), STIM1/2∆EC and Orai1∆EC endothe-
lial cells 24hs and 48hs after gap formation B) Quantification of migrated cells, n=3-5
independent experiments, P values were determined by t test; * P<0.05
knockout mice. The proliferation rate was assessed using carboxyfluorescein succin-
imidyl ester (CFSE), a dye which is incorporated into proteins, passed to the daughter
generations and can be quantified by flow cytometry. We identified a reduced prolif-
eration rate in STIM1/2∆EC and unchanged proliferation rate in Orai1∆EC (see figure
4.21).
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Figure 4.20: Mitochondrial superoxide levels in STIM1/2∆EC and Orai1∆EC.
A) Representative images of MitoSOX red (mitochondrial superoxide indicator)
stained VE-Cre (control), STIM1/2∆EC and Orai1∆EC MPMVECs B) Quantifica-
tion of MitoSOX red fluorescence intensity, n=3 independent experiments, n= 62-102
cells, f.a.u.: fluorescence arbitrary units, P values were determined by rank sum test;
* P<0.05.
4.2.4 Contribution of SOCE to edema formation and vascular
inflammation
Endothelial cells play an important role during inflammation. Bacterial products like
lipopolysaccharide (LPS) stimulate the endothelium and increase endothelial barrier
permeability. On one hand this cellular reaction helps to combat infection, on the
other hand it can induce a dysfunction of endothelial cells. Dysfunctional endothelial
cells allow fluid to leak into the surrounding tissues which results into lung edema
formation [99] [116]. Vascular permeability of endothelial cells can be investigated
on cellular levels using the coagulation protease thrombin. Under non-stimulated
conditions, the myosin light chain (MLC) phosphatase dephosphorylates the MLC
and consequently prevents opening of the tight junctions. After thrombin stimulation
this preventive mechanism is inhibited [99].
Thrombin stimulation induces stress fiber formation which can be quantified by stain-
ing of F-actin with fluorescence labeled phalloidin. We show that the relative phal-
loidin staining intensity of thrombin-stimulated STIM1+/-/Orai1+/- MPMVECs was
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Figure 4.21: Proliferation in STIM1/2∆EC and Orai1∆EC. A) Representative
FACS panels of non-proliferated (red) and proliferated (blue) CFSE-stained VE-Cre,
STIM1/2∆EC and Orai1∆EC B) Relative proliferation rates of proliferating endothelial
cells to non-proliferating cells of the same genotype, CFSE = carboxyfluorescein suc-
cinimidyl ester, n=3 independent experiments, P values were determined by one-way
ANOVA; * P<0.05.
reduced compared to thrombin-stimulated wildtype MPMVECs (see figure 4.22).
Gandhirajan et al. have shown that STIM1 is essential for the NFATc3-mediated
transcription of proinflammatory mediators. STIM1∆EC transfected with adenovirus
encoding NFATc3-GFP displayed a significantly reduced number of NFATc3-GFP
translocated cells compared to wildtype MPMVECs. This was further confirmed
by the significantly reduced luciferase activity in STIM1KD MPMVECs compared to
wildtype MPMVECs [39]. Based on these findings the question arose if only STIM1
or both STIM isoforms, STIM1 and STIM2, or Orai attenuate the NFAT nuclear
translocation. Thus, MPMVECs were transfected with adenovirus encoding NFATc3-
GFP for 36 hours, followed by LPS treatment for additional 16hs as described in [39].
According to our expectations, the number of NFATc3-GFP translocated cells in LPS-
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Figure 4.22: Thrombin-induced formation of stress fibers. A) Representative
images of phalloidin staining for Wt (left) and STIM1+/-/Orai1+/- (right) MPMVECs
B) Quantification of phalloidin staining intensity of actin stress fibers after thrombin
(5nM) stimulation of STIM1+/-/Orai1+/- and Wt MPMVECs in comparison to un-
stimulated cells of the same genotype, 80-87 cells isolated from 4 different mice, P
values were determined by t test; * P<0.05
stimulated VE-Cre MPMVECs compared to unstimulated MPMVECs was increased
and this increase was abrogated in LPS-stimulated STIM1/2∆EC compared to un-
stimulated STIM1/2∆EC and in LPS-stimulated Orai1∆EC compared to unstimulated
Orai1∆EC. The number of NFATc3-GFP translocated cells was moreover significantly
reduced in LPS-stimulated STIM1/2∆EC compared to LPS-stimulated VE-Cre MP-
MVECs (see figure 4.23). Comparing our result to Gandhirajan et al. we did not
observe a different number of NFATc3-GFP translocated cells in double STIM1/2∆EC
or Orai1∆EC compared to the single STIM1∆EC analyzed in [39].
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Figure 4.23: LPS-induced nuclear NFATc3-GFP translocation in
STIM1/2∆EC and Orai1∆EC. A) Representative images of nuclear NFATc3-GFP
translocation of VE-Cre, STIM1/2∆EC and Orai1∆EC MPMVECs with and without
pretreatment of LPS B) Quantification of cells with translocated NFATc3 to the nu-
clei. n=3 independent experiments, P values were determined by t test; * P<0.05
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4.3 Contribution of mitochondrial uniporter
regulator 1 (MCUR1) to Ca2+ uptake in
mitochondria
4.3.1 Analysis of mitochondrial Ca2+ uptake and ∆Ψm in
MCUR1∆EC and MCU∆EC
MCUR1 was identified as a positive regulator of the MCU complex through its inter-
action with MCU [81]. Our group was recently able to characterize MCUR1 as a MCU
complex scaffold factor. MCUR1 and MCU interact via their highly conserved coiled-
coil domains. A lack of MCUR1 resulted into the failure of MCU heterooligomeric
complex assembly and suppressed the IMCU current in isolated cardiac mitoplasts
[132]. The functional role of MCUR1 during mitochondrial Ca2+ entry, its impact on
the ∆Ψm and on the mitochondrial bioenergetics however has not been investigated
yet in primary cells.
Figure 4.24: Deletion of MCUR1 and MCU in MPMVEC. A) MCU and B)
MCUR1 Wt-mRNA (left panels) and protein levels (Western Blots and right panels)
in MPMVECs isolated from VE-Cre, MCUR1∆EC and MCU∆EC mice, n=3, P values
were determined by t test; * P<0.05
To investigate the functional role of MCUR1, our group recently created MCUR1∆EC
mice. Even though these mice did not have any morphological phenotype, they had a
higher heat production at rest than MCUR1 floxed mice. The knockout of MCU and
MCUR1 in MPMVECs isolated from MCU∆EC and MCUR1∆EC mice was confirmed
by mRNA and protein analysis (see figure 4.24).
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Figure 4.25: Mitochondrial membrane potential (∆Ψm) in MCUR1
∆EC, VE-
Cre MPMVECs, MCUR1∆MLF or MCU∆MLF. Murine lung fibroblasts (MLF) were
isolated from MCUR1∆EC or MCU∆EC mice and transfected with adenoviruses en-
coding Cre-recombinase-GFP (MCUR1∆MLF and MCU∆MLF). Cells were loaded with
tetramethylrhodamine methyl ester (TMRM) (50 nM) to assess the ∆Ψm. Represen-
tative confocal images (A) and quantification of ∆Ψm (B)
Mitochondrial Ca2+ influx is driven by the electrochemical potential gradient. The
potential is maintained by the process of mitochondrial respiration and the Na+-Ca2+
exchanger [31]. Because the mitochondrial Ca2+ uptake is dependent on the ∆Ψm,
we investigated if the ∆Ψm was physiological in MCU
∆EC and MCUR1∆EC.
Figure 4.26: MCU-dependent mitochondrial Ca2+ ([Ca2+]m) entry in
MCUR1∆EC. A) Ionomycin-induced (1 µM) [Ca2+]m-entry in VE-Cre MPMVECs
(left) and MCUR1∆EC (right) loaded with the mitochondrial Ca2+ indicator
Rho2/AM B) Quantification of [Ca2+]m-entry C) Cytosolic Ca
2+ ([Ca2+]c) entry in
VE-Cre MPMVECs (red) and MCUR1∆EC (blue) loaded with the cytosolic Ca2+
indicator Fluo-4/AM, n=3 independent experiments, P values were determined by
one-way ANOVA, *P < 0.05.
Neither in MLFs nor in MPMVECs isolated from MCU∆EC and MCUR1∆EC mice the
∆Ψm was altered compared to cells from floxed or VE-Cre mice. MPMVECs or adeno-
Cre-GFP viruses transfected MLFs were stained with tetramethylrhodamine methyl
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ester (TMRM) and fluorescence intensities of the mitochondrial ∆Ψm indicator was
quantified (see figure 4.25).
Figure 4.27: MCU-dependent mitochondrial Ca2+ ([Ca2+]m) entry in
MCUR1∆MLF and MCU∆MLF. A/D) Ionomycin-induced (1 µM) [Ca2+]m-entry
in murine lung fibroblasts (MLF) isolated from MCUR1∆EC or MCU∆EC mice
and transfected with adenoviruses encoding Cre-recombinase (A:MCUR1∆MLF and
D:MCU∆MLF right panel, non-transfected MLFs left panel) were loaded with
Rho2/AM. B/E) Quantification of [Ca2+]m-entry. Cytosolic Ca
2+ ([Ca2+]c) entry
in MCUR1∆MLF (C) and MCU∆MLF (F) loaded with Fluo-4/AM, n=3 independent
experiments, The P values were determined by one-way ANOVA, *P < 0.05.
After having confirmed that the ∆Ψm was unaltered in MCU
∆EC and MCUR1∆EC, we
next analyzed if the knockout resulted into a functional Ca2+ entry defect. MPMVECs
or MLFs transfected with adenoviruses encoding Cre-recombinase (MCUR1∆MLF and
MCU∆MLF) were grown on glass cover slips and loaded with the cytosolic Ca2+ indica-
tor Fluo-4AM and the mitochondrial Ca2+ indicator Rhod-2AM. The Ca2+ entry was
observed after ionomycin stimulation under a Zeiss LSM510 META microscope. As
expected, only a nominal mitochondrial Ca2+ uptake was observed in MCUR1∆EC,
MCUR1∆MLF and MCU∆MLF. The extracellular Ca2+ entry into the cytosol was
unchanged from VE-Cre MPMVECs or floxed MLFs (see figure 4.26 and 4.27).
Imaging techniques allow the analysis of only a small population of selected cells
per coverslip. Furthermore, a simultaneous recording of time-dependent Ca2+ up-
take and ∆Ψm is not possible. Consequently, we used a multiwavelength excitation,
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dual-wavelength emission fluorimeter for further analysis. This fluorimeter allows
the analysis of 106 cells per sample compared to 10 cells per coverslip with imaging
techniques. The cell membrane MPMVECs was permeabilized with digitonin. Thap-
sigargin, to block the SERCA pump, the mitochondrial substrate succinate and the
intracellular Ca2+ indicator Fura-2FF were added. After baseline recording, the ∆Ψm
indicator JC-1 was applied. Simultaneously, the excitation ratio of Fura-2FF and JC-
1 were measured quantifying the intracellular Ca2+ concentration and the ∆Ψm. The
mitochondrial Ca2+ uptake is indicated indirectly by a decrease of the intracellular
Ca2+ concentration. Because ∆Ψm affects the mitochondrial Ca
2+ uptake, Ca2+ can
be added to the cells until the ∆Ψm is disrupted.
Figure 4.28: Simultaneous measurement of MCU-mediated [Ca2+]m uptake
and ∆Ψm in VE-Cre, MCU
∆EC and MCUR1∆EC MPMVECs. After reaching
steady state ∆Ψm, permeabilized VE-Cre, MCU
∆EC and MCUR1∆EC MPMVECs
were treated in intracellular like media (containing 2 µM thapsigargin and 1 µM bath
Ca2+ indicator Fura2FF) with series of extramitochondrial Ca2+ (10µM) pulses before
the addition of mitochondrial uncoupler CCCP (2 µM), purple: [Ca2+]out indicated
by Fura2FF, green: ∆Ψm(RJC-1) indicated by JC-1, CCCP: carbonyl cyanide m-
chorophenylhydrazone, representative traces
Mitochondrial Ca2+ uptake capacity was evaluated in MCU∆EC, MCUR1∆EC and VE-
Cre MPMVECs by adding 10 µM Ca2+ pulses. The simultaneous recording of [Ca2+]m
uptake and ∆Ψm discovered that both MCU
∆EC and MCUR1∆EC failed to take up
Ca2+ (see figure 4.29 and 4.28). Upon exposure to excessive Ca2+, the VE-Cre cells
exhibited a rapid mitochondrial membrane potential collapse due to mitochondrial
Ca2+ entry, which was not observed in MCU∆EC and MCUR1∆EC MPMVECs (see
figure 4.29).
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Figure 4.29: MCU-mediated mitochondrial Ca2+ ([Ca2+]m) uptake in
MCU∆EC and MCUR1∆EC MPMVECs. A) Comparison of representative
traces of extramitochondrial Ca2+ ([Ca2+]out) of VE-Cre MPMVECs, MCU
∆EC and
MCUR1∆EC MPMVECs. B) Quantification of rate of mitochondrial Ca2+ uptake
([Ca2+]m) before addition of mitochondrial uncoupler CCCP (2 µM) C) Representa-
tive traces of [Ca2+]out of MPMVECs in the presence of SERCA inhibitor thapsigar-
gin (2 µM), Na+/Ca2+ exchanger inhibitor (CGP-37157, 1 µM) and MCU inhibitor
(Ru360, 1 µM). After addition of CCCP, free [Ca2+]m was released from the mitochon-
drial matrix and quantified (D). CCCP: carbonyl cyanide m-chorophenylhydrazone,
n=3 independent experiments, The P values were determined by one-way ANOVA,
*P < 0.05.
To examine baseline [Ca2+]m content, permeabilized MPMVECs were loaded with
Fura-2FF, SERCA inhibitor thapsigargin (2 µM), Na+/Ca2+ exchanger inhibitor (CGP-
37157, 1 µM) and MCU inhibitor (Ru360, 1 µM) to block all Ca2+ flux. CCCP was
injected to dissipate ∆Ψm and free [Ca
2+]m was released from the mitochondrial ma-
trix and quantified. Quantification demonstrated a reduced [Ca2+]m release after
addition of CCCP in MCU∆EC and MCUR1∆EC(see figure 4.28).
4.3.2 Contribution of MCU and MCUR1 to the mitochondrial
respiratory chain and ATP production
Mitochondrial Ca2+ regulates metabolic functions, such as ATP production by ox-
idative phosphorylation. ATP production is either stimulated directly by Ca2+ or
indirectly by NADH, activation of the pyruvate dehydrogenase, enhanced respiratory
chain complex activity or Ψm [106] [130] [146]. A perturbed [Ca
2+]m uptake may lead
to cellular bioenergetic crisis [85] [120].
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Figure 4.30: ATP levels in MCUR1∆EC, MCU∆EC. Normalized ATP lumi-
nescence of MCUR1∆EC, MCU∆EC and VE-Cre MPMVECs, n=3-6, P values were
determined by one-way ANOVA; *P<0.05.
To determine if the reduced mitochondrial Ca2+ uptake decreases ATP production, we
measured ATP levels of MPMVECs derived from MCUR1∆EC and MCU∆EC mice. As
expected basal ATP levels were significantly reduced in MCUR1∆EC and MCU∆EC
endothelial cells (see figure 4.30). ATP levels were reduced significantly more in
MCUR1∆EC compared to MCU∆EC MPMVECs (see figure 4.30).
We next analyzed if reduced ATP levels are the result of decreased mitochondrial Ca2+
levels or of an impaired function of respiratory chain complexes. The activity of the
respiratory chain complexes was investigated by measuring the oxygen consumption
rate (OCR). The reduction of oxygen to water by complex IV consumes electrons
which are transferred by complex I, II and III. Addition of substrates of individual
complexes, enhances specific complex activity, electron flow increases and therefore
the oxygen consumption rate of the final electron acceptor complex IV increases. The
current measured by the Clark electrode is correlated to the oxygen consumed [141]
[153]. Ca2+ enhances the activity of the mitochondrial complexes I, III and IV and
the pyruvate dehydrogenase activity which provides NADH from the TCA cycle to
oxidative phosphorylation, is Ca2+ dependent [106] [130] [146] [93]. Therefore, we
proposed that the OCR might be reduced in MCUR1∆EC and MCU∆EC MPMVECs.
In contrast to MCU∆EC, MCUR1∆EC did not result in a significant increase of the
oxygen consumption rate levels after addition of complex 1 and 2 substrates. After
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Figure 4.31: Complex I, II and IV activity in MCUR1∆EC and MCU∆EC
analyzed by Clark electrode. Oxygen consumption rate (OCR) in digitonin-
permeabilized MCUR1∆EC, MCU∆EC and VE-Cre MPMVECs after addition of
pyruvate, maleate, succinate, TMPD (tetramethylphenylendiamine), ascorbate and
sodium azide. A/B) representative traces of MCUR1∆EC (A) and MCU∆EC (B) C)
Quantification of OCR, n= 3, Mann-Whitney test; *P<0.05
application of complex IV substrates, TMPD and ascorbate, the OCR levels between
VE-Cre, MCU∆EC and MCUR1∆EC remained the same (see figure 4.31). This result
indicates that the function of complex I, II and IV is not impaired in MCU∆EC and
MCUR1∆EC. The observed enhanced complex I and II activity in MCU∆EC needs
further investigation. Protein levels of the mitochondrial oxidative phosphorylation
components indicates that all components were equally expressed in MCUR1∆EC,
MCU∆EC and VE-Cre MPMVECs (see figure 4.32).
To further investigate the function of the respiratory chain in MCU∆EC and MCUR1∆EC,
we analyzed MPMVECs with the XF-96 Extracellular Flux AnalyzerTm quantifying
oxygen consumption rates (OCR) and extracellular acidification rate (ECAR) in ad-
herent, permeabilized cells before and after adding drugs which inhibit or acceler-
ate oxidative phosphorylation or glycolysis. The basal OCR values were similar in
MCU∆EC, MCUR1∆EC and VE-Cre MPMVECs. Similarly, we observed that oxygen
consumption of MCUR1∆EC mice were not different from control mice under a normal
chow diet at 8 weeks [132].
After addition of oligomycin blocking ATP-synthase, the remaining OCR is due to
proton leakage and therefore caused by uncoupling. Because oligomycin blocks the
ATP synthesis during oxidative phosphorylation, the cell shifts its ATP production to
glycolysis [113] [10]. After addition of oligomycin we did not observe any difference in
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Figure 4.32: Expression of mitochondrial oxidative phosphorylation complex
components in MCUR1∆EC and MCU∆EC. Western Blot analysis of cell lysates
from MCUR1∆EC, MCU∆EC and VE-Cre MPMVECs probed for anti-mTFA (Mito-
chondrial Transcription Factor A), PGC1 (Peroxisome proliferator-activated receptor
gamma coactivator), Drp1 (Dynamin-related protein), Mfn2 (Mitofusin-2), OXPHOS
(antibody cocktail showing complex II-30kDa, complex IV subunit I and complex V
α subunit) and CypD (Cyclophilin D), lysates of cells isolated from 3 different mice
the OCR values in MCU∆EC, MCUR1∆EC compared to VE-Cre MPMVECs (see figure
4.33) indicating that protons are pumped during electron transport which results in
oxygen consumption but not ATP production in MCU∆EC and MCUR1∆EC. The
unaltered ATP-linked OCR values in MCU∆EC and MCUR1∆EC further illustrates
that ATP demand and substrate availability is intact in MCU∆EC and MCUR1∆EC.
FCCP (carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone) uncouples respiration
from oxidative phosphorylation and therefore allows H+ to diffuse back to the matrix
without passing the ATP synthase which induces a collapse of ∆Ψm. In an attempt
to rescue the ∆Ψm OCR rises and the cell switches its metabolism from oxidative
phosphorylation to glycolysis. As a result, any substrate available in the medium is
oxidized and contributes to the maximal respiration rate [113] [10]. The values for
the ’maximal respiration rate’ were increased in MCUR1∆EC and MCU∆EC compared
to VE-Cre MPMVEC (see figure 4.33) and were significantly higher in MCUR1∆EC
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Figure 4.33: Oxygen consumption rate in MCUR1∆EC and MCU∆EC using
the XF-96 Extracellular Flux AnalyzerTm. A) Representative traces for oxygen
consumption rate (OCR) after addition of oligomycin, FCCP, rotenone and antimycin
in MCUR1∆EC, MCU∆EC and VE-Cre MPMVECs B) Basal OCR values before ad-
dition of oligomycin subtracted of non-mitochondrial respiration values C) ’Maximal
respiration values’ after addition of FCCP subtracted of non-mitochondrial respiration
values, FCCP: carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone, representative
experiment from n=3, one-way ANOVA, *P<0.05
compared to MCU∆EC.
Addition of the complex inhibitors I and III, rotenone and antimycin A completely
blocked the electron transfer of the respiratory chain. This resulted into decreased
OCR values to maintain energy homeostasis [113] [10]. Rotenone and antimycin A
decreased the OCR values in all genotypes in a similar way (see figure 4.33) indicating
that the non-mitochondrial respiration is intact in MCUR1∆EC and MCU∆EC.
Pyruvate is converted to lactic acid during anaerobic glycolysis. When lactic acid
is released, it acidifies the extracellular space and can be measured as an increase
in ECAR [113] [10]. Values for the basal extracellular acidification rate (ECAR) in
glucose-free media were similar in MCU∆EC, MCUR1∆EC and VE-Cre MPMVECs
(see figure 4.34) and addition of glucose generates glycolysis and thereby produces
ATP and protons. The protons are released and acidify the media which results in
an increase in ECAR values [113]. We did not observe any differences in ECAR
glycolysis between MCUR1∆EC, MCU∆EC and VE-Cre MPMVECs after addition of
glucose (see figure 4.34).
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Figure 4.34: Extracellular acidification rate (ECAR) in MCUR1∆EC and
MCU∆EC. A) Representative traces of ECAR after addition of glucose, oligomycin
and 2-DG (2-deoxy-D-glucose)in MCUR1∆EC, MCU∆EC and VE-Cre MPMVECs B)
Glycolysis rate after addition of glucose minus non-glycolytic ECAR C) Glycolytic
capacity after addition of oligomycin minus non-glycolytic ECAR, representative ex-
periment from n=3, one-way ANOVA, *P<0.05
The second injection of oligomycin (1 µM), inhibits mitochondrial ATP production
and therefore shifts metabolically the energy production to glycolysis (maximal gly-
colytic capacity) [113]. Values for the ’maximum glycolytic capacity’ were enhanced
in MCUR1∆EC and MCU∆EC compared to VE-Cre MPMVEC (see figure 4.34). Inter-
estingly, the serum glucose levels of MCUR1∆EC mice were not different from control
mice under a normal chow diet of 8 weeks [132].
The final injection of 2-DG (2-deoxy-D-glucose), a glucose analog, inhibits the first en-
zyme during glycolysis, glucose hexakinase. The residual ECAR values after blocking
glycolysis are non-glycolytic [113]. MCUR1∆EC, MCU∆EC and VE-Cre MPMVECs
showed similar non-glycolytic ECAR values after 2-DG injection.
Enhanced maximal OCR and ECAR values in MCUR1∆EC and MCU∆EC could be
due to the stimulation of compensatory substrate utilization pathways. If the stim-
ulating effect of Ca2+ on mitochondrial complex activity, pyruvate dehydrogenase,
proton gradient and ∆Ψm is abrogated, MCUR1
∆EC and MCU∆EC might express
compensatory proteins to rescue the energy supply of the cell. Along these lines,
we investigated if expression of UCP2, the main isoform in endothelial cells [127],
was changed in MCUR1∆EC and MCU∆EC. UCP2 has been shown to be involved
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in the mitochondrial uptake of intracellular Ca2+ [140] [22] [7] but does not interact
directly with MCU [110]. In contrast to UCP1, it seems unlikely that UCP2 acts as
an uncoupler [119]. Instead, UCP2 is assumed to play a role in the reprogramming
of metabolic pathways [139].
Western Blot analysis of cell lysates from MCUR1∆EC, MCU∆EC and VE-Cre MP-
MVECs revealed that UCP2 protein levels were significantly increased in MCUR1∆EC
compared to VE-Cre MPMVECs (see figure 4.35). High UCP2 levels have been re-
ported to limit the contribution of glucose to OCR and to promote the oxidation of
substitute substrates such as glutamine and fatty acids. Moreover, high UCP2 levels
are assumed to promote the conversion of pyruvate to lactate [139]. We therefore
assume, that the upregulation of UCP2 protein levels allows a better energy supply
which might explain the enhanced OCR values after addition of substrates which
fuel complex I (pyruvate and maleate) or complex II substrate (succinate) (see figure
4.31) as well as the enhanced glycolytic capacity after uncoupling (see figure 4.33 and
4.34).
Figure 4.35: UCP2 expression in MCUR1∆EC and MCU∆EC. Western
Blot analysis of cell lysates from MCUR1∆EC, MCU∆EC and VE-Cre MPMVECs
probed for anti-UCP2 antibody A) Representative Western Blot, P:precursor (non-
glutathioylated), M:mature protein (glutathioylated) B) Quantification of the mature
normalized UCP2 protein levels, n=3 independent experiments, P values were deter-
mined by the Mann-Whitney test; *P<0.05.
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4.3.3 Contribution of MCUR1 and MCU to proliferation,
migration and autophagy
ROS is produced in mitochondria by premature utilization of oxygen which can occur
at complex I, II and III of the electron transport chain. Oxygen can accept an addi-
tional electron to form superoxide. If antioxidant scavenging enzymes are expressed
sufficiently they can detoxify superoxide. Otherwise superoxide can react with other
components and damage irreversibly proteins of the electron transport chain [47] [20].
UCPs and ANTs limit ROS production by lowering the ∆Ψm [63].
MCUR1∆EC and MCU∆EC display an intact function of the respiratory chain (see
figure 4.31) but a decreased ATP production (see figure 4.30). Based on the influence
of mitochondrial calcium uptake 1 (MICU1), SLC25A23 and UCP2 on superoxide
formation, we hypothesized that superoxide levels would be reduced in MCUR1∆EC
and MCU∆EC. MPMVECs were stained with the superoxide indicator MitoSOX
Red and the intensity of mitochondrial superoxide levels was quantified. MCUR1∆EC
and MCU∆EC showed significantly reduced superoxide levels compared to VE-Cre
MPMVECs (see figure 4.36).
Moderate levels of ROS are proposed to be essential for cell proliferation and migra-
Figure 4.36: Superoxide levels in MCUR1∆EC and MCU∆EC. MCUR1∆EC,
MCU∆EC and VE-Cre MPMVECs were stained with MitoSOX Red A) Represen-
tative confocal images B) Quantification of fluorescence intensities, f.a.u.: fluores-
cence arbitrary units, n=3 independent experiments, P values were determined by
the Mann-Whitney test, *P<0.05.
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tion [47] and mitochondrial Ca2+ handling could affect endothelial proliferation and
migration which are important during wound healing [20]. Therefore, we investigated
whether the lack of MCU or MCUR1 affects proliferation and migration by assessing
MCU∆EC and MCUR1∆EC by flow cytometry and scratch assay.
Figure 4.37: Migration behavior of MCUR1∆EC and MCU∆EC MPMVECs.
A) Representative images of VE-Cre, MCUR1∆EC and MCU∆EC MPMVECs which
have migrated 24hs and 48hs after gap formation B) Scatter Blots summarizing values
of migrated cells 24 and 48h after gap formation, n=3-4 independent experiments, P
values were determined by one-way ANOVA; * P<0.05
The scratch assay showed a significantly reduced migration rate for MCU∆EC and
MCUR1∆EC compared to VE-Cre endothelial cells 24hs and 48hs after gap formation
(see figure 4.37). These results suggest that Ca2+ influx between cytosol and mito-
chondria was perturbed. Proliferation rates were assessed by using carboxyfluorescein
succinimidyl ester (CFSE), a dye which is incorporated in proteins, passed to the
daughter generations and quantified by flow cytometry. MCU∆EC and MCUR1∆EC
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MPMVECs showed a significantly attenuated proliferation (see figure 4.38).
Figure 4.38: Proliferation in VE-Cre, MCU∆EC and MCUR1∆EC. A) Repre-
sentative FACS panels of non-proliferated (red) and proliferated (blue) CFSE-stained
VE-Cre, MCUR1∆EC, MCU∆EC MPMVECs B) Relative proliferation rates of pro-
liferating endothelial cells to non-proliferating cells of the same genotype, CFSE:
carboxyfluorescein succinimidyl ester, n=3 independent experiments, P values were
determined by one-way ANOVA; * P<0.05.
Having demonstrated that MCUR1-deficiency in MPMVECs results in low cellular
ATP levels, we propose that alternative modes of cell survival might be upregulated.
One mode of cell survival which might be induced is autophagy. Autophagy rescues
the cell from energy deprivation by activation of the AMP-activated protein kinase
(AMPK). The AMPK phosphorylates substrates to limit anabolic pathways, that
consume ATP and activates catabolic pathways to generate substrates supporting
oxidative phosphorylation [12] [48]. We hypothesized that the low ATP levels in
MCUR1∆EC and MCU∆EC would result into enhanced autophagic activity.
To investigate the role of MCUR1 and MCU in autophagy MPMVEC protein lysates
of MCUR1∆EC, MCU∆EC and VE-Cre mice were analyzed by Western Blotting. Ac-
cording to our expectation, the phosphorylated AMPK and LC3 protein expression
was significantly enhanced in MCUR1∆EC and MCU∆EC. To answer the question if
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autophagy was terminated by rescue of MCU or MCUR1, MCUR1∆EC and MCU∆EC
were transfected with adenoviral MCUR1 and MCU. As expected, the rescue ter-
minated the autophagy in MCUR1∆EC and MCU∆EC indicated by the significantly
lower microtubule-associated protein light chain 3 (LC3) and phosphorylated AMPK
protein levels (see figure 4.39).
Figure 4.39: Microtubule-associated protein light chain3 (LC3) and
phosphorylated AMP-activated protein kinase (p-AMPK) expression in
MCUR1∆EC and MCU∆EC. A) Western Blot analysis of cell lysates from
MCUR1∆EC, MCU∆EC and VE-Cre MPMVECs probed with anti-LC3, anti p-AMPK
and anti-AMPK antibody B) Quantification of normalized LC3 and p-AMPK pro-
tein levels, n=3 independent blots, mean ± SEM, *P< 0.05, This result was kindly
provided by Zhiwei Dong with the MPMVECs isolated by me.
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Chapter 5
Discussion
5.1 STIM1/2 proteins are not involved in receptor-
operated Ca2+ entry (ROCE), but TRPC1, TRPC3
and TRPC6 channels may be activated by store-
operated Ca2+ entry (SOCE)
TRPCs, the first cloned mammalian transient receptor potential channels, were origi-
nally described as store-operated Ca2+ (SOC) channels . After cloning STIM proteins
and Orai channels and their identification as molecular correlates of SOCE (summa-
rized in [11]), regulation and activation of TRPCs were questioned and extensively
discussed. Some research groups reported interaction of TRPC channels with Orai
and STIM proteins in vitro in cell lines ([73], [69] summarized in [14]), while others
postulated a receptor-operated activation of TRPC channels independent of Orai and
STIM ([23]). The scientific community agrees that it is essential to dissect molecular
components of SOCE in native cells or whole organs from appropriate gene-deficient
’knock-out’ mice. However, STIM/Orai-deficient mice are embryonic lethal and dou-
ble heterozygous STIM1+/-/Orai1+/- mice show only insufficient down-regulation of
these proteins (see figure 4.4). Therefore, we decided to use lentiviral mediated Cre-
recombinase expression in STIM1/2 floxed cells to delete both proteins in precapillary
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pulmonary arterial smooth muscle cells (PPASMCs).
TRPC6 and TRPC3 have been shown to be upregulated in smooth muscle cells of
IPAH patients and in a rat model of pulmonary hypertension [25] and several reports
identified TRPC1 as the most important TRPC channel involved in SOCE ([25]).
Thus, we compared TRPC1/3/6-/- triple deficient with STIM1/2 double deficient
and Wt control PPASMC in ROCE and SOCE experiments.
When investigating the function of TRPC as SOCE, one has to deal with several
challenges: The main challenge is definitely to distinguish SOCE from other Ca2+
entry. TRPCs can be activated by DAG which might mask the STIM-dependent
activation. Mutation of TRPCs which electrolytically interact with STIM are an
important tool to distinguish between the Orai and and TRPC-mediated SOCE but
only in easily to transfect cell lines.
We have shown that TRPC1/3/6 channels are clearly receptor operated in PPASMC.
TRPC1/3/6 -/- PPASMCs showed an almost completely abolished endothelin-1-induced
ROCE in comparison to Wt and STIM1/2 double deficient cells (see figure 4.12). A
quintuple STIM1/2/TRPC1/3/6 knock-out did not further reduce ROCE in PPASMCs
(see figure 4.12). Next we analyzed different postulated SOCE pathways (1-4) by
STIM/Orai and TRPC channels in PPASMC (see figure 5.1).
The research group of Lutz Birnbaumer claims that TRPCs and Orai form heteromers
which could be involved in both ROCE and SOCE based on co-immunoprecipitation
and functional Ca2+ entry experiments of Orai1, TRPC3 and TRPC6 [71][73] next
to the identified STIM/Orai pathway (see 2 and 1 in figure 5.1). We can not exclude
such a pathway, because we did not down-regulate Orai1/2/3 channels in PPASMC.
But a vast almost complete reduction of SOCE in STIM1/2 deficient PPASMCs, does
not favor a prominent role of this pathway (2) in SOCE.
According to the research group of Shmuel Muallem, the SOAR region of STIM
interacts separately with the coiled coil domains of either TRPCs or Orai. This in-
teraction allows STIM to interact electrostatically with TRPC1 and therefore gates
TRPC-mediated SOCE [152] [68]. The use of Orai mutants which allow interaction
with STIM but do not mediate Orai-induced SOCE would be an approach to distin-
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Figure 5.1: Four postulated SOCE signaling pathways. 1)STIM/Orai interac-
tion 2) Proposed TRPC-Orai interaction by Lutz Birnbaumer’s research group [71][73]
3) Proposed TRPC-STIM interaction by Shmuel Muallem’s research group [152] [68]
4) Indirect activation of TRPC channels by SOCE proposed by Attila Braun’s re-
search group in platelets [13]
guish between TRPC and Orai-mediated SOCE. However, primary cells are difficult
to transfect and an overexpression of these proteins does not represent the in-vivo
situation. The generation of so called ’knock-in’ mice expressing the Orai-mutants is
highly desirable but a technical difficult and time consuming approach. Therefore, we
used our experimental set-up to challenge their hypothesis. SOCE experiments with
PPASMCs after siRNA mediated down-regulation of Orai1/2/3 or with Orai1/2/3 de-
ficient PPASMCs in comparison to STIM1/2-deficient PPASMCs would be essential
to further investigate their hypothesis.
Thapsigargin-induced SOCE was slightly but significantly reduced in TRPC1/3/6 -/-
PPASMCs compared to wildtype cells (see figure 4.13 and pathway 4 in figure 5.1).
The knockout of both TRPC1/3/6 and STIM1/2 reduced SOCE not significantly
further than STIM1/2∆SMC (see figure 4.13). These results exclude any prominent
role of pathway 2,3 and 4 in SOCE.
However, we did not investigate in our experimental setup if the Orai expression was
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affected by the TRPC1/3/6 knockout. Cheng et al. has reported that the TRPC1
expression was affected by Orai1 knockdown [14]. Therefore, TRPC1/3/6 knockout
mice might express reduced levels of Orai1/2/3 and consequently show decreased
SOCE. Future experiments with siRNA directed against Orai1/2/3 or Orai1/2/3∆SMC
PPASMC in comparison to TRPC1/3/6 -/- PPASMC and STIM1/2∆SMC will clarify
functionally if reduced SOCE in TRPC1/3/6 -/- PPASMC is due to altered expression
of Orai channels.
Our collaboration partner in Würzburg, Attila Braun, collected data for a fourth
signaling pathway in platelets. They demonstrated that thapsigargin-induced Orai
mediated SOCE activates phospholipase C (PLC) and phospholipase D (PLD). PLC
and PLD can in turn activate Ca2+ entry via heteromeric channels of TRPC1 with
TRPC3 and TRPC6 by the production of diacylglycerol (DAG) [13]. According to
them, PLC and PLD activity would be enhanced during thapsigargin-induced SOCE
in Wt but not in Orai-deficient platelets but could not result into TRPC 3 and 6
mediated Ca2+ entry because of the TRPC1/3/6 knockout in PPASMCs. Experi-
ments with siRNA directed against PLC and PLD in wildtype cells will demonstrate
if knockdown of these phospholipases reduces SOCE compared to wildtype cells.
Different from these research groups, we didn’t focus on the molecular setup and
the functional interaction of the TRPC/STIM/Orai but on Ca2+ entry in primary
cells of TRPC1/3/6 -/-, STIM1/2∆SMC and STIM1/2∆SMC/TRPC1/3/6 -/- mice and
Wt control mice. We are the first who are able to study TRPC-dependent SOCE in
PPASMCs from different gene-deficient mice. Previous authors implemented exper-
iments using transfected cell lines or TRPC inhibitors of unknown specificity. The
use of these gene-deficient mice is an important tool to further analyze the role of
TRPC1/3/6 channels and STIM1/2 proteins for ROCE and SOCE in lung cells.
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5.2 Role of SOCE in vasoconstriction, migration,
proliferation and lung edema formation
5.2.1 SOCE and NO-induced vasorelaxation and
vasoconstriction
We bred STIM1/2∆EC and Orai1∆EC mice as outlined in the methods section. Ex-
vivo lungs showed no morphological significant differences in size and distribution of
arterial vessels (see figure 4.17) in comparison to control mice. To analyze SOCE in
endothelial function, we isolated and identified endothelial cells from these mice and
control mice.
NO-mediated vasodilatation is initiated by the Ca2+-sensitive endothelial
NO-synthase [45]. Because SOCE is an important Ca2+ entry pathway in endothe-
lial cells [102] [94], we investigated how STIM1/2 and Orai1-deficiency contributes
to endothelium-induced vasodilatation. We have shown that endothelial-dependent
acetylcholine-induced vasodilatation did not differ in STIM1/2∆EC and Orai1∆EC mice
compared to Wt mice (see figure 4.18). Our results contrast Kassan et al. demon-
strating that STIM1∆EC aortic rings after application of acetylcholine dilatated sig-
nificantly less than heterozygous STIM1∆EC and wildtype aortic rings [61]. If an
endothelial STIM1 knockout results into less vasodilatation, we would have expected
an even stronger impaired dilatation in endothelial STIM1/2 double knockout. This
discrepancy may be due to much higher variation of our data compared to Kassan et
al. which detected significant differences between data points with very low variation.
The reason for high variations in vasorelaxation of up to 25% is not known, but might
be due to different sample preparation and handling. Existing differences in vasore-
laxation of gene-deficient aortic rings compared to control rings might be masked by
these variations. Using a SOCE protocol where internal stores where depleted by
phenylephrine and thapsigargin, the research group of Donald Gill concluded that
aortic rings from STIM1∆SMC showed a reduced SOCE-mediated contraction [83].
Even though thapsigargin and cyclopiazonic acid, which empty internal Ca2+ stores,
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are cell permeable, it is not clear which concentration finally reaches the cytosol of
smooth muscle cells after passing the endothelial layer of the aorta and the contraction
after Ca2+ addition must not necessarily be due to SOCE. Due to these challenges,
we decided not to proceed and canceled experiments on the role of SOCE in vasocon-
striction by pulmonary arterial smooth muscle cells. The same was true for bronchial
rings analyzed in double heterozygous STIM/Orai and control mice (see figure 4.6).
To investigate boncho- or vasoconstriction with a myograph intact bronchial or vascu-
lar rings are a prerequisite. However, quality control from the tissue is difficult and can
only be carried out by KCl-mediated contraction and visual observation. Therefore,
we tried to quantify bronchoconstriction in an alternative precision cut lung slices
(PCLS) model (see figure 4.7). Even though first experiments were promising, we
faced several other difficulties. After seeking advice from PCLS experts, we realized
that the different response of bronchi resulted from the dichotomous branching of the
lung and only the main bronchus can be quantified. A further challenge was the time
of quantification because of constant oscillations of the bronchus. Because we were
originally interested in implementing a SOCE-induced constriction protocol, it was
necessary to exchange extracellular Ca2+ containing and Ca2+-free buffer. However
this was not possible without loosing the position of the bronchus of interest.
Furthermore, it is noteworthy that we used heterozygous mice for initial experiments
in which the STIM1 and Orai1 levels are downregulated only slightly similar to a
STIM1 protein reduction of 11,44%±2,652 in MPMVECs (see figure 4.16). Conse-
quently, we would have been able to detect only huge differences in constriction with
these heterozygous mice. Because only STIM1 but not STIM2 is downregulated in
these mice, STIM2 could also substitute the defect STIM1 protein. The exact role of
STIM2 is still debated [78].
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5.2.2 Reduced proliferation and migration in STIM1/2∆EC and
Orai1∆EC
Bovine aortic endothelial cells treated with SERCA-inhibitors have been reported
to migrate less. Removal of cyclopiazonic acid 6hs after scratch formation rescued
migration measured after 24hs [15]. These results suggest that SOCE plays an impor-
tant role during endothelial migration. In line with this hypothesis, we demonstrated
that STIM1/2∆EC and Orai1∆EC showed a significantly reduced migration compared
to VE-Cre endothelial cells 24hs and 48hs after gap formation (see figure 4.19).
Our result differs from that of Gandhirajan et al. showing that gap closure of
STIM1∆EC was unaltered after 24h [39]. Futher investigation is needed to distinguish
if the reduced migration is a direct effect of reduced SOC-mediated Ca2+ entry or lower
internal Ca2+ store levels resulting from the SOCE defect. Ca2+ which triggers mi-
gration could also originate from the mitochondrium. Santhanam et al. have recently
shown that lack of STIM1 or Orai1 reduced MCU-mediated mitochondrial Ca2+-
uptake in DT40 lymphocytes [120]. Treatment of STIM1/2∆EC and Orai1∆EC with
the MCU inhibitor ruthenium red, a Na+/Ca2+ exchanger inhibitor and a SERCA
inhibitor in a scratch assay could show if Ca2+ originating from the internal stores or
from the extracellular space is responsible for the endothelial migration.
We assumed that similar to migration, proliferation of endothelial cells requires in-
tracellular Ca2+. Therefore, we investigated if proliferation of endothelial cells was
reduced in STIM1/2 and Orai1 deficient MPMVECs isolated from STIM1/2∆EC and
Orai1∆EC mice. The proliferation rate was assessed after 72h using carboxyfluores-
cein succinimidyl ester (CFSE), a dye which after incorporation in proteins, is passed
to the daughter generations and can be quantified by flow cytometry. STIM1/2∆EC
displayed a reduced proliferation rate while proliferation rates of Orai1∆EC were un-
changed (see figure 4.21). Our results for STIM1/2∆EC are in line with Abdullaev et
al. but are in contrast to Orai1∆EC. Abdullaev et al. transfected human umbilical
vein endothelial cells (HUVECs) with siRNA for 72 hrs and stained with trypan blue.
According to his results HUVECs transfected with siRNA specific for STIM 1/2 and
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Orai1 showed a reduced proliferation rate compared to control cells. Moreover, HU-
VECs transfected with siRNA specific for Orai proliferated even less than STIM 1/2
siRNA transfected cells. Different from our experiment for which we used murine
lung microvascular endothelial cells isolated from gene-deficient mice, Abdullaev et
al. used siRNA transfected primary human umbilical vein endothelial cells in which
the protein of interest is downregulated according to the efficiency of the siRNA but
not deleted completely.
Abdullaev et al. also employed a trypan blue exclusion assay. Trypan blue cannot
pass the cell membrane of intact, but of dead cells. An aliquot of the resuspended
cells has to be counted either manually or with a cell counter. In both cases only a
relatively small number of cells is counted and extrapolated to the entire population.
To be precise, trypan blue exclusion assay indicates the viability of cells and one of
the characteristics of viable cells are that they proliferate. In comparison to trypan
blue exclusion, the FACS measurement of CFSE is a more elegant method. During
cell division CFSE is passed from the mother to the daughter cell and thereby the
intensity of CFSE reduces. Subsequently, the intensity of CFSE is a direct marker of
proliferation and not an indirect marker such as trypan blue. Therefore we were able
to analyze 15 000 cells per sample. However as a result of the gene-deficiency during
early development other genes may compensate the lack of the proteins. Further
studies are need to exclude any compensation by up-regulation of related proteins.
Cytosolic Ca2+ is not only essential for migration but also for NO synthesis. In accor-
dance with the lower intracellular Ca2+ levels in STIM1/2 deficient endothelial cells,
the NO-synthase activity may be reduced. A dysfunctional eNOS produces superox-
ide instead of NO. ROS has been shown to trigger SOCE [39] which could stimulate
endothelial migration. Even though Gandhirajan et al. had demonstrated that the
cytosolic superoxide production and NOX levels were unaltered in STIM1∆EC, we ob-
served enhanced mitochondrial superoxide levels in STIM1/2∆EC and Orai1∆EC (see
figure 4.20). Further studies are needed to evaluate if SOCE protects from mitochon-
drial superoxide production and if antioxidant scavenging enzymes are upregulated
in STIM1/2∆EC and Orai1∆EC.
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5.2.3 Reduced nuclear NFAT translocation in endothelial STIM1/2
or Orai1 KO mice and challenges to reproduce
endothelial permeability models
Dysfunctional endothelial cells, induced by bacterial LPS, allow fluid to leak into
the surrounding tissues which results into lung edema formation [99] [116]. Under
non-stimulated conditions, MLC phosphatase dephosphorylates the MLC and con-
sequently prevents opening of the tight junctions. After thrombin stimulation this
preventive mechanism is inhibited [99].
Thrombin stimulation induces stress fiber formation which can be quantified by stain-
ing of F-actin with fluorescence labeled phalloidin. We showed that phalloidin stain-
ing intensities of thrombin-stimulated STIM1+/-/Orai1+/- MPMVECs were reduced
compared to thrombin-stimulated wildtype MPMVECs (see figure 4.22).
The research group of Mohammed Trebak has previously shown that immortalized
HUVECs transfected transiently with siRNA specific for STIM1 were protected from
disruption of the endothelial barrier after stimulation with 100nM thrombin analyzed
by electrical cellular impedance sensing (ECIS). Transfection of HUVECs with Orai-
specfic siRNAs did not show any difference compared to control cells [121]. However,
we failed to establish an ECIS or permeability transwell assay which could have shown
if a SOCE defect in primary MPMVECs protects from endothelial barrier disruption.
The reason for this was the failure of primary MPMVECs to grow completely confluent
and to form tight junctions.
Gandhirajan et al. have shown that STIM1 is essential for NFAT-mediated transcrip-
tion of proinflammatory mediators. NFATc3-GFP transfected STIM1∆EC translo-
cated significant lower amounts of NFATc3-GFP to the nucleus compared to control
MPMVECs expressing NFATc3-GFP. This was further confirmed by significantly re-
duced luciferase activity in STIM1KD MPMVECs compared to wildtype MPMVECs
[39]. Based on these findings the question arose if only STIM1 or both STIM iso-
forms, STIM1 and STIM2, or Orai attenuate the NFATc3 nuclear translocation. Thus,
MPMVECs were transfected with adenovirus encoding NFATc3-GFP for 36 hours,
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followed by LPS treatment for additional 16h [39]. According to our expectations, the
number of VE-Cre MPMVECs with nuclear translocation of NFATc3-GFP after LPS
stimulation was increased compared to unstimulated MPMVECs was increased and
this increase after LPS stimulation was abrogated in LPS-stimulated STIM1/2∆EC
compared to unstimulated STIM1/2∆EC and in LPS-stimulated Orai1∆EC compared
to unstimulated Orai1∆EC. The number of cells with NFATc3-GFP translocated to
nuclei was also significantly reduced in LPS-stimulated STIM1/2∆EC compared to
LPS-stimulated Ve-Cre MPMVECs (see figure 4.23). Comparing our result to Gand-
hirajan et al., we did not observe a different number of NFATc3-GFP translocated
to nuclei in double STIM1/2∆EC or Orai1∆EC compared to the single STIM 1 ∆EC
analyzed [39].
5.3 The influence of mitochondrial Ca2+ uniporter
(MCU) and mitochondrial Ca2+ uniporter
regulator 1 (MCUR1) in endothelial cells on
mitochondrial bioenergetics
MCUR1 was identified as a positive regulator of the MCU complex through its in-
teraction with MCU [81]. We investigated the functional role of MCUR1 during
mitochondrial Ca2+ entry demonstrating that only a nominal mitochondrial Ca2+
uptake was observed in MCUR1∆EC, MCUR1∆MLF and MCU∆MLF (see figure 4.26
and 4.27) while the ∆Ψm was similar compared to cells from floxed or VE-Cre mice
(see figure 4.25). These results support our previous data demonstrating that both
MCU and MCUR1 are essential for the MCU-mediated Ca2+ uptake in a HeLa cell
line stably overexpressing MCUR1 [81]. Overexpressing MCUR1 HeLa cells showed
an enhanced histamine-stimulated mitochondrial Ca2+ uptake and this uptake was
abrogated after knockdown of MCU in the MCUR1 overexpressing cells. Vise versa,
overexpression of MCU elevated mitochondrial Ca2+ uptake in wildtype but not after
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down-regulation of MCUR1 [81].
Simultaneous recording of [Ca2+]m uptake and ∆Ψm discovered that both MCU
∆EC
and MCUR1∆EC failed to take up Ca2+ (see figure 4.29 and 4.28). Upon exposure to
excessive Ca2+, the VE-Cre cells exhibited a rapid ∆Ψm collapse due to mitochondrial
Ca2+ entry, which was not observed in MCU∆EC and MCUR1∆EC MPMVECs (see
figure 4.29). Basal [Ca2+]m was reduced in in MCU
∆EC and MCUR1∆EC compared
to VE-Cre MPMVECs (see figure 4.28).
These results confirm our previous data showing that permeabilized MCUR1KD HeLa
or HEK293T cells display a reduced Ru360 (MCU blocker)- and CCCP (uncoupler)-
sensitive mitochondrial Ca2+ uptake after 10 µM Ca2+ pulses. Overexpression of
MCUR1 in HeLa cells rescued the mitochondrial Ca2+ uptake. Basal mitochon-
drial Ca2+ was reduced in HEK293T cells expressing downregulated levels of MCUR1
(MCUR1KD) indicated by the mitochondrial Ca2+ release after the addition of car-
bonyl cyanide 3-chlorophenylhydrazone (CCCP). Basal mitochondrial Ca2+ levels
were enhanced after rescue of MCUR1. Overexpression of MCUR1 in MCU knock-
down cells and vise versa demonstrated a requirement of both MCU and MCUR1 for
the mitochondrial Ca2+ uptake [81]. Luongo et al. reported that murine embryonic
fibroblasts isolated from floxed MCU mice, infected with adenoviral Cre-recombinase
(MCU∆MLF), showed nearly a complete loss of mitochondrial Ca2+ uptake after 5 µM
Ca2+ pulses [76].
Moreover, our group was able to characterize MCUR1 as MCU complex scaffold
factor. MCUR1 and MCU interact via their highly conserved coiled-coil domains. A
lack of MCUR1 resulted into defective MCU heterooligomeric complex assembly and
suppressed the IMCU current in isolated cardiac mitoplasts [132].
The impact of MCUR1 and MCU on the mitochondrial bioenergetics has not been
investigated yet in primary cells. Based on the finding that perturbed [Ca2+]m uptake
may lead to a cellular bioenergetic crisis [85] [120], we investigated ATP levels of
MCU∆EC and MCUR1∆EC. ATP levels were reduced in both, but significant smaller
in MCUR1∆EC than in MCU∆EC (see figure 4.30). These data confirm previous results
showing an enhanced AMP/ATP ratio, and therefore a reduced ATP production, in
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HeLa cells with downregulated expression levels of MCUR1 [81]. Our group further
examined whether agonist-induced [Ca2+]m uptake affects ATP levels in MCUR1
∆EC
and MCU∆EC. VE-Cre MPMVECs stimulated with the GPCR agonist thrombin
(500mU/ml) showed increased ATP levels compared to MCUR1∆EC [132].
We next analyzed if reduced ATP levels resulted directly from decreased mitochon-
drial Ca2+ levels or from an impaired function of the respiratory chain complexes.
Oxygen consumption rate (OCR) measurements with the Clark electrode and the
XF-96 Extracellular Flux AnalyzerTm revealed an elevated complex I and II activity
in MCU∆EC (see figure 4.31) and an enhanced maximal respiration rate after addition
of the uncoupler FCCP in MCU∆EC and MCUR1∆EC (see figure 4.33). But theses
results are in contrast to previous data showing that the basal OCR was reduced in
MCUR1KD HeLa but the maximal OCR after addition of FCCP was not significantly
different from control cells. The rescue of MCUR1 resulted into comparable maxi-
mal OCR levels compared to control cells [81]. However, the previous results were
obtained in a human cancer cell line while we used murine primary endothelial cells
now. Therefore, it has to be taken into account that different cellular properties may
influence the results.
The research group of T. Finkel showed that murine embryonic fibroblasts isolated
from MCU KOmice had a similar maximal OCR as wildtype fibroblasts after addition
of FCCP [93] and that hepatic mitochondria isolated from MCU KOmice treated with
complex I substrates glutamate and malate displayed similar levels of respiration as
wildtype mitochondria. The basal oxygen consumption of the MCU KO mice was not
altered. Serum lactate levels were elevated but not other TCA intermetabolites such
as succinate, malate, fumarate and citrate [93]. Proteins of mitochondrial oxidative
phosphorylation components were equally expressed in MCUR1∆EC, MCU∆EC and
VE-Cre MPMVECs (see figure 4.32). Consequently, we conclude from our results,
that OCR is intact in MCU∆EC and MCUR1∆EC.
The enhanced maximal respiration rate in MCUR1∆EC and MCU∆EC could indicate
an utilization of the proton gradient that prevents ∆Ψm hyperpolarization. An un-
changed ∆Ψm in MCUR1
∆EC, MCU∆EC would support this hypothesis. Similar to
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us, Mallilankaraman et al. had shown that HeLa cells with down-regulated MCUR1
did not show an altered ∆Ψm compared to wildtype cells [81].
Dissipation of the proton gradient without involvement of the ATP-synthase is facili-
tated by uncoupling proteins (UCPs) or adenine nucleotide transporters (ANTs). H+
enters the matrix and consequently decreases ∆Ψm [63]. The proton gradient which
is not used for ATP production, would be used for heat generation by UCP proteins
instead. Therefore, UCP, especially its main isoform expressed in endothelial cells
UCP2 [127], could be responsible for the higher heat dissipation of MCUR1∆EC mice.
According to our hypothesis, UCP2 protein levels were upregulated (see figure 4.35)
in MCUR1∆EC. We therefore concluded that upregulation of UCP2 is a compen-
satory mechanism to MCUR1 deficiency and UCP2 fluxes protons to prevent ∆Ψm
hyperpolarization.
However, other groups have presented data which argues against the role of UCP2
in uncoupling [66][119]. They suggest that UCP2 promotes a metabolic switch which
limits the contribution of glucose to OCR and promotes the oxidation of substitute
substrates such as glutamine and fatty acids [139]. We observed an elevated extra-
cellular acidification rate (ECAR) in in MCU∆EC and MCUR1∆EC after addition of
oligomycin (see figure 4.34). Oligomycin inhibits mitochondrial ATP production and
therefore shifts metabolically the energy production to glycolysis [113]. From this re-
sult we could speculate that MCUR1∆EC MPMVECs, in which UCP2 is upregulated,
depend more on glycolysis than MPMVECs with normal level of UCP2. Endothe-
lial cells mainly use glucose, fatty acids and glutamine as substrates and glucose for
glycolysis but not for oxidative phosphorylation even when oxygen is present [100].
Because of this substrate demand, MPMVECs were grown in our experiments in high
glucose medium containing 4.5 gml−1 glucose and 4mM glutamine. As an alternative
to this hypothesis MCUR1∆EC MPMVECs, in which UCP2 is upregulated, might uti-
lize substrates which fuel complex I, pyruvate and maleate, or complex II substrate
succinate better as indicated by the enhanced OCR (see figure 4.31). We further ob-
served an AMP-kinase (AMPK) activation in MCU∆EC and MCUR1∆EC which was
abrogated by a rescue of MCU and MCUR1(see figure 4.39). AMPK is activated dur-
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ing energy deprivation indicated by low ATP levels and induces catabolic pathways
[48].
A third approach, postulated by the Graier group, claims that UCP2 is involved in
[Ca2+]m uptake [140] [22] [7]. In a Nature cell biology paper, the Graier group has
demonstrated that UCP2 overexpression in the human endothelial cell line EA.hy926
significantly enhanced [Ca2+]m stimulation by histamine. SiRNA-mediated knock-
down of UCP2 reduced [Ca2+]m levels to levels in control cells [134]. However, their
results were controversially discussed by Matthijnssens et al. They criticized that
the observed higher [Ca2+]m levels were not due to mitochondrial Ca
2+ uptake or
efflux mechanisms but rather due to a defective UCP2 protein expressed in abnormal
high levels. Alternatively, they suggest that UCP2 could mediate the Na+/Ca2+ or
H+/Ca2+ exchangers [84]. In 2013, Sancak et al. demonstrated the absence of a direct
interaction between UCP2 and MCU in a proteomic assay [110].
Recent studies on cardiac mitochondria isolated from UCP2-/- mice showed that the
Ru360 sensitive [Ca2+]m was significantly reduced. Measuring the Ru360 sensitive
current in cardiac mitoplast from UCP2-/- mice revealed a reduced channel activity
compared to control mitoplasts [88]. In 2015, the Graier group presented results
that overexpression of UCP2 enhanced the open probability of extralarge mitoplast
Ca2+ currents but did not result in an additional mitoplast Ca2+ current indicating
that UCP2 does not form a new Ca2+ channel itself. SiRNA-mediated knockdown of
UCP2 HeLa cells reduced the open probability of extralarge mitoplast Ca2+ currents
[7].
According to this hypothesis, UCP2 is upregulated in MCUR1∆EC as a compensatory
mechanism to rescue [Ca2+]m-uptake. However, in our experiments, MCUR1
∆EC
showed only a nominal [Ca2+]m uptake after stimulation with ionomycin. Only ex-
periments with double knockout cells for MCUR1 and UCP2 will reveal if [Ca2+]m
uptake is abolished completely after stimulation by agonists.
Superoxide is mainly produced if oxygen is used prematurely during the electron
transport chain [47] [20]. It has been proposed that ROS promotes autophagy and
apoptosis [60]. Our group has previously demonstrated that loss of the negative MCU
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regulator MICU1 induces basal mitochondrial Ca2+ accumulation and increased mi-
tochondrial ROS production [82]. Intact OCR levels in MCUR1∆EC and MCU∆EC
suggest that electron leakage does not occur more often than in control cells and
superoxide levels are expected to be unchanged. But also downregulation of several
proteins involved in the MCU-mediated mitochondrial Ca2+ uptake have demon-
strated to influence superoxide production [49] [82]. According to our expectation,
superoxide levels were not elevated in MCUR1∆EC and MCU∆EC (see figure 4.36).
Presumably, due to reduced mitochondrial Ca2+ levels, basal superoxide formation
was even reduced in MCUR1∆EC and MCU∆EC (see figure 4.36).
If UCP2 acts as an uncoupler, the UCP2 upregulation in MCUR1∆EC may explain the
observed reduced ROS production. This hypothesis would be supported by Szewczyk
et al.[127] who has reported that high UCP2 levels protect from ROS overproduc-
tion. Teshima et al. reported that high UCP2 levels prevented from oxidative-
stress induced cell death. They added H2O2 to cardiomyocytes which increased the
fluorescence of the cellular oxidative stress marker DCF (2’,7’-dichlorofluorescein).
Cardiomyocytes stably overexpressing adenoviral UCP2 showed significantly reduced
DCF fluorescence levels after H2O2 stimulation [131].
Alternatively, MCUR1 and MCU deficiency might affect adenine nucleotide trans-
porters (ANT) expression. Besides UCP, ANT also dissipates the proton gradient
without involvement of the ATP-synthase [63]. Thus, it would be of interest if ANT
levels are upregulated in MCUR1∆EC and MCU∆EC. Furthermore, silencing of UCP2
and ANT in MCUR1∆EC and MCU∆EC may show if UCP2 and ANT or the lack
of Ca2+ is responsible for the low levels of superoxide production. Investigation of
antioxidant enzymes could highlight if ROS is produced but scavenged or if less ROS
is produced in MCUR1∆EC and MCU∆EC. If Ca2+ is required for ANT activity is not
known.
Moderate levels of ROS have been proposed to be essential for cell proliferation and
migration [47]. In accordance with lower superoxide production and mitochondrial
Ca2+ uptake, we observed a reduced proliferation and migration in MCUR1∆EC and
MCU∆EC (see figure 4.21 and 4.37). If upregulation of UCP2 has an effect on pro-
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liferation and migration in endothelial cells is not clear but UCP2 has been reported
to play a role in the Warburg effect describing the capability of fast-proliferating
cancer cells to switch their metabolism from oxidative phosphorylation to anaerobic
glycolysis [139]. Further investigation is needed on MCU1- and MCUR1-deficient en-
dothelial cells overexpressing UCP2 to reveal if they have an altered migration and
proliferation.
Low mitochondrial Ca2+ uptake and low cellular ATP levels in MCUR1∆EC and
MCU∆EC activated AMPK and turned on autophagy, as indicated by enhanced
microtubule-associated protein light chain 3 (LC3) expression (see figure 4.39). The
elevated levels of phosphorylated AMPK and LC3 was abrogated after rescue of
MCUR1 and MCU (see figure 4.39). Our data obtained with murine primary en-
dothelial cells confirmed our previous results demonstrating enhanced phosphorylated
AMPK and LC3-II protein levels which were again normal after rescue of MCUR1
expression in the human MCUR1 KD HeLa cell line. This clearly demonstrates that
MCU and MCUR1 have an essential function during autophagy. However, we do not
know if autophagy is induced by the lack of Ca2+ uptake or the lack of MCUR1 and
MCU itself.
MacVicar et al. have already investigated the role of intracellular Ca2+ and MCU
in a Parkin-induced mitophagy model [77]. Parkin is an ubiquitin E3 ligase which is
recruited to depolarized mitochondria and induces mitochondrial autophagy, called
mitophagy. To deplete the cytosol from Ca2+, MacVicar et al. treated YFP-Parkin
expressing RPE1 cells with 10µM BAPTA-AM (a cell-permeant chelator, which is a
highly selective for Ca2+ over Mg2+) to buffer cytosolic Ca2+. BAPTA-AM blocked
CCCP-induced mitophagy dose dependently. Transient MCU or IP3R knockdown
of YFP-Parkin expressing RPE1 cells treated with 10 µM CCCP for 24hs showed
reduced mitophagy [77]. They conclude that an intact MCU-mediated Ca2+-uptake
would predispose cells to mitophagy and that reduced mitochondrial Ca2+ levels could
have an inhibitory effect on Parkin-mediated mitophagy.
These data clearly contrasts our result showing that a lack of MCU makes endothelial
cells more vulnerable to autophagy. However, one has to keep in mind that the
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CCCP they used for their experiments induces a collapse of the ∆Ψm and a reduced
mitochondrial Ca2+ uptake. Different from our autophagy model in murine primary
endothelial cells, they used a Parkin-induced mitophagy model in the human retinal
pigment epithelial cell line RPE1. Therefore, only a detailed further analysis will
reveal the role of Ca2+ and its downstream targets in autophagy pathways.
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Chapter 6
Appendix
6.1 Acronyms
∆Ψm mitochondrial membrane potential.
acetyl-CoA acetyl coenzyme A.
AMPK AMP-activated protein kinase.
ANT adenine nucleotide transporters.
BH4 tetrahydrobiopterin.
CaMKK calmodulin-dependent protein kinase kinases.
CFSE 5-(and-6)-carboxyfluorescein diacetate succinimidyl ester.
cGMP cyclic guanosine monophosphate.
CPA cyclopiazonic acid.
CRAC Ca2+ release-activated Ca2+ current.
DAG diacylglycerol.
ECAR extracellular acidification rate.
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ECIS Electrical Cell-Substrate Impedance Sensing.
ECM extracellular medium.
eNOS endothelial NOS.
ER endoplasmatic reticulum.
ES embryonic stem.
FAD flavin adenine dinucleotide.
FMN flavin mononucleotide.
GqPCR Gq protein coupled receptor.
HDMECs human dermal microvascular endothelial cells.
HUVECs human umbilical vein endothelial cells.
ICAM1 intercellular adhesion molecule 1.
IMM inner mitochondrial membrane.
IP3 inositoltriphosphate.
IPAH idiopathic pulmonary arterial hypertension.
LC microtubule-associated protein light chain.
LPS lipopolysaccharide.
MCU mitochondrial Ca2+ uniporter.
MCUR1 mitochondrial Ca2+ uniporter regulator1.
MICU1 mitochondrial calcium uptake 1.
MLC myosin light chain.
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MLCK myosin light chain kinase.
MLF murine lung fibroblasts.
MPMVEC mouse pulmonary microvascular endothelial cells.
Myh11 myosin heavy chain 11.
NADH nicotinamide adenine dinucleotide.
NADPH nicotinamide adenine dinucleotide phosphate.
NFAT nuclear factor of activated T-cells.
NOS nitrite oxide synthase.
NOX NADPH oxidase.
OCR oxygen consumption rate.
PA phosphatidic acid.
PAH pulmonary arterial hypertension.
PAP phosphatidic acid phosphohydrolase.
PCLS precision cut lung slices.
PIP2 phosphatidylinositol 4,5-bisphosphate.
PLC phospholipase C.
PLD phospholipase D.
PPASMC precapillary pulmonary arterial smooth muscle cells.
PTP permeability transition pore.
Rho–GEF guanine nucleotide exchange factor.
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ROC receptor operated Ca2+.
ROS reactive oxygen species.
SCID severe combined immunodeficiency.
Ser serine.
SERCA sarcoplasmic/endoplasmic reticulum ATPase.
SOAR STIM-Orai activating region.
SOC store-operated Ca2+.
STIM stromal interaction molecule.
tBH3 trihydrobiopterin.
TCA tricarboxylic acid cycle.
TLR4 Toll-like receptor4.
TMRM tetramethyl rhodamine methyl ester.
TRP transient receptor potential.
TRPC classical transient receptor potential.
TSMC tracheal smooth muscle cells.
UCP uncoupling proteins.
VCAM1 vascular cell-adhesion molecule 1.
VEGF vascular endothelial growth factor.
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